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Abstract 
Endometrial glands provide histiotrophic support for the developing conceptus prior 
to the onset of the haemochorial placenta. Several lines of evidence suggest that 
glands also play an important role in endometrial receptivity, decidualization of the 
stromal compartment, and in maternal immune tolerance during pregnancy. However, 
glandular epithelial cells isolated during the luteal phase become acutely arrested in 
vitro, precluding in-depth analysis of this cellular compartment of the human 
endometrium. In this thesis, I tested various approaches to overcome the 
senescence-associated cell cycle block of primary human endometrial epithelial cells 
(HEECs). I demonstrate that conditional reprogramming of HEECs, using conditioned 
medium of irradiated fibroblast and a Rho kinase inhibitor (Y-27632), partially 
reverses the senescent phenotype and enables expansion of primary HEEC cultures. 
However, the responsiveness of reprogrammed HEECs to embryo-derived signals 
and hormonal cues remained highly variable. To overcome this hurdle, I used a novel 
3D culture system that enabled formation of glandular structures from clonal HEECs 
seeded in Matrigel and cultured in modified adult stem cell medium. Treatment of 
glandular organoids with cyclic AMP and steroid hormones induced the expression of 
PAEP, a glandular differentiation marker. Organoid-forming efficiency experiments 
revealed that missed miscarriage, characterized by early-onset foetal growth 
retardation, is associated with glandular progenitor cell deficiency. To validate this 
observation, I used laser capture microdissection coupled to RNA-sequencing to 
compare mid-luteal glandular gene expression between missed miscarriage cases 
and control subjects. Gene ontology analysis of differentially expressed genes 
revealed that miscarriage may be caused by bioenergetics defects in the glands, 
exemplified by altered expression of mitochondrial-related genes. Taken together, the 
ability to grow and differentiate endometrial glands from isolated clonal HEECs 
provides a powerful new tool to study the mechanisms underpinning reproductive 
failure.  
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1.1 The Human Endometrium 
The endometrium is the inner mucous membrane that lines the uterine cavity. This 
complex tissue provides a receptive environment for embryo implantation in the 
maternal organism. Many cell types take part in its composition. Simple columnar 
epithelial cells comprise the organ lumen coating, and the tubular glands extend from 
the surface epithelium to the endometrial-myometrial interface. Underlying the luminal 
epithelium, and surrounding the glands, the endometrial stroma consists of a 
balanced assortment of different cell types. Specialized fibroblasts that undergo 
mesenchymal-to-epithelial differentiation in every menstrual cycle are the main 
components (Brosens et al., 1999). Immune cells, such as natural killer cells, 
macrophages, T cells and granulocytes also reside in this endometrial compartment 
(Lee et al. 2011). Basal and spiral arteries with their endothelial cells and stem-like 
perivascular cells are also present in the stroma (Masuda et al., 2012). From the 
histophysiological aspect, the endometrium consists of two distinct layers. The 
superficial transient and dynamic functionalis, which is shed during menstruation, and 
the deeper persistent basalis, which contains the glandular fundi, and from which the 
post-menstrual regeneration process arises (Figure 1.1). 
The plasticity of the endometrium is extraordinary, alternating regeneration, 
proliferation, differentiation and sloughing. The whole sequence occurs in mean 28 
day intervals, and a woman is expected to have around 400 menstrual cycles during 
her reproductive life (Collins, 1985). These cyclic changes are tightly regulated by the 
secreted ovarian steroid hormones progesterone (P4) and oestradiol (E2). There is a 
gradient of responsiveness to these hormones across the endometrial layers, the 
upper portions undergoing marked progression of histological changes, while the 
basal compartment exhibits only subtle alterations. 
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Figure 1.1 Cartoon of the endometrium with the different cell types and spiral 
arteries. The endometrium comprises the epithelial and stromal compartments.  
 
The regeneration process is initiated by progenitor cells, through asymmetric division, 
producing the differentiated cells for uterine cavity reepithelization. The first evidence 
for the existence of human endometrial epithelial and stromal progenitor cells was 
described by Chan et al. (2004). The authors demonstrated the presence of 0.22 % 
clonogenic cells amongst the endometrial epithelial population and 1.25 % amongst 
stromal cells. Other properties of stem cells, such as self-renewal and pluripotency 
were also demonstrated later (Gargett et al., 2016). More recently, the identification 
of progenitor cell markers allowed the use of magnetic and fluorescent separation for 
their isolation and phenotyping (Masuda et al., 2012, Valentijn et al., 2013, Murakami 
Epithelial cell Stromal cell Immune cell 
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et al., 2014). Initially, it was believed the endometrial stem-like cells would reside 
exclusively in the basalis, but progenitor cell niches were also later detected in the 
functionalis (Schüring et al., 2011, Valentijn et al., 2013).  
1.2 The Dynamics of Endometrium, During the Menstrual Cycle  
The endometrium is one of the main target tissues of sex steroid hormones. Cycles 
of proliferation, differentiation, shedding and regeneration take place monthly, during 
the reproductive lifespan, in response to fluctuating serum levels of P4 and E2, with 
the purpose of preparing for embryo implantation. Specific changes occur in the 
epithelial and stromal compartments, and a striking cross-talk between these 
endometrial compartments is critical for the normal cycling and function. The length 
of the menstrual cycle is variable, and actually, only 10% of women have a typical 28 
day cycle. The follicular phase accounts for most of the variability, ranging from 10 to 
23 days (Mihm et al., 2011). 
1.2.1 Proliferative Phase 
The first day of menstrual bleeding is considered day 1 of the menstrual cycle. During 
the proliferative phase of the endometrium, which corresponds to the follicular phase 
of the ovaries, increasing levels of granulosa cell-synthesized E2 induce proliferation 
in glands and stroma. The thickness of the endometrium changes from less than 2 
mm to 7 mm, from the beginning to the end of the proliferative phase (Hawkins and 
Matzuk, 2008). The regeneration is triggered by E2, and starts from the basalis. The 
luminal epithelium (LE) is completely restored by day 5, and no scarring is observed. 
The stromal and epithelial progenitor cells may contribute for this phenomenon 
(Gargett and Masuda, 2010). 
In the early proliferative phase, glands are narrow, straight and tubular, and are 
comprised of low columnar epithelial cells. Later, they become tortuous and more 
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convoluted, columnar cells are higher, and sub-nuclear vacuoles are occasionally 
observed. Also in the late proliferative phase, the stroma is densely cellular, and by 
the pre-ovulatory period, oedema starts to develop in this compartment. Ciliation in 
focal areas on the luminal epithelium is also present, right before the secretory phase. 
E2-driven proliferation peaks between days 8 and 10. With the luteinisation of the 
dominant follicle, by increasing secretion of luteinizing hormone (LH), serum P4 levels 
rise, inhibiting the mitogenic effects of E2 in the pre-ovulatory period (Archer et al., 
1991).  
The actions of the sex steroids in the endometrium are carried out through binding of 
these ligands to their cognate nuclear receptors, oestrogen receptor (ER) and 
progesterone receptor (PR).  
There are two isoforms of ER: ERα and ERβ, encoded by two distinct genes. ERα is 
the predominant isoform expressed in the endometrium, and is sufficient to trigger 
endometrial proliferation (Hewitt et al., 2003). ERα is highly expressed in glands and 
stroma during the proliferative phase, with a dramatic decline in the secretory phase 
(Brenner et al., 1990). Upon ligand binding, ERα induces cell cycle progression by 
activation of the PI3K/AKT pathway and hyperphosphorylation of retinoblastoma 
protein (Rb) and p107 proteins, activating the DNA replication machinery for entry in 
the S-phase (Chen et al., 2005; Wang et al., 2007). The effects of E2 in epithelial 
proliferation is mediated by a paracrine action of stromal ERα (Cooke et al., 2007), 
while epithelial ERα is suggested to prevent apoptosis (Winuthayanon et al., 2010).  
Increasing levels of E2 in the late follicular phase trigger the mid-cycle LH surge, 
leading to ovulation, which marks the beginning of luteal phase in the ovary and the 
secretory phase in the endometrium.  
 
 
6 
 
1.2.2 Secretory Phase 
After ovulation, the dominant follicle, now known as the corpus luteum (CL), 
progressively increases P4 secretion in response to LH. The effects of P4 will prevail 
during the secretory phase, counteracting the mitogenic effects of E2. P4 also drives 
the striking changes observed in the stroma and the secretory function of the glands.  
There are two isoforms of PR: PRA and PRB, both encoded by the same gene. PRA 
is the predominant functional variant in the endometrium. The expression of PR is 
higher during proliferative phase, markedly decreasing in secretory phase. PR 
expression is induced by E2 and inhibited by P4 (Moutsatsou and Sekeris, 2006). 
Ablation of murine PR resulted in endometrial epithelial hyperplastic response to E2 
and P4 (Lyndon et al., 1995; Kurita et al. 1998). Specific knockout of PRA also 
produced epithelial proliferation upon P4 treatment, and the proliferation was 
demonstrated to be dependent on PRB (Mulac-Jericevic et al., 2000).  
The anti-proliferative actions of P4 in the epithelial compartment occur in a paracrine 
manner, through stromal PR. Heart and neural crest derivatives expressed 2 
(HAND2) is a P4 regulated gene in the stroma, and it downregulates fibroblast growth 
factor (FGF) expression. FGF binds to FGF receptor in the epithelial cells to activate 
extracellular signal-regulator kinase (ERK) 1 and 2 or the phosphoinositide 3-
kinase/protein kinase B (PI3K/AKT) pathways, both involved in epithelial proliferation 
(Li et al., 2011). Another indirect mechanism for P4 is the induction of 17β-
hydroxysteroid dehydrogenase type 2 (17β-HSD2) in the epithelium, through binding 
to stromal PR. This enzyme catalyses the conversion of E2, a potent oestrogen, into 
oestrone, a weak form, thereby reducing the proliferative effects of E2 (Yang et al., 
2001). A direct effect on epithelial PR is also described in murine endometrium. Upon 
ligand binding, epithelial PR induces the expression of Krüppel-like factor (KLF) 15, 
which, in turn, negatively regulates E2-induced epithelial cell proliferation, by 
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inhibition of mini-chromosome maintenance protein 2 (Mcm2) expression (Ray and 
Pollard, 2012). MCM2 is required for initiation of DNA synthesis. Epithelial PR also 
affects stromal functions: at least in mice, the selective knockdown of epithelial Pgr 
resulted in infertile mice and lack of decidualization (Franco et al., 2012).   
Accumulation of glycogen rich sub-nuclear vacuoles in the columnar cells of the 
glands can be detected in early secretory phase. Later, these vacuoles shift to a 
supra-nuclear position, and by the peak of secretory activity in the mid-secretory 
phase, they are lost into the glandular lumen and are absorbed by the embryo 
(McCluggage, 2011). A spherical stack of interdigitating nuclear tubules can be 
observed in 5% of the epithelial cells in the mid-secretory phase. This structure, 
named nucleolar channel system (NCS), has only been described in the 
endometrium. Its role is still elusive. It has been suggested that the blastocyst would 
select a cluster of luminal cells containing NCS for apposition (Isaac et al., 2001). An 
enlargement of mitochondria with prominent cristae (Armstrong et al., 1973) is also 
present in epithelial cells.   
In the stromal compartment, oedema is marked, and pronounced changes develop in 
the mesenchymal cells, in the mid-secretory phase. The cells around the blood 
vessels are enlarged, present an eosinophilic cytoplasm, and an extracellular matrix 
(ECM) is easily identified. These alterations progressively extend to the sub-epithelial 
cells, and later, becomes a global event in the stroma. The changes are referred to 
as decidualization, and occur in response to the rising levels of serum P4 and local 
secretion of cyclic adenosine monophosphate (cAMP; Gellersen and Brosens, 2003). 
The stromal cells shift to a secretory phenotype. An influx of specialized uterine 
natural killer (uNK) cells, also starting around the blood vessels, is observed in the 
mid-secretory phase. This phase is the endometrial receptive period, when a 
supportive environment is created to accommodate the implanting blastocyst.  
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In the late secretory phase, serum levels of P4 gradually decrease, leading to 
regression of gland secretion and inflammation process in the stroma, culminating in 
menstruation.  
1.2.3 Menstruation 
If pregnancy does not ensue, CL function declines, resulting in decreasing levels of 
P4 in the late secretory phase. That triggers the cascade of molecular and cellular 
interactions that result in epithelial and stromal breakdown, and eventually, 
menstruation. There is glandular collapse, bestowing them a serrated appearance. 
The stroma is condensed, presenting tight aggregates of stromal cells with 
hyperchromatic nuclei, the so called ‘stromal blue balls’ (McClugagge, 2011). 
Decidual cells lose their enlarged round features. An influx of neutrophils and 
monocytes can be observed in the premenstrual period, along with interstitial 
haemorrhage and fibrin deposition, and uNK cells undergo apoptosis. In the glands, 
both the NCS and the giant mitochondria disappear (McClugagge, 2011). 
Inflammation is initiated by activation of nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-ƙB) pathway, with increased secretion of several mediators:  
interleukin (IL) 8, monocyte chemotactic protein 1 (MCP1), cyclooxygenase 2 (COX2), 
IL6, IL1, IL33, granulocyte-macrophage colony-stimulating factor (GM-CSF) (Evans 
and Salamonsen, 2014). Matrix metalloproteases (MMP) are mainly secreted by the 
infiltrating neutrophils. The enzymes catabolize ECM, collaborating in stromal 
collapse. Vasoconstriction of spiral arteries is induced by prostaglandin F2α (PGF2α) 
and endothelins. Fibrinolysis is activated in the late secretory phase. Tissue 
plasminogen activator (tPA) and urokinase plasminogen activator (uPA) are up-
regulated and their inhibitor PAI1 (plasminogen activator inhibitor 1) is downregulated 
during the period. Apoptosis is observed in the functionalis, with high expression of 
caspases 3, 8 and 9, and translocation of forkhead box protein O1 (FOXO1) to the 
nucleus. Conversely, BCL-2, an anti-apoptotic molecule, is expressed in the basalis 
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(Henriet et al., 2012). Interestingly, exogenous P4 can only reverse the process within 
the first 36 hours of P4 withdrawal. This suggests that menstruation is initiated by P4 
withdrawal-induced vasoconstriction and inflammatory response. However, in a 
second phase, the released chemokines attract the leukocytes which secrete MMP, 
leading to ECM breakdown and tissue collapse (Slayden and Brenner, 2006). Another 
remarkable fact is that spontaneous decidualization always precedes the cyclic 
shedding of the endometrium in menstruating species, linking these two phenomena 
(Brosens and Blanks, 2013).   
Normal function of the coagulation system is required to cease the menstrual 
bleeding. Tissue factor-derived thrombin and von Willebrand factor interaction with 
platelet glycoproteins act together to form the fibrin plugs that prevent excessive blood 
loss (Davies and Kadir, 2012).  
The inflammation must be self-limiting to avoid excessive tissue injury. The pro-
inflammatory cytokine IL1 induces expression of 11β hydroxysteroid dehydrogenase-
1 (11βHSD1). This enzyme catalyses the conversion of cortisone into cortisol, a 
glucocorticoid that is a potent inhibitor of the inflammatory response. The 
glucocorticoid receptor is expressed in the stromal compartment, including leukocytes 
and endothelial cells. MMP activity is also limited during the menstruation to avoid 
uncontrolled local damage. Tissue inhibitors of MMP (TIMPs), protease inhibitor α2-
macroglobulin and low-density lipoprotein receptor-related protein-1 (LRP1) are 
involved in the repression of MMP activity (Maybin and Critchley, 2015).   
After the tissue detachment and sloughing of the functionalis, regeneration must be 
attained. Reepithelization of the endometrial surface and blood vessel regrowth are 
the main events involved in the endometrial repair. Stem-like cells in the gland stumps 
of the basalis are likely to be involved in the restoration of the surface epithelium 
(Gargett et al., 2016), but mesenchymal-to-epithelial transition has also been 
described (Gary et al., 2009, Patterson et al., 2013). This initial process is 
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independent of oestrogen stimulation (Bigsby, 2002, Kaitu’u-Lino et al., 2010). Blood 
vessel repair involves hypoxia-inducible angiogenic factors, such as hypoxia-
inducible factor 1 (HIF1), angiopoeitins, vascular epithelial growth factor (VEGF), 
platelet-derived growth factor (PDGF) and FGF, some of them known to have 
mitogenic effects on endometrial epithelial cells (Jabour et al., 2006, Maybin et al., 
2011).  
With the regeneration of the functionalis layer and rising levels of E2 secreted by the 
ovarian follicles, endometrial proliferation is resumed, and a new menstrual cycle 
begins.  
 1.3 Human embryo implantation 
Implantation is a complex process comprising a highly co-ordinated crosstalk 
between the embryo and the uterus, as well as communication amongst the 
endometrial compartments (epithelium, stroma and, possibly, myometrium). This 
phenomenon is believed to involve a precisely timed arrival of a competent blastocyst 
into a uterine cavity lined by a receptive endometrium. Due to ethical concerns and 
technical limitations, most of our knowledge on this issue derives from animal 
research, predominantly from mouse knock-out studies. 
1.3.1 Embryo Implantation Steps 
After oocyte fertilization, exponential cell division occurs simultaneously with 
establishment of cell polarity and compaction of blastomeres, to produce a morula. 
Between 4 and 5 days after fertilization, the development of a cavity within the cell 
bulk, and the differentiation of two cell lineages, the outer specialized trophoectoderm 
and inner cell mass (ICM), defines the blastocyst phase. The late phase blastocyst 
develops two other cell types from the ICM: the epiblast and the primitive endoderm 
(Cockburn and Rossant, 2010). Next, the blastocyst hatches from the zona pellucida, 
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before initiating the implantation process. Serine proteases seem to be crucial for 
hatching (Lin et al., 2001, O’Sullivan et al., 2001). The blastocyst enters the 
endometrial cavity, approximately 5 days after fertilization, and the phases of 
implantation unfold (Wang and Dey, 2006).  
1.3.1.1 Apposition 
Before initial adhesion to the luminal epithelium, the human blastocyst orients itself 
with the trophoectoderm overlying the ICM apposing to the endometrium. The embryo 
approaches and becomes loosely adhered to the uterine wall on the implantation site. 
At this stage in mice, intact blastocysts can be retrieved by uterine flushing (Su and 
Fazleabas, 2015). The dialogue between conceptus and endometrium drives this 
sequence. Many chemokines such as monocyte chemoattractant protein 1 (MCP1), 
IL8 and regulated on activation, normal T cell expressed and secreted (RANTES) are 
produced by the blastocyst during this phase (Caballero-Campo et al., 2002). L-
selectin mediates initial adhesion to the endometrial epithelium through MECA-79 
and HECA 452, its carbohydrate ligands (Fukuda and Sugihara, 2008). MUC1 acts 
as a scaffold for L-selectin ligands. MUC1 is an anti-adherent glycoprotein present on 
the epithelial surface of the endometrium, inhibiting cell-cell and cell-matrix adhesion. 
MUC1 is up-regulated in humans during the mid-secretory phase. However, it was 
demonstrated that it disappears at the implantation site (Meseguer et al., 2001, 
Thathian and Carson, 2004). Some proteases (MMP14 and ADAM17) are involved in 
this clearance of apical surface MUC1 (Aplin, 2006). Trophoblasts expresses heparin-
binding EGF-like growth factor (HB-EGF) and its receptor, ErbB4. In a paracrine and 
juxtacrine mode, embryo-derived HB-EGF induces its own expression in the luminal 
epithelium. Epithelial-derived HB-EGF, in turn, triggers trophoblast modifications 
required for apposition and the following steps. Another molecule crucially involved in 
the initial adhesion of the embryo is trophinin. This transmembrane protein expressed 
by trophoblasts mediates homophilic cell adhesion via trophinin-trophinin binding. 
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Human chorionic gonadotrophin (hCG) stimulates trophinin synthesis by luminal 
epithelial cells of implantation site, which bind to trophoblastic cells expressing the 
same protein (Fukuda and Sugihara, 2008).  
1.3.1.2 Attachment 
During this integrin-dependent phase, the blastocyst attaches more stably to the 
maternal surface. Many adhesion molecules expressed in the trophoblasts and the 
luminal epithelium are involved in the coupling process. Integrins are plasma 
membrane glycoproteins comprising heterodimeric α and β subunits. They bind to 
other cells and to ECM ligands, such as osteopontin, fibronectin, vitronectin, heparan 
sulphate proteoglycans and laminin (Bazer et al., 2009). Osteopontin contain the 
integrin binding RGD motif, and is up-regulated by P4 in the epithelial compartment 
and trophoblasts. The blastocyst induces integrin expression in the endometrial 
surface. These receptors also work as signal transduction factors, driving 
cytoskeleton remodelling. Some adhesion molecules, such as basigin and activated 
leukocyte cell adhesion molecule (ALCAM), activate MMPs, triggering the ECM 
remodelling necessary for blastocyst invasion (Singh and Aplin, 2009). 
1.3.1.3 Invasion 
After attachment, the blastocyst must cross the endometrial surface epithelial barrier, 
and invade the underlying stroma. Different mechanisms have been proposed for this 
breaching process. Penetration of the trophoblast through gaps between 
neighbouring luminal epithelial cells, defined as interstitial implantation, was inferred 
based on histological findings in the implantation site (Bischof and Campana, 1996). 
Epithelial cell apoptosis induced by trophoblast FAS ligand interaction with epithelial 
FAS receptor or mediated by trophinin has also been suggested (Boeddeker and 
Hess, 2015). Uchida et al. (2012) demonstrated epithelial-to-mesenchymal transition 
of Ishikawa cells, a human endometrial epithelial cancer cell line, induced by JAR 
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cells, a human choriocarcinoma cell line, postulating that this transformation would 
underpin the embryo invasion. After breaching the surface epithelium, a thin layer of 
collagen type IV, the basal lamina, is ruptured. The stromal matrix is the last obstacle 
to be transposed. During penetration, trophoblast cells proliferate, differentiate and 
fuse to form the syncytiotrophoblasts. These cells secrete MMPs that degrade the 
stromal ECM (Wang et al., 2001). By day 10 after fertilization, the blastocyst is 
completely embedded in the stroma and overlaid by a newly grown luminal 
epithelium. The decidualized stromal cells, through a constant cross-talk with the 
blastocyst, control trophoblast invasion and indeed participate actively in the process 
of surrounding the conceptus (Gellersen et al., 2010). The endometrial arteries are 
also invaded by trophoblasts to establish the haemochorial placenta. However, the 
maternal-foetal circulation is only thoroughly functional, having blood from spiral 
arteries flowing to the lacunar spaces, by the end of the first trimester of pregnancy. 
Before that, aggregates of trophoblasts plug the distal segments of the arteries. Table 
1.1 summarizes some of the embryonic signals are their roles in implantation.  
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Table 1.1 Embryo signals and roles in implantation 
Embryo signal Role  Referrence  
hCG -  Corpus luteum rescue 
-   Trophoblast differentiation 
-   Trophoblast migration 
-   Endometrial gland differentiation 
-   Induction of LIF, IL6, IL11, MMP7, 
VEGF, CXCL14, GM-CSF, PGE2 in 
endometrium 
-   Decidualization 
Järvelä et al., 20098 
Shi et al., 1993 
Zygmunt et al., 2005 
Fazleabas et al., 1999 
Banaszak et al., 2000 
Paiva et al., 2011 
Kasahara et al., 2001 
EGF -   Syncytialization Dakour et al., 1999 
Platelet 
activating 
factor (PAF) 
-   Embryo development  Stoddart et al., 1996 
Pregancy-
associated 
plasma protein 
A (PAPPA) 
- Embryo development and 
adhesion 
Wang et al., 2014 
IL1α -   Adhesion (induction of integrin β3) Simon et al., 1997 
IL1β -   Decidualization Strakova et al., 2005 
Preimplantation 
factor (PIF) 
-   Adhesion, decidualization Barnea et al., 2012 
HB-EGF -   Apposition  
-   Embryo development 
Jessmon et al., 2009 
Wang et al., 2000 
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Trophinin -   Adhesion Fukuda and Sugihara 2008 
L-selectin -   Adhesion Genbacev et al. 2003 
Integrins -   Adhesion Burrow et al. 1993 
Proteases -   Decidualization 
-   Embryo selection 
Ruan et al., 2012 
Brosens et al., 2014 
hPL -   Endometrial gland secretion Noel et al., 2003 
WNT - Trophoblast invasiveness Pollheimer et al., 2006 
 
1.3.2 Endometrial Preparation 
In order to allow the blastocyst to implant, the endometrium must shift to a receptive 
phenotype. The endometrial receptive phase is also known as the window of 
implantation (WOI), and occurs in the secretory phase of the menstrual cycle, 
spanning day 20 to day 24 of a standard 28 day menstrual cycle, or 6 to 10 days after 
the LH surge (van Mourik et al., 2009). Morphological changes in the endometrium 
are observed during this period, as described in section 1.2.2. Protrusions on the 
apical membrane of luminal epithelial cells, defined as pinopodes or uterodomes, 
have been described. These variable-sized bleb-like structures appear for around 48 
hours, in the mid-secretory phase, and were reported as a preferential site for 
blastocyst-epithelial physical interaction (Quinn and Casper, 2009).  
The acquisition of receptivity depends chiefly on coordinated and sequential exposure 
to oestrogen and P4 from the beginning of the menstrual cycle. These sex steroid 
hormones act mainly binding to their respective nuclear receptors, and recruiting co-
chaperones and co-regulators. The resulting transcription machinery mobilizes 
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several molecular modulators in a spatiotemporal mode, affecting various signal 
transduction pathways. The steroid hormones also exert their effects in non-canonical 
manners, binding to G protein-coupled receptors in the plasma membrane, through 
interaction of the nuclear receptors with other transcription factors, or affecting mRNA 
stability (Young, 2013). Oestrogen is crucial for endometrial proliferation, but its role 
in receptivity in humans is controversial. Negative effect on in vitro fertilization 
implantation rates has been indeed demonstrated (Shapiro et al., 2011). P4, in turn, 
is absolutely essential and sufficient for implantation and early pregnancy survival, as 
proved by inhibition of its biosynthesis and use of anti-progestins (Rashid et al., 2012). 
Signals from the embryo are also involved in endometrial receptivity attainment. hCG 
flushed into the uterine cavity triggers the endometrial expression of various genes 
involved in implantation (Sherwin et al., 2007, Paiva et al., 2011). Human embryo 
conditioned media have similar effects in human endometrial epithelial cells (HEEC) 
and in mouse uterus (Cuman et al., 2013, Brosens et al., 2014). A vast repertoire of 
molecules and their receptors steer the modifications taking place in the endometrium 
during the window of implantation. Cytokines (LIF, lL6, IL1, IL11, IL18, prostaglandins, 
TNFα, CSF1, osteopontin), chemokines (CX3CL1, CCL7, CCL14, CCL4), leptin, IHH, 
WNT members, growth factors (HB-EGF, IGFs, TGFβ, EGF), morphogens (HOXA10 
and 11, MSX1 and 2) and the aforementioned adhesion molecules act in synchrony 
with signals relayed from the embryo to create a supportive environment for the 
arriving blastocyst (Dimitriadis, 2005, van Mourik et al., 2009). The role of some of 
these factors are summarized in Table 1.2. 
 
 
 
 
17 
 
Table 1.2 Factors involved in endometrial receptivity and the roles in 
implantation. 
Factor Roles  References 
COX2 - Knockout mice exhibit implantation 
failure. 
Lim et al., 1997 
cPLA2α - Releases arachidonic acid for 
prostaglandin synthesis. 
- Null mice exhibit implantation defects 
that are rescued by exogenous PGE2 
and PGI2. 
Song et al., 2002 
FKBP52  - P4 co-chaperone. 
- Knockout mice exhibit implantation 
failure and excessive epithelial 
proliferation. 
Yang et al., 2006 
HB-EGF - Apposition. 
- Trophoblast differentiation (invasion). 
- Knockout mice show implantation 
failure. 
Xie et al., 2007 
  
Wang et al., 2000 
HOXA10/11 - Knockout mice show implantation 
failure, lack of decidualization and 
absence of Lif expression. 
Gendron et al., 1997 
  
Das, 2010 
IHH - Implantation and decidualization. 
- Control of epithelial proliferation by 
paracrine signalling to stroma. 
Kurihara et al., 2007 
IL1 - Regulates β3 integrin expression. 
- Induces Lif and leptin expression in 
endometrium and hCG in trophoblast. 
Dimitriadis et al., 2005 
  
Gonzalez et al., 2004 
IL6st 
(Gp130) 
- Dimerises with IL6 receptors to 
phosphorylate STAT3. 
- Secretion of soluble form is reduced in 
infertile women during WOI. 
Ernst et al., 2001 
  
Sherwin et al., 2002 
IL11 - Reduced peri-implantation epithelial 
expression in recurrent miscarriages.  
- Required for decidualization. 
Linjawi et al., 2004 
  
Robb et al., 1998 
18 
 
Leptin - Interacts with IL1R to induce Lif and β3 
integrin expression. 
Gonzalez et al., 2004 
LIF  
(lL6 family) 
- Adhesion and decidualization. 
- Growth and differentiation of trophoblast 
(invasion). 
- Regulated by P4, hCG, TGFβ, IL1, HB-
EGF, PDGF TNFα. 
- Inhibit Msx1 expression. 
- Knockout mice show implantation failure 
and lack of decidualization. 
- Patients with multiple implantation 
failures show lower levels, in secretory 
phase. 
Salleh and Giribabu, 2014 
  
van Mourik et al., 2009 
  
Stewart et al., 1992 
  
Song et al., 2000 
  
Hambartsoumian, 1998 
MSX1/2 - Paracrine signalling between epithelium 
and stroma.  
- Knockout mice exhibit implantation 
failure and impaired luminal polarity. 
Daikoku et al., 2011 
  
Nallasamy et al., 2012 
MUC1 - Anti-adhesion molecule. 
- Up-regulated during WOI, but locally 
cleared at implantation site by 
blastocyst. 
Messeger et al., 2001 
Thathiah and Carson, 
2004 
P53 - Knockout mice exhibit implantation 
failure which is rescued by exogenous 
Lif. 
Hu et al., 2007 
SRC2  - Co-activator of PR. 
- Knockout mice exhibit implantation 
failure. 
Mukherjee et al., 2002 
TGFβ - Induces VEGF expression in 
trophoblast. 
Chung et al., 2000 
WNT4 - Knockout mice exhibit implantation and 
decidualization defects. 
Franco et al., 2011 
WNT7a - Knockout mice are devoid of uterine 
glands, show reduced Lif, and fail to 
implant.  
Dunlap et al., 2011 
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There is scarce information about the factors defining the post-receptive phase, or 
the closure of the WOI. Fall in P4 levels triggers a cascade of events that culminate 
in menstruation, whereas hCG rescues CL from luteolysis, preventing decrease in P4 
secretion and excessive inflammation (Tabibzadeh, 1998, Salker et al., 2012).  
Impaired receptivity is considered an important cause of infertility and a limiting factor 
in assisted reproductive technology success (Fatemi and Popovic-Todorovic, 2013). 
Consequently, multiple approaches for assessing endometrial receptivity have been 
developed. One of the first attempts to define the histological changes in the 
endometrium occurring along the menstrual cycle was described by Noyes et al, in 
1950. However this method proved to be inadequate due to low reproducibility and to 
not correlate with infertility (Díaz-Gimeno et al., 2013). Visualization of pinopodes was 
also described as a method to determine the WOI (Nikas et al., 1995). Besides the 
unavailability of electron microscopes for wider use, these structures are not exclusive 
to the mid-secretory phase, being identified during the whole secretory phase and 
even in pregnancy (Quinn and Casper, 2009). Analysis of individual markers such as 
LIF, CSF1, IL1, MUC1, trophinin, L-selectin ligands and integrins were not validated 
to be used for this purpose (Lessey, 2011, Malhotra et al., 2012). The echographic 
appearance, thickness and blood flow of endometrium evaluated through 
transvaginal ultrasound is currently used, but also demonstrates a disappointing 
performance for clinical use (Schild et al., 2001).  
1.4 Stromal Decidualization 
In addition to all the remodelling taking place in the luminal epithelium during the mid-
secretory phase, remarkable changes occur in the underlying stroma. This 
transformation is essential to accommodate the blastocyst and ensure the 
development of a healthy pregnancy.  
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Decidualization is the mesenchymal to epithelial transition of the endometrial 
fibroblasts, arising in the mid-luteal phase, and conferring on them a specialized 
secretory phenotype. This phenomenon is observed in all the species in which the 
embryo breaches the luminal epithelium and invades the stromal compartment. 
However, in contrast with most species, decidualization in humans unfolds in the mid-
luteal phase, independently of the blastocyst presence. The earliest sign of 
decidualization is stromal oedema, starting around day 18 of the cycle. Morphological 
changes can be detected in the cells surrounding the spiral arteries around day 23. 
Next, these modifications span the cells underlying the luminal epithelium, later 
becoming a global stromal feature (Gellersen et al., 2007). The spindle-shape 
morphology is replaced by a round configuration due to cytoplasm increase (Figure 
1.2). At sub-cellular level, expansion of the endoplasmic reticulum and Golgi 
apparatus, and accumulation of glycogen and lipid droplets in the cytoplasm are 
present. Projections of cell surface extending into the ECM or indenting into 
neighbouring cells can be detected.  An influx of immune cells can be later observed 
in response to local production of chemokines. Profound changes in ECM volume 
and composition are characteristic of this process. The expanding matrix show an 
increase in collagen type IV and laminin (Gellersen and Brosens, 2014).  
 
Figure 1.2 Decidualizing human endometrial stromal cells (HESCs). A confluent 
HESC culture before decidualization (left panel), and after two days of treatment with 
0.5 mM cAMP and 1 µM medroxyprogesterone acetate (MPA) (right panel). 
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1.4.1 Decidualization Markers 
Prolactin (PRL) and insulin-like growth factor binding protein 1 (IGFBP1) are 
massively enriched in amniotic fluid and their source was discovered to be the 
decidua (Riddick et al., 1978, Rutanen et al., 1986). These factors are established as 
decidual phenotype markers, and are widely used to assess decidualization in 
endometrial stromal cell cultures (Gellersen and Brosens, 2014).  
1.4.2 Mechanisms of Decidualization 
1.4.2.1 P4 Signalling  
The postovulatory rise of P4, secreted by the CL, is the main cue for stromal 
differentiation. As aforementioned, P4 acts through binding and activation of its 
cognate nuclear receptors. PRA seems to be a truncated version of the more 
transcriptionally active PRB (Vegeto et al., 1993). The two isoforms actually present 
distinct transactivational effects, specific to the cell type. While PRB is pivotal for 
mammary gland morphogenesis, PRA is critical for endometrial function (Mulac-
Jerivic et al., 2000, Mulac-Jerivic et al., 2003). PRA knockout mice were unable to 
develop stromal decidualization. By contrast, selective ablation of PRB confirmed that 
PRA is necessary and sufficient to mediate endometrial P4 responses (Mulac-Jerivic 
et al., 2000). 
PR is part of a transcription complex assembly, being associated with several 
chaperone proteins, such as heat-shock proteins (HSP40, HSP70, HSP90 and 
immunophilins (FK506 Binding Protein [FKBP] 4 and 5). These chaperone proteins 
maintain a conformational structure that makes the ligand binding domain accessible 
(Gellersen and Brosens, 2003). Upon P4 binding, the receptor changes its 
conformation, leading to phosphorylation, dissociation from the chaperones, 
dimerization, binding to responsive elements in promoter regions of the target genes, 
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and recruitment of co-activators SRC2, cAMP response element binding protein 
binding protein [CBP], p300/CBP associated factor [pCAF] and coactivator 
associated arginine methyltransferase 1 [CARM1]) (Wardell et al., 2002, Szwarc et 
al., 2014). The transcriptional machinery is complemented by interaction with factors 
induced by cAMP (Gellersen and Brosens, 2014), and dissociation of co-repressors 
(nuclear receptor co-repressor 1 [NCOR], nuclear receptor co-repressor 2 [SMRT]) 
(Wagner et al., 1998), resulting in transcription initiation.  
The first morphological changes associated with decidual transformation can be 
detected approximately 10 days after the postovulatory rise in P4 levels (Noyes et al. 
1950), indicating that the expression of decidua-specific genes is unlikely to be under 
direct control of activated PR.  The fact that HESCs in culture require, at least, 8 days 
of treatment with P4 or a progestin to secrete detectable levels of PRL, corroborates 
the idea of an initiation factor for decidualization, other than P4 (Gellersen and 
Brosens, 2003).    
1.4.2.2 cAMP Signalling 
 Cyclic AMP is produced upon ligand biding to G protein-coupled receptors. The alpha 
s (αs) subunit is released from heterotrimeric αβγ G-protein complex, following 
binding of ligand to the receptor. Next, αs activates the enzyme adenylyl cyclase (AC), 
which, in turn, synthesizes cAMP from adenosine triphosphate (ATP). This small 
molecule acts as a second messenger, activating the cAMP-dependent protein 
kinase (PKA). PKA complex is comprised of two regulatory and two catalytic subunits. 
The catalytic subunits are dissociated from the complex, and activated upon binding 
of cAMP to the regulatory subunits. Activated PKA phosphorylates target proteins in 
the cytoplasm or diffuses into the nucleus to modulate the activity of transcription 
factors (Fimia and Sassone-Corsi, 2001). The nuclear factors cAMP response 
element binding protein (CREB) and cAMP response element modulator (CREM) are 
23 
 
targets for PKA activation through phosphorylation. Once activated, CREB and 
CREM dimerize and bind to c-AMP response element (CRE) in the promoter region 
of target genes, recruiting the co-activator CBP. An alternative CREM promoter 
encodes inducible cAMP early repressor (ICER), which functions as a potent 
repressor of cAMP-induced transcription (Sassone-Corsi, 1998). Cyclic nucleotide 
phosphodiesterases (PDEs) are enzymes that degrade cAMP. The intracellular levels 
of the cyclic nucleotide are regulated by the balance between the activities of ACs 
and PDEs.   
Huang et al. (1987) showed that PRL induction by HESCs treated with E2 and 
medroxyprogesterone acetate (MPA) was further enhanced by the addition of relaxin. 
Based on that observation, and on the fact that relaxin up-regulates cAMP in the 
endometrium, Tang et al. (1993) treated HESCs with forskolin and cAMP and 
observed PRL induction at mRNA, protein and secretion level. Ever since, a great 
amount of effort has been applied to unravel the role of this second messenger in 
endometrial decidualization. Many GPCR ligands, such as relaxin, PGE2, hCG, LH, 
follicle stimulating hormone (FSH) and corticotropin releasing hormone (CRH) are 
involved in the rise of intracellular cAMP levels in HESCs, through activation of 
adenylyl cyclase (Fei et al., 1990, Yee and Kennedy, 1991, Tang and Gurpide, 1993, 
Makrigiannakis et al., 1999). cAMP signalling is controlled by a balance between 
synthesis and mechanisms that operate to terminate its effects (Sassone-Corsi, 
2012). Decidualizing HESCs act in such a manner to ensure continuous stimulation 
of this pathway, in order to maintain the decidual phenotype. Some suggested 
mechanisms to sustain cAMP effects in HESCs, include: inactivation of PDE by 
tyrosine kinase (Bartsch and Ivell, 2004); alterations in the composition of PKA 
holoenzyme, shifting the ratio catalytic:regulatory subunits towards the catalytic 
subunits (Telgmann et al., 1997); and the recruitment of the co-activator CBP (Smith 
et al., 1996). 
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The actions of cAMP in decidualizing HESCs are mediated by some important 
downstream effectors. The CCAAT/enhancer-binding protein β (C/EBPβ) is a key 
mediator of cAMP-induced transcription of PRL (Pohnke et al., 1999).  FOXO1 
interacts with C/EBPβ to activate PRL promoter (Christian et al., 2002). cAMP induces 
phosphorylation, dimerization and nuclear translocation of signal transducer and 
activator of transcription 5 (STAT5) in a Janus kinase (JAK)-independent way. This 
transcription factor enhances activity of the PRL promoter in the same region as 
C/EBPβ and FOXO1 (Mak et al., 2002). 
1.4.2.3 Convergence of P4 and cAMP Signalling  
Accumulated evidence points to an intricate cross-talk between PR and cAMP signal 
transduction pathways during the decidualization process. HESC cultures only 
maintain high sustained levels of PRL secretion, if treated with both progestin and 
cAMP analogue (Brosens et al., 1999). P4 potentiates PGE2-promoted production of 
cAMP in HESCs (Houserman et al., 1989). Onapristone, an antiprogestin, inhibited 
cAMP-induced PRL expression in HESCs (Brosens et al., 1999). Several 
transcription factors induced by cAMP (C/EBPβ, FOXO1, STAT5 and STAT3) interact 
with PR in the PRL promoter (Christian et al., 2002, Mak et al., 2002, Takano et al., 
2007). cAMP has been demonstrated to disrupt the interaction between PR and the 
co-repressors NCOR and SMRT, enabling the recruitment of co-activators (Wagner 
et al., 1998). Sumoylation is a post-translational modification of proteins by the 
covalent attachment of a small ubiquitin-related modifier (SUMO). cAMP triggers 
global decrease in sumoylation and redistribution of SUMO-1 modified proteins in 
decidualizing HESCs. Loss of PRA sumoylation results in increased transcription 
activity (Jones et al., 2006).  
In a concerted operation with cAMP pathway, PR function as a platform for assembly 
of a transcription complex. This transcription machinery, recruiting co-activators, and 
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interacting with other transcription factors, controls the expression of a decidual 
specific genotype (Figure 1.3). 
 
 
 
Figure1.3 Convergence of P4 and cAMP signalling in HESC decidualization. 
Ligand-bound progesterone receptor (PR) form a complex with co-activators (SRC, 
CBP, CARM1) and transcription factors induced by cAMP signalling (C/EBPβ, STAT5 
and FOXO1), and is dissociated from co-repressors (NCoR and SMRT). The 
transcription machinery activates the promoter of decidua-specific genes.  
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1.4.3 Roles of Decidualization 
1.4.3.1 Haemostasis 
Human implantation requires intrusion into the endometrial stroma by the blastocyst, 
along with extensive remodelling of the uterine vasculature by the trophoblast and 
uNK cells (Chakraborty et al., 2012). This invasive process may lead to rupture of the 
endometrial vasculature. The risk of haemorrhage is counteracted by haemostatic 
mechanisms provided by the decidualized stroma.  
Tissue factor (TF) is a type 2 cytokine receptor, considered the primary initiator of the 
extrinsic pathway of coagulation. It acts as a receptor for blood coagulation factor VII.  
TF is constitutively expressed at perivascular sites, but not in endothelial cells. 
TF/VIIa activates factors X and IX, ultimately leading to activation of thrombin 
(Lockwood et al., 2009) (Figure 1.4). Thrombin cleaves protease activated receptors 
(PARs). These receptors have a tethered ligand, which is released for binding by 
protease cleavage. While trypsin activates PAR2, thrombin acts on PAR1, 2 and 3 to 
convert fibrinogen into fibrin and promote platelet aggregation (Coughlin, 2000).  
Thrombin also induces secretion of soluble fms-like tyrosine kinase 1 (sFlt1) by 
dendritic cells from first trimester decidua. This soluble receptor binds to the 
angiogenic factors VEGF and placental growth factor (PlGF), preventing them to 
interact with  the active membrane bound isoform of Flt1 (Lockwood et al., 2007).  
Being induced in HESCs by a concerted action of cAMP and P4, TF has been used 
as a decidualization marker (Lockwood et al., 1993, Christian et al., 2001). The 
stimulatory effect of P4 on TF was suggested to be modulated by interaction of PR 
and epithelial growth factor receptor (EGFR) signalling, leading to phosphorylation of 
the transcription factor SP1 (Lockwood et al., 2000). The same interaction (PR/EGFR 
signalling) is involved in up-regulation of PAI1 in HESCs. PAI1 inhibits tPA and uPA, 
impeding clot degradation (Lockwood, 2001).  
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These observations indicate that decidualization prevents bleeding at implantation by 
activating haemostatic mechanisms and by control of blood vessel remodelling and 
embryo invasion.  
 
 
 
Figure 1.4 The coagulation cascade. Upon vascular damage, tissue factor (TF) 
comes into contact with its ligand, factor VII (FVII). The complex TF/FVIIa ultimately 
activates thrombin, which triggers platelet aggregation and fibrin production to 
generate a clot. The fibrin clot is degraded by plasmin, resulting in fibrin degradation 
products (FDP). Plasminogen activator inhibitor 1 (PAI1) inhibit the conversion of 
plasminogen to plasmin.  
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1.4.3.2 Control of Trophoblast Invasion 
Human implantation is characterized by deep penetration of the embryo in the 
endometrium, and even in the stromal-myometrium border, termed junctional zone 
(Brosens et al., 2002). Trophoblast cells share some striking similarities with cancer 
cells, being highly proliferative, extremely invasive, immunologically tolerated by the 
host, and infiltrating the local vasculature (Ferretti et al. 2007). This remarkably 
invasive nature of the trophoblast must be tightly controlled in a temporal and spatial 
manner, to meet the embryo demand at the same time that the maternal integrity is 
safeguarded.  
Embryo invasion involves proteolytic degradation and remodelling of the stromal 
ECM. In order to limit this process, a fine balance between the activity of MMPs and 
the opposing effect of TIMPs, both produced by the trophoblast and the decidualized 
stroma, must be achieved. TIMP3 was induced in HESC when co-cultured with first 
trimester trophoblast implants (Popovici et al., 2006). Decidualizing cells secrete 
TGFβ, which, in turn, inhibits the synthesis of MMPs. During decidualization, HESCs 
also secrete the proteoglycan decorin into the ECM. Decorin, besides acting as a 
TGFβ repository, inhibits proliferation, migration and invasiveness of extravillous 
trophoblast (EVT) cells (Xu et al., 2002). Plasmin is a serine protease, also involved 
in ECM remodelling. It is produced from its precursor, plasminogen, by action of tPA 
and uPA. PAI1 is up-regulated upon decidualization and inhibits the activity of 
plasminogen activators, reducing the synthesis of plasmin (Lockwood, 2001).  
Decidualized stroma and ECM express adhesion molecules that contribute to limit 
trophoblast invasion (Burrows et al., 1996). CD38 is a tetraspanin expressed in the 
decidualized cells surrounding the embryo. This tumour suppressor interacts with 
other tetraspanins, integrins and E-cadherin, being engaged in cell adhesion, motility 
and invasion (Zhang et al., 2012). Elastin microfibril interface 1 (EMILIN1) is produced 
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by decidual HESCs in a gradient of increasing concentration towards the perivascular 
sites. This is consistent with the directional migration of EVT. Interaction between 
trophoblast and EMILIN1 is carried out via α4/β1 integrin (Spessotto et al., 2006).    
More recent evidence suggests that the maternal decidua, rather than acting as an 
inert tissue awaiting for invasion, plays an essential role in the encapsulation of the 
conceptus. The chemokine CXCL12, secreted by the trophoblast induces expression 
of its receptor CXCR4 and invasiveness of first trimester decidual HESCs (Ren et al., 
2012). Trophoblast-secreted PDGFAA triggers decidualizing HESC chemotaxis 
(Schwenke et al., 2012). Gellersen et al. (2010) demonstrated that secretion of MMP2 
and 9 was increased in HESCs upon decidualization. The authors also showed that 
decidualization bestows HESCs with increased migration and invasiveness, when co-
cultured with an EVT cell line. These data indicate that, upon decidualization, HESCs 
acquire the ability to respond to embryo signals by increasing motility, migration and 
invasiveness. These properties enable encapsulation of the conceptus by the decidua 
(Quenby and Brosens, 2013, Weimar et al., 2013). 
1.4.3.3 Control of Oxidative Stress Responses 
In the first trimester of pregnancy, endovascular EVT form plugs in the spiral arteries, 
creating a hypoxic environment, which is essential to avoid generation of excessive 
amount of reactive oxygen species (ROS) (Burton et al., 1999). There are key roles 
for controlled oxidative stress in the development of the placenta, such as 
syncytialization, cytotrophoblast differentiation and angiogenesis (Myatt and Cui, 
2004). Oxidative stress can lead to DNA repair (Tram et al., 2002), however it can 
also trigger cell cycle arrest (Barnouin et al, 2002), senescence (Toussaint et al., 
2001), apoptosis (Kannan and Jain, 2000) and necrosis (Fiers et al., 1999), which 
could be deleterious for the vulnerable developing embryo. Oxidative damage at the 
maternal-foetal interface has been associated with early pregnancy loss (Jauniaux et 
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al., 2000), foetal growth restriction (Myatt and Cui, 2004) and preeclampsia (Burton 
and Jauniaux, 2004, Elliot, 2016).  
There is evidence that decidualizing cells are adapted to inhibit excessive ROS 
signalling, preventing oxidative cell death, and maintaining pregnancy homeostasis 
(Gellersen et al., 2007). The expression of key antioxidants, such as glutathione 
peroxidase (GPX) 3, monoaminoxidase A and superoxide dismutase (SOD) 2 is up-
regulated during the mid-secretory phase in the endometrium (Díaz-Gimeno et al., 
2011). Uterine secretion of glutathione transferase and peroxiredoxin 4 is also 
increased in mid-secretory phase (Scotchie et al., 2009, Garrido-Gomez et al., 2010). 
Maruyama et al (1999) demonstrated increased secretion of the antioxidant 
thioredoxin by HESCs, upon treatment with E2 and P4. Xu et al. (2014) showed a 
reduction in pregnancy rate in mice, with intraperitoneal injection of a GPX inhibitor.  
Growth arrest and DNA damage 45 α (GADD45α) is a  protein involved in response 
to stressful growth arrest conditions and DNA damage, acting as a gatekeeper to 
eliminate cells with excessive DNA damage. Up-regulation is observed in mid-
secretory endometrium (Díaz-Gimeno et al., 2011) and in decidualized HESCs in vitro 
(Kajihara et al., 2006). This induction of GADD45α is mediated by the cAMP-induced 
transcription factor FOXO1 (Tran et al., 2002).  
Decidualizing HESCs are more resistant to oxidative cell death than un-differentiated 
cells. This effect is associated with the ability of differentiated HESCs to prevent up-
regulation of FOXOa3, upon oxidative stress (Kajihara er al., 2006).  
Salker et al. (2011) studied the role of serum and glucocorticoid-regulated kinase 1 
(SGK1) in implantation. SGK1 is a serine-threonine kinase induced in decidualizing 
HESCs. This enzyme plays an essential role in cellular stress response. mRNA levels 
were decreased and increased  in mid-secretory endometrium from women suffering 
of recurrent pregnancy loss (RPL) and infertile women, respectively, when compared 
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with control subjects. Sgk1 knock-out mice exhibited decreased litter size. Upon 
SGK1 knock-down, decidualizing HESCs showed a higher oxidation status in 
response to exogenous ROS (H2O2), and an impaired induction of free-radical 
scavengers (SOD2, thioredoxins, peroxiredoxin 2 and GPX1). Expression of the 
same scavengers was significantly lower in decidualizing HESCs from subjects with 
RPL compared to controls. 
Taken together, these evidence point to a critical role of decidualization in bestowing 
a defence mechanism against excessive oxidative stress in the maternal-foetal 
interface.  
1.4.3.4 Immune Tolerance to the Implanting Embryo 
Pregnancy evokes an immunological conflict: the maternal organism must 
accommodate a non-self foetal semiallograft, providing a supportive environment, 
and safeguarding its own integrity. It is logical to question how the foetus elude 
maternal immune surveillance. However, evidence suggests that the decidual 
immune system has evolved to establish a cooperative arrangement with the 
trophoblast (Mor et al., 2011).  
Decidualization bestows on the endometrial stromal compartment a specific 
immunological milieu, where specialized NK cells, dendritic cells (DCs), regulatory T 
cells (Treg cells) and macrophages interact to promote tolerance to the implanting 
blastocyst. In mice, the decidua prevents influx of cytotoxic T lymphocytes by 
silencing of chemokines through histone modification (Nancy et al., 2012).   
DCs typically migrate to the local lymph nodes for antigen presentation. It was 
believed that, during pregnancy, these cells would be depleted in the maternal-foetal 
interface in order to avoid recognition of the semiallogenic embryo. Later, it was 
demonstrated that these cells, by changes of ECM and cytokine gradient, were 
indeed entrapped in the decidua (Collins et al., 2009, Erlebacher, 2013). DCs in 
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decidua secrete sFLT1 and TGFβ1, playing an important role in local angiogenesis. 
In mice, depletion of decidual DCs led to impaired implantation and embryo resorption 
(Plaks et al., 2008). Decidua macrophages contribute to reduced cytotoxicity of NK 
cells and cooperate with uNK cells to induce immunosuppressive Treg cells (Gormley 
et al., 2013, Vacca et al., 2010). 
Galectin1 is involved in tumour immune evasion and restraint of autoimmune 
diseases, inhibiting T cell proliferation and survival (Camby et al., 2006). Galectin1-
deficient mice exhibited increased foetal loss in allogenic, but not in syngeneic mating. 
Treatment with recombinant galectin1 prevented foetal loss and restored tolerance 
through induction of tolerogenic DCs and Treg cells (Blois et al., 2007). Kopcow et al. 
(2008) have demonstrated the apoptotic effect of uNK-derived galectin1 in activated 
T cells.  
Decidua-derived Fas ligand triggers apoptosis of activated T cells in the maternal 
foetal interface and promotes trophoblast invasion (Qiu et al., 2005).  
Indoleamine 2,3-dioxygenase (IDO), an enzyme highly expressed by decidualizing 
HESCs,  degrades tryptophan, leading to growth arrest of T cells (Mellor and Munn, 
2001). Pregnant mice treated with an IDO inhibitor exhibited extensive inflammation, 
massive complement deposition and haemorrhagic necrosis at foetal-maternal 
interface in allogenic, but not syngeneic pregnancies (Mellor et al., 2002).  
uNK cells are less cytotoxic than their peripheral counterparts (Hanna et al., 2006). 
Local decidual factors contribute to the development of this special property. Co-
culturing with decidualizing HESCs, and even conditioned medium from these cells, 
converted peripheral NK cells into an uNK cell-like phenotype (Keskin et al., 2007, 
Vacca et al., 2011). Cerdeira et al. (2013), using a combination of hypoxia, DNA 
demethylation and TGFβ1, managed to attenuate the cytotoxicity of peripheral NK 
cells, increase secretion of VEGF, and induce the ability of these cells to stimulate 
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trophoblast invasiveness. Recently, it has been demonstrated that decidualizing 
HESCs can reduce NK cytotoxicity, promote dendritic cell differentiation, and induce 
Treg cells (Erkers et al., 2013, Croxatto et al., 2014).  
These data illustrate the compelling immunosuppressive potential of stromal 
decidualization, which may account for the immunological paradox of pregnancy.  
1.4.3.5 Embryo selection 
Reproduction in humans is exceptionally inefficient. The monthly fecundity rate is only 
20 % (Evers, 2012). Human embryos are highly invasive, and chromosomal errors 
can be often found in preimplantation stages (Vaneste et al., 2009, Fragouli et al., 
2013, Mertzanidou et al., 2013). Considering pre-clinical losses, 50-60 % of 
pregnancies fail to proceed to an ongoing pregnancy, and more than 50 % of 
chromosome abnormalities are encountered in spontaneous miscarriages (Macklon 
et al., 2002). This indicates that numerous developmentally impaired embryos first 
implant to be eventually rejected and discarded. These data suggest that a selective 
mechanism operates, in order to limit maternal investment in a compromised 
conceptus. First evidence to propose the endometrium as a biosensor for embryo 
quality came from a study with livestock. Mansouri-Attia et al. (2009) demonstrated a 
tailored response of bovine endometrium to transferred embryos produced either by 
in vivo fertilization (artificial insemination; AI), somatic cell nuclear transfer (SCNT) or 
in vitro fertilization. The differences in peri-implantation endometrial gene expression 
were more pronounced between AI and SCNT embryos, with biological functions 
involving metabolism and immunity being identified.  
Recent studies point to decidualization as the human process that bestow upon the 
endometrium the aptness to sense and select the embryos for support or exclusion. 
Teklenburg et al. (2010) showed that developmentally arrested embryos down-
regulated the expression of implantation factors (IL1β, IL6, lL10, IL, 17, IL18, eotaxin 
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and HB-EGF) in decidual HESCs, which was not observed with developing embryos. 
Furthermore, it was demonstrated that HESCs only engage in embryo sensoring upon 
decidualization. The same group of researchers examined this role of the 
endometrium in the context of recurrent pregnancy loss (RPL). First, they 
demonstrated that endometrium and decidualized HESCs from patients with RPL 
expressed lower levels of PRL and higher levels of prokineticin 1 (PROK1), a factor 
induced during the receptive phase. Second, decidualized HESCs were treated with 
hCG, resulting in down-regulation of PRL and PROK1 in the control group and up-
regulation in the RPL group. Based on these data, the authors proposed that defective 
decidualization in RPL patients would elicit prolonged endometrial receptivity coupled 
with impaired selectivity (Salker et al., 2010). Brosens et al. (2014) tested the same 
hypothesis in vivo. Mouse uteri were flushed with conditioned media from 
developmentally impaired embryos (DIE) and embryos that resulted in ongoing 
pregnancy (developmentally competent embryos [DCE]), and were submitted to 
genome-wide expression profiling. While DCE triggered a modest response (15 
differentially expressed genes [DEGs]), 449 DEGs were detected in DIE conditioned 
media-flushed uteri. Endoplasmic reticulum stress response was demonstrated to be 
induced by DIE. Decidualized HESCs were exposed to the same embryonic stimuli 
and displayed a similar response. It was also observed that cells treated with DCE 
conditioned media up-regulated genes involved in implantation and metabolism. 
Trypsin-like serine proteases were suggested as the putative embryo-released signal 
for the uterine luminal epithelium, relaying cues about embryo quality. A previous 
study showed that trypsin cleavage activated epithelial sodium channels in 
endometrial luminal cells from mice, triggering plasma membrane depolarization and 
Ca2+ influx. As a consequence, phosphorylation of the transcription factor CREB 
induced expression of the COX2 gene (prostaglandin-endoperoxide Synthase 2 
[PTGS2]), and eventually, PGE2 secretion. This cytokine is a major ligand for 
activation of cAMP signalling (Ruan et al., 2012). In vitro trypsin evoked intracellular 
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Ca2+ oscillations in HEECs similar to those generated by DIE conditioned medium 
(Brosens et al., 2014). The oscillations induced by spent embryo medium were 
attenuated by a trypsin inhibitor. It was postulated that embryo-released serine 
proteases would signal to the luminal epithelium not only to modulate decidualization, 
but as well to allow embryo quality sensoring.  
Taken together these observations suggests that cyclic decidualization may limit 
maternal investment in invasive but developmentally impaired embryos.  
1.5 Endometrial Glands 
Uterine glands are part of the endometrial epithelial compartment, with ultrastructure 
and gene expression profile distinct from the luminal epithelium (Demir et al., 2002, 
Niklaus and Pollard, 2006). These structures are formed by a single layer of columnar 
cells in a tube-like arrangement that undergo constant modification along the 
menstrual cycle. 
1.5.1 Development of Endometrial Glands 
Uterine epithelium originates from the central tubular epithelium of paramesonephric 
ducts. All mammals share a similar sequence of events for gland development, 
termed adenogenesis.  First, buds arise from luminal epithelium (LE), and next form 
a lumen as they progressively invaginate into the underlying stroma. In ruminants and 
primates, coiling and branching are further observed (Cooke et al., 2013). In rodents, 
pigs and sheep, gland morphogenesis is primarily a post-natal event (Cunha et al., 
1976, Wiley et al., 1987, Bartol et al., 1993), whereas prenatal development of the 
uterus is crucial for future adenogenesis. In humans, fusion of the Müllerian ducts 
occurs before 8 weeks of pregnancy. By 20-22 weeks of gestation, sparse buds can 
be detected in the adluminal stroma. At birth, histoarchitecture is similar to that of an 
adult, though complete development, with glands extending to the myometrium, will 
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only take place in puberty (Gray et al., 2001). Curiously, these events are distinct from 
development in the post-menstrual phase and puerperium, where the glands arise 
from the crypts at the basalis and possibly from the stroma (Huang et al., 2012, 
Valentijn et al., 2013).  
Adenogenesis is regulated in endocrine (steroid hormones), paracrine (factors 
expressed by stromal and LE cells), juxtacrine (cell-cell and cell-ECM matrix) and 
autocrine (factors expressed by glandular epithelium [GE]) manners (Figure 1.5). The 
cues control gland cell proliferation, differentiation, adhesion and motility, shaping the 
developing structures (Gray et al., 2001).  
 
Figure 1.5 Control of endometrial adenogenesis. Uterine gland formation is 
regulated by steroid hormones, and factors derived from stroma, LE, ECM and GE.  
 
The effect of steroid hormones in adenogenesis has been examined. P4 inhibits 
neonatal gland development, and this property has been explored to generate mice 
and female ewes devoid of uterine glands, allowing to unravel new roles for these 
secretory structures (Spencer et al., 1999, Cooke et al., 2012). The results with E2 
are rather conflicting, varying between different species and the time of administration 
of the steroid (Branham, et al., 1985, Tarleton et al., 1999, Carpenter et al., 2003).  
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Branham et al. (1985) showed that exogenous E2 could alter adenogenesis in rats, 
in an age-specific manner. When administered between days 1 - 5 after birth, and 
between days 10 – 14, the final number of glands was reduced. Conversely, the use 
of E2 between days 20 – 24 increases the number of glands compared to controls. It 
was previously postulated that, despite the initial oestrogen-independent 
adenogenesis, Erα was required in the neonatal period, and was activated in a ligand-
independent manner by growth factors such as EGF and IGF1 (Gray et al., 2001, 
Curtis et al., 1996, Klotz et al., 2002). However, this hypothesis was not supported by 
studies demonstrating that ablation of the ERα did not disturb gland formation 
(Stewart et al., 2011; Nanjappa et al., 2015).  Simitsidellis et al. (2016) showed a 
striking increase of gland numbers in ovariectomized mice using dihydrotestosterone 
(DHT), revealing a novel role for androgens in endometrial function. Glucocorticoids 
have an antiproliferative effect on uterine epithelium, but the specific results in uterine 
glands have not been reported (Bigsby and Cunha, 1985). It has been proposed that 
at birth, the increased levels of both P4 from placenta and cortisol from parturition 
drop, ceasing the inhibition of uterine epithelial proliferation in female offspring (Cooke 
et al., 2013).  
Epithelial-mesenchymal cross-talk can be mediated by modifications in the 
composition of ECM (Werb et al., 1996). Glycosaminoglycans (GAGs) can affect the 
cells directly or by enabling access of growth factors and other ligands to their 
receptors. During glandular development in other tissues (salivary glands, pancreas 
and mammary glands), sulfatated GAGs, e.g. chondroitin and heparans, are detected 
in morphogenically inactive areas, such as the neck of glands, whereas non-sulfated 
GAGs, e.g. hyaluronic acid, localizes in more active sites, such as the tips of the 
glands (Bernfield et al., 1973, Silberstein and Daniel, 1982). MMPs and their tissue 
inhibitors are also suggested to be involved in endometrial adenogenesis (Hu et al., 
2004).  
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Wnt family members are secreted ligands that bind frizzled receptors (Fzd), a family 
of GPCRs, leading to activation of dishevelled proteins (Dsh). The activation of the 
canonical pathway promotes recruitment of the co-activator β-catenin (Ctnnb1) by 
target members of T cell factor/lymphoid enhancer factor (TCP/LEF) family to the 
enhancer elements of their target genes. These transcription factors regulate cell fate 
and morphogenesis (Nusse, 2012). Several Wnt members are involved in uterine 
adenogenesis in mice. Wnt4 and Wnt5a are secreted by the stroma and act on the 
gland cells of the epithelial compartment (Mericksay et al., 2004, Franco et al., 2011). 
By contrast, Wnt7a is produced by LE and acts on gland formation by controlling the 
expression of Wnt5a, Wnt4 and the morphogens Hoxa10 and Hoxa11 in the stroma 
(Dunlap et al., 2011). Hoxa 10 mutant mice exhibits deficient endometrial gland 
patterning. Other members of the pathway, such as Wnt11, Wnt16 and Wnt7b, were 
localized in neonatal mouse uteri, although their ablation did not disturb the uterine 
phenotype. Fzd6 and Fzd10 were also found in LE, but studies about their role in 
adenogenesis are still lacking (Hayashi et al., 2011). Other evidence underpinning 
the importance of Wnt signalling is the impaired gland development upon ablation of 
Ctnnb1, Lef1 and the co-receptor Lgr4 (Jeong et al., 2009, Shelton et al., 2012, Sone 
et al., 2013).  As mentioned previously, P4 inhibits adenogenesis if administered in 
the neonatal phase. Cooke et al. (2012) demonstrated inhibition of Wnt7a, Wnt4, 
Hoxa10, Hoxa11 and Fzd6 using P4 from postnatal day 3 until 9, suggesting a 
possible mechanism for the effect of this steroid. Diethylstilbestrol (DES), a synthetic 
oestrogen, was administered from day postnatal 1 to 5 and caused impaired 
adenogenesis and down-regulation of Wnt7a and Wnt4 (Hayashi et al., 2011). The 
adhesion molecule e-cadherin (Cdh1) forms a complex with β-catenin and plays an 
important role in maintaining epithelial integrity (Tian et al., 2012). Ablation of Cdh1, 
in mice, resulted in disturbed endometrial adenogenesis and downregulation of 
Wnt7a, Fzd6, Fzd10, Hoxa10 and Hoxa11 (Benson et al., 1996).  
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The transcription factor forkhead box a 2 (Foxa2) is expressed exclusively by GE and 
its ablation disrupts uterine gland development in mouse (Jeong et al., 2010; Kelleher 
et al., 2017). Evidence indicates that Foxa2 is regulated by β-catenin in the 
endometrium (Villacorte et al., 2013). A recent study has demonstrated that ablation 
of SRY (sex determining region Y)-Box 17 (Sox17) in endometrial stroma inhibited 
gland formation. Null mice exhibited decreased uterine expression of Lef1, and 
Foxa2, and increased expression of Wnt7a, although up-regulation was not observed 
at protein level (Guimarães-Young et al., 2016). Dicer encodes a ribonuclease 
involved in microRNA biosynthesis. MicroRNAs bind to complementary nucleotide 
sequences in untranslated regions of mRNA, leading to translation repression. Dicer 
knockout mice displayed reduced number of uterine glands on postnatal day 21, and 
presented aberrant expression of Wnt members, i.e. ectopic expression of Wnt4 and 
Wnt5a in the epithelial compartment of endometrium (Gonzalez and Behringer, 
2009).  
Growth factors are also involved in endometrial gland morphogenesis. Stromal 
derived hepatocyte growth factor (HGF), and FGFs 7 and 10 are implicated in gland 
differentiation, proliferation and branching in other organs, such as lung and prostate 
(Bellusci et al., 1997, Ohmichi et al., 1998, Lu et al., 1999). HGF acts through binding 
to its receptor c-met, whereas FGF7 and FGF10 bind to a common epithelial receptor, 
defined as FGFR2IIIb (Komi-Kuramochi et al., 2005). Insulin-like growth factors 1 and 
2 (IGF1 and IGF2) are secreted by stroma and, their biological effects are mainly 
mediated by the IGF1R, which is expressed in both endometrial compartments 
(Stevenson et al., 1994,Jones and Clemmons, 1995).   Analysing neonatal ovine uteri, 
Taylor et al. (2001) have demonstrated  an expression pattern of FGF7, FGF10, HGF, 
IGF1, IGF2, and their epithelial receptors in endometrial, remarkably consistent with 
the gland development. Furthermore, in another study, neonatal inhibition of 
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adenogenesis with a progestin, altered the expression pattern of these growth factors 
and receptors in neonatal ewe uteri (Gray et al., 2000).  
Some evidence suggests a role for PRL in the development of uterine glands. PRL 
receptor (PRLR) is expressed in GE of sheep and humans (Jones et al., 1998, Taylor 
et al., 2000). Hyperprolactinemia induces endometrial gland hypertrophy (Kelly et al., 
1997). Placental lactogen, another member of the PRL/growth hormone family 
induces uterine gland proliferation in sheep (Spencer et al., 1999).  
1.5.2 Roles of Endometrial Glands 
1.5.2.1 Histiotrophic Support of the Conceptus 
The transition to viviparity requires the ability to support the conceptus whilst it 
remains within the maternal organism. Humans evolved to a haemochorial placenta, 
but during pre-implantation development, and until chorionic villi establish contact 
with maternal blood, the embryo must be nourished by decidual gland secretions 
(Burton et al., 2002). This mode of subsistence is named histiotrophic support.  
Two circumstances led to the belief that the period of histiotrophic support would be 
rather short in human pregnancy. First, the invasive embryo is completely imbedded 
in the endometrial stroma by day 10 post conception, being sealed from the uterine 
luminal secretions (Gellersen et al., 2010). Second, histological examination of 
implantation sites suggests that migrating EVT, soon after implantation, invades 
maternal vasculature of the superficial endometrium (Burton et al., 1999).  
Endometrial glands opening to the intervillous space (IVS) were documented in 
histologic sections of first trimester decidual-placental interface, and the same 
glycogen and lipid rich secretions observed in the glands were found dispersed in the 
IVS. Furthermore, glycogen staining was detected in the inner surface of villi, 
suggesting that products secreted by the decidual glands were absorbed by the 
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trophoblast. Immunostaining of utero-placental tissue for proteins specifically 
secreted by endometrial glands (glycodelin and MUC1), demonstrated staining of 
glands, IVS and villi close to the cytotrophoblasts shell. Glycodelin was further 
detected in villous macrophages, and MUC1 in small vesicles within the 
syncytiotrophoblast (Burton et al., 2002). Using co-staining with glycodelin and 
cathepsin D, a marker of lysosome activity, Hempstock et al. (2004) demonstrated 
digestion of the gland-derived protein in lysosomes within the chorionic villi of first 
trimester placentas. The authors also observed communications of gland lumens with 
IVS until at least 10 weeks. Moser et al. (2015) have even demonstrated the presence 
of endoglandular EVT as early as day 10 post-conception. These data indicate that 
the conceptus is not deprived from the uterine histiotrophe.   
In vivo studies, using Doppler ultrasound, could only observe sparse sites with non-
pulsatile flow in the intervillous spaces, before 10-12 weeks of gestation (Jaffe et al., 
1997). Further histological studies of placenta-in situ specimens, with focus on the 
maternal-placental circulation, yielded some important observations. It was 
demonstrated that the spiral arteries are not invaded until 6 weeks, since they do not 
reach the superficial portions of the endometrium where the embryo is located. After 
8 weeks, the connections between maternal arteries and placental villi were more 
frequent. However, aggregates of cytotrophoblast cells seems to plug the distal part 
of the arteries. Direct communications between endometrial arteries and IVS were 
only observed after 10 weeks of gestation (Burton et al., 1999). As result, a hypoxic 
environment is created in the first trimester of pregnancy. This hypothesis was 
confirmed by measuring oxygen tension within the placenta. A rise from < 20 mmHg 
at 8 weeks of pregnancy to > 50 mmHg at 12 weeks was concomitant with increased 
genomic expression and activity of antioxidant enzymes, such as catalases, GPXs 
and SODs (Jauniaux et al., 2000). Later, the same group analysed pH, O2 and CO2 
tension of first trimester human foetal fluid (blood, amniotic fluid and exocelomic fluid) 
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and utero-placental tissue, corroborating the previous findings (Jauniaux et al., 2001). 
The hypoxic environment coincides with the period when the organs are developing. 
The potential benefit of avoiding premature exposure to oxygen is to prevent 
excessive production of ROS, which could be deleterious for the fragile developing 
embryo. Free radicals could elicit DNA damage, disturbance of signalling pathways, 
nitrosylation of tyrosine kinases and mitochondrial stress-induced apoptosis, 
negatively affecting organogenesis (Ahmed and Rahman, 2015).  
Considering that villi are poorly vascularised in the first weeks of pregnancy, the route 
by which nutrients are transported to the foetus is not obvious. Mesenchyme of early 
villi exhibit channels that blend with the mesenchyme lining the coelomic cavity at the 
chorionic plate (Castellucci et al., 1980). It is possible that molecules engulfed from 
the IVS diffuse through these channels into the coelom, and once there, they are 
absorbed by the well vascularized secondary yolk sac (Burton et al. 2001). In many 
species, vitelline circulation is the initial system used for gas and nutrient exchange 
(Carter, 2007). At the end of first trimester of gestation, when the haemochorial 
placenta is established, coelom is obliterated and secondary yolk sac degenerates 
(Burton et al. 2001). The high concentrations of folate and vitamin B12 in the coelom 
also suggest this surface is an important site for maternal-foetal exchange of nutrients 
(Campbell et al., 1993). Glycodelin was detected in the epithelium of the secondary 
yolk sac lining the coelomic cavity, at 8 weeks of gestation. At 12 weeks the staining 
was attenuated (Burton et al., 2002). These data suggest that the pathway through 
the coelom and secondary yolk sac may play a key role in nutrient exchange, before 
adequate villous vascularization is established.  
The components of endometrial gland secretions responsible for embryo nutrition are 
not fully elucidated. The importance of these secretions for conceptus development 
inspired the term ‘uterine milk’ (Hansen et al. 1987). It is clear though, that glycogen, 
lipids, glycoproteins and micronutrients contribute to the nutrient milieu. Glycogen and 
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lipids were identified in human endometrial gland lumen by periodic acid Schiff and 
neutral red staining, respectively (Burton et al., 2002, Hempstock et al., 2004). The 
glycoproteins in the uterine milk lose the sialic acid capping during the pregnancy, 
facilitating absorption by the trophoblast and enhancing the availability of substrates 
for degradation. The latter role is desirable, for growth factors within IVS can 
occasionally enter maternal circulation via uterine veins, increasing the risk for 
cancer. This sialyation change may ensure early clearance of these factors by the the 
liver (Burton et al., 2011). These modifications during pregnancy also indicate embryo 
modulation of uterine gland function. A recent study demonstrated how glycogen 
metabolism unfolds in decidual-placental interface. In the first trimester of pregnancy, 
glycogenolysis begins within the gland cells, by effect of glycogen phosphorylase, 
soon after synthesis by glycogen synthase. Further degradation occurs in the gland 
lumen via α-amylase. Part of the glycogen substrates are absorbed by 
syncytiotrophoblast, and used for metabolic processes; and part is reassembled and 
stored by cytotrophoblasts (Jones et al., 2015).  
A high content of glycoproteins is also reported in uterine fluid (Burton et al., 2002, 
Hempstock et al., 2004; Jones et al., 2015). The most highly expressed of those is 
glycodelin, also known as placental protein 14 (PP14), pregnancy-associated 
endometrial alpha-2 globulin (α2PEG) or progesterone-associated endometrial 
protein (PAEP). There are 3 isoforms of glycodelin. Glycodelin A is the endometrial 
isoform. This protein is involved in pregnancy immune tolerance, endometrial gland 
differentiation, blastocyst adhesion, and trophoblast invasion (Seppälä et al., 2002, 
Uchida et al., 2012). Its expression is mainly regulated by P4, but gland cells are also 
responsive to hCG (Seppälä et al., 1987, Fazleabas et al., 1999). Glycodelin secretion 
increases until 10 weeks of gestation, and then declines (Seppälä et al., 1992). 
Another known glycoprotein secreted by uterine glands is MUC1. This anti-adhesion 
molecule has an important role in implantation, as previously mentioned and was 
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identified in uterine flushings (Hey et al., 1995). MUC1 expression in utero-placental 
interface can be strongly detected during first and second trimester of pregnancy, 
declining in the third trimester (Jeschke et al., 2002). Protein and lipids in uterine fluid 
have been assessed in an attempt to define a receptive profile (Beier and Beier-
Hellwig, 1998, Scotchie et al., 2009, Salamonsen et al., 2013, Vilella et al., 2013). 
These studies identified a large number of secreted proteins and lipids, demonstrating 
a temporal change in the endometrial gland secretion composition, but the specific 
roles for each of these glandular secretion components are far from being elucidated.  
1.5.2.2 Endometrial Receptivity and Embryo Implantation 
A large body of evidence indicates that, apart from conceptus nourishment, the 
endometrial glands play a crucial role in endometrial receptivity and embryo 
implantation. Analysis of uterine luminal fluid (ULF) has identified cytokines, 
chemokines, proteases, protease inhibitors, several solute carriers, and other factors 
that modulates blastocyst and LE functions (Salamonsen et al., 2016). Once more, 
the progestin-induced gland knock-out animals helped to shed light on this uterine 
gland function. These animals were exposed to a progestin in the neonatal period, 
resulting in complete inhibition of adenogenesis. Uterine gland knock-out (UGKO) 
female sheep exhibited developed functional ovaries, did not present fertilization 
defects, and when mated with fertile males, normal blastocysts could be retrieved 
from uteri at gestation day 9 (Gray et al. 2001b). At day 14, conceptus were absent 
or severely growth-restricted (Gray et al. 2002). Progestin uterine gland knock-out 
(PUGKO) mouse phenotype includes infertility due to complete implantation failure. 
Intact embryos could be retrieved by flushing of uterine cavity on gestation day 5 
(post-receptive phase), and those embryos implanted and resulted in normal 
pregnancy, when transferred to wild type recipients (Kelleher et al., 2016). PUGKO 
mice uteri displayed reduced uterine expression of key implantation genes (Lif, Ihh, 
Prss28, Prss29 and Hbegf). In mice, clearance of the anti-adhesion protein MUC1 
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from LE, along with LE microvilli flattening and disappearance, a hallmark of polarity 
loss, are important parameters indicating endometrial receptivity. MUC1 remained 
abundant in PUGKO mice LE at day 4 (receptive phase). In addition, PUGKO uteri 
failed to undergo microvilli flattening and reduction in number (Kelleher et al., 2016).  
Growth factors in ULF regulate conceptus proliferation, differentiation and adhesion. 
Hempstock et al. (2004) identified EGF, VEGF and TGFβ expression in human GE. 
Receptors for these growth factors are present in trophectoderm of pre-implanting 
blastocysts.  EGF receptors are expressed by trophoblast until 10 weeks of gestation, 
declining in later pregnancy (Ladines-Llave et al., 1991). EGF induces 
cytotrophoblast proliferation, and also stimulates hCG and human placental lactogen 
(hPL) secretion by syncytiotrophoblasts, in first trimester placental explants (Maruo 
et al., 1992). VEGF promotes trophoblast adhesion to LE and outgrowth of mouse 
embryos (Hannan et al., 2011, Binder et al., 2014). TGFβ increases trophoblast 
fibronectin secretion, inducing adhesion (Feinberg et al., 1994). At the same time, this 
growth factor inhibits invasiveness, through down-regulation of vascular endothelial-
cadherin protein (Chen et al., 2013). Furthermore, trophoblast stem cell proliferation 
is stimulated by TGFβ in mice (Erlebacher et al., 2004).  
GE also secretes other factors that promote trophectoderm adhesion to LE. Secreted 
phosphoprotein 1 (SPP1), also termed osteopontin, contains the integrin binding motif 
RGD, and mediates adhesion between embryo and LE (Singh and Aplin, 2009). This 
protein is induced in GE by P4, and promotes ovine trophectoderm cell attachment in 
vitro (Dunlap et al., 2008). LIF is an important protein secreted by GE, with multiple 
key roles in implantation, such as blastocyst/LE adhesion, embryo development, 
trophoblast differentiation and invasion, decidualization and leukocyte recruitment 
(Salleh and Geribabu, 2014). Recently, an interesting observation was the absence 
of LIF in mouse ULF (Kelleher et al., 2016). This finding suggests that this factor could 
be secreted basolaterally, rather than to the uterine lumen, acting on the LE and the 
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underlying stromal compartment. Glycodelin, a major secreted glycoprotein, as 
previously referred, is also involved in blastocyst interaction with uterine surface 
epithelium. Glycodelin induction in Ishikawa cells improves trophoblast spheroid 
attachment. This effect was completely abrogated by glycodelin gene (PAEP) 
silencing (Uchida et al., 2007). Proprotein convertase 5/6 (PC5/6) is a serine protease 
expressed by GE in mid-secretory phase. Cleavage of α-dystroglycan N-terminal in 
HEECs by PC5/6 is necessary for embryo attachment (Heng et al., 2015). Exosomes 
are 30-150 nm nanoparticles released from cells into the extracellular space, and 
used for intercellular communication. They were identified in human ULF, but some 
are retained in the glycocalyx (Ng et al., 2013). It has been suggested that the 
clearance of the glycocalyx during implantation releases exosomes, which are taken 
up by trophectoderm, switching it to a more adhesive phenotype (Salamonsen et al., 
2015). Exosomes from P4 treated HEECs increased adhesive ability of trophoblast 
cells (Salamonsen et al., 2015).  
Endometrial gland secretions in the mid-luteal phase also contain chemokines. 
CX3CL1, CCL14 AND CCL4 are amongst the most abundant attractants in human 
ULF, and their receptors are expressed by trophoblast cells.  In vivo stimulation of 
trophoblast migration was demonstrated, and neutralizing antibodies to CX3CL1 and 
CCL4 attenuated this effect (Hannan et al., 2006). Transmembrane water channel, 
aquaporin 2 (AQP2) is mostly up-regulated during the mid-secretory phase, in GE 
and LE, at gene and protein level (He et al., 2006). This protein is involved in 
regulation of water absorption. In mice, during receptive phase, the volume of ULF 
decreases drastically, leading to ‘lumen closure’. This phenomenon is essential for 
embryo apposition. In humans, a significant reduction in ULF has also been detected 
during the mid-secretory phase (Ruan et al., 2014). The control of fluid volume in the 
uterine cavity by AQP2 could contribute for the movement of the blastocyst to the 
eventual site of implantation.  
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Taken together, these data demonstrate the crucial role of endometrial glands in the 
establishment of uterine receptivity and the promotion of embryo implantation.  
1.5.2.3 Stromal Decidualization 
Histologic analysis of uteri of mouse models that are devoid of endometrial glands 
has demonstrated lack of decidualization upon pregnancy or pseudo-pregnancy 
(Jeong et al., 2010, Franco et al., 2011, Filant and Spencer, 2013a, Sone et al., 2013). 
Apart from the absence of uterine glands, these mice have a phenotype that 
resembles that of Lif null mice. LIF is solely expressed by GE in rodents, and is up-
regulated during the receptive phase, in response to the nidatory E2 surge (Salleh 
and Giribabu, 2014). Conditional Esr1 (Erα gene) ablation in GE and LE leads to 
failed decidualization which is rescued by exogenous administration of LIF (Pawar et 
al., 2015). PUGKO mice are infertile due to implantation failure, and do not exhibit 
decidualization. These animals have normal oestrous cycle and expression of steroid 
receptors in the endometrium. Artificial decidualization in PUGKO mice after 
ovariectomy, using E2, P4 and intraluminal injection of oil, was attempted without 
success. The normal increase in uterine Lif expression in the receptive phase was 
abrogated (Filant and Spencer, 2013a). Similar results were observed with 
conditional ablation of Foxa2, Wnt4 and Lgr4 in mice. The phenotypes included failed 
adenogenesis and decreased Lif expression (Jeong et al., 2010, Franco et al., 2011, 
Sone et al. 2013). The results with LIF treatment, in replacement of E2 nidatory surge, 
were conflicting. Treatment could rescue decidualization defects in Foxa2 and Lgr4 
ablation, but failed in PUGKO and Wnt4 ablation mice. This suggests that there may 
be some other uterine gland-secreted factors involved in the process. Glands in 
receptive phase of pregnant and pseudopregnant mice express several candidate 
genes encoding for enzymes, solute carriers and secreted proteins that could be 
involved in the differentiation of the stromal cells (Filant et al., 2014, Filant and 
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Spencer, 2013b). Amongst these genes, serine peptidase inhibitor, Kazal type 3 
(Spink3) is frequently present.  Spink3 mRNA is exclusively expressed in GE, 
whereas the protein is localized on both GE and LE in decidua. The enzyme is not 
regulated by the blastocyst, but is induced by P4 (Chen et al., 2010). Spink3 is not 
conserved in human species, but its homolog, SPINK1, is a potent protease inhibitor, 
acting as an inactivation factor of intra-pancreatic trypsin activity. Mutations in the 
gene are associated with hereditary or chronic pancreatitis (Witt et al., 2000). Brosens 
et al. (2014) have suggested that SPINK1 could protect decidual cells from 
proteotoxic stress triggered by excessive activation of embryo proteases. A striking 
observation is the absence of Lif and Spink3 in mouse ULF (Kelleher et al., 2016). It 
suggests that these factors are not apically released, but may be basolaterally 
secreted for signalling to the stroma.   
In humans, maximal expression of LIF is observed during the mid-secretory phase in 
GE and LE (Paiva et al., 2009). LIF enhances P4-induced decidualization in HESC 
cultures, via STAT3 phosphorylation (Shuya et al., 2011). The cytokine shows an 
increase in human ULF in receptive phase (Laird et al., 1997) LIF could not be 
detected in supernatant of HESC, and concentration in HEEC supernatant was 
maximal when the cells were obtained from secretory phase endometrium (Laird et 
al., 1997). Besides LIF, many factors secreted by endometrial glands in women, such 
as IL11, TGFβ, phospholipase A2 (PLA2), HB-EGF, KLF5 and IHH have been 
implicated in decidualization. IL11 and TGFβ enhance P4-induced decidualization in 
HESC cultures (Dimitriadis et al. 2001, Kim et al., 2005). Phospholipase A2 releases 
arachidonic acid from membrane phospholipids (Rosenson and Gelb, 2009). 
Arachidonic acid is converted to prostaglandins by COX2 (Greenhough et al. 2009). 
PGE2, as previously mentioned, is a potent ligand for cAMP synthesis (Yee and 
Kennedy, 1991). Prostacyclin activates PPARδ, leading to VEGF secretion. VEGF is 
involved in the angiogenesis process observed during decidualization (Prakasi and 
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Jain, 2008). The use of neutralizing antibodies, or an inhibitor for HB-EGF, attenuated 
cAMP-induced PRL expression in HESCs (Chobotova et al., 2005). Conditional KLF5 
ablation prevents decidualization in mice. Furthermore, these factor was 
demonstrated to regulate PTGS2 expression in HEEC (Sun et al., 2012). IHH is a 
mediator of PR signalling in the endometrium. Its effector COUP-TFII is also a 
regulator of stromal angiogenesis (Lee et al., 2006).  
Even though the mechanisms are not fully elucidated, the evidence indicates an 
essential role for endometrial glands in stromal decidualization.  
1.5.2.4 Immunomodulatory Effects of Endometrial Glands 
Protection of the embryo from the maternal immune system is crucial for a successful 
pregnancy. Besides the aforementioned role of stromal decidualization, factors 
secreted by the endometrial glands also aid in this accommodation process.  
Glycodelin A plays a key role in regulation of immune cell-rich decidual environment. 
Numerous immune suppressive effects have been described for this glycoprotein: 
 Suppression of NK cell cytotoxicity (Okamoto et al., 1991) 
 Inhibition of T cell proliferation/activity (Rachmilewitz et al., 1999) 
 Induction of T cell apoptosis (SundarRaj et al., 2008) 
 Induction of tolerogenic phenotype in dendritic cell (Scholz et al., 2008) 
 Inhibition of B cell proliferation/activity (Yaniv et al., 2003) 
 Inhibition of monocyte proliferation (Alok et al., 2009) 
 Induction of monocyte apoptosis (Alok et al., 2009) 
 Furthermore, glycodelin induces secretion of Th2 cytokines (IL6, IL13 and 
GM-CSF) from uNK cells, thereby favouring an advantageous Th2 dominant 
response in early pregnancy (Lee et al., 2011).   
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Other uterine gland products are also components of the innate immune system. 
Serpins are the most broadly distributed superfamily of protease inhibitors. All 
multicellular eukaryotes express serpins. In humans, some function as hormone 
transporters, molecular chaperones and tumour suppressors (Law et al., 2006). ULF 
of 16 day pregnant ewes contain SERPINA14, also called uterine serpin or uterine 
milk protein (UTMP; Koch et al., 2010). This serine protease inhibits lymphocyte 
proliferation, reduces humoral response against albumin, and inhibits NK activity 
(Padua and Hansen, 2010). SERPINA14 could inhibit miscarriage induced by 
polyinosinic:polycytidilic acid, a stimulator of NK activity, in mice (Liu and Hansen, 
1993). This serpin is not expressed in humans, but SERPING1 is up-regulated in mid-
secretory phase endometrium in several genome wide profiling studies (Riesewijk et 
al., 2003, Mirkin et al., 2005, Talbi et al., 2006, Díaz-Gimeno et al., 2011). SERPING1 
is a C1 esterase inhibitor, preventing spontaneous activation of the complement 
system (Law et al., 2006). Uteroglobins are cytokine-like anti-inflammatory proteins, 
produced by decidual glands. Uteroglobin is a potent inhibitor of neutrophil and 
monocyte chemotaxis in vitro (Kundu et al., 1996). Whey acidic proteins (WAP) are 
natural antimicrobials produced by mucosal surfaces (Bouchard et al., 2006). 
Secretory leukocyte protease inhibitor (SLPI) is a WAP, also known as 
antileukoproteinase 1. SLPI is also up-regulated in mid-secretory phase in 
endometrial transcriptome studies (Mirkin et al., 2005, Díaz-Gimeno et al., 2011, Hu 
et al., 2014), and the highest protein expression was found in first trimester decidua 
(King et al., 2000). Curiously, SLPI is also a member of the Kazal superfamily of serine 
protease inhibitors, just like SPINKs. Defensins (DEF) are small cationic proteins with 
antimicrobial properties. β-defensins (DEFB) are the main isoform secreted by 
epithelial glands. These proteins also function as immune cell chemoattractants (King 
et al., 2003). DEFB1 is as well often detected as a mid-secretory up-regulated gene 
(Riesewijk et al., 2003, Talbi et al., 2006, Díaz-Gimeno et al., 2011). 
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These observations are consistent with a simultaneous role for endometrial glands in 
modulation of maternal immune tolerance to the embryo and protection of the 
intrauterine environment from pathogens.  
1.5.3 Regulation of Endometrial Gland Secretion 
Secretory activity of endometrial glands is regulated by the endometrial stroma 
(decidua), the embryo and the ovaries (CL).  
Endocrine support of the decidualizing stroma is accomplished by P4 released from 
CL. This structure is, in turn, rescued from luteolysis by trophoblast derived chorionic 
gonadotropin. PRL is a major decidua-secreted protein. PRL receptor (PRLR) in 
pregnant ewe is exclusively localized in GE, and the expression of UTMP follows PRL 
production by the decidua (Stewart et al., 2000). In humans, PRLR shows maximal 
expression, at both transcript and protein level, in mid-secretory phase and first 
trimester GE (Jones et al., 1998).  Jabbour et al. (2002) suggest that PRL activates 
JAK/STAT and mitogen-activated protein kinase (MAPK) pathways, promoting 
glandular differentiation. At the same time the activation of phosphatidylinositol 3 
kinase (PI3K) pathway would prevent gland cell apoptosis. PRL also enhances P4-
induced secretion of uteroglobin in mouse rabbit (Kleis-SanFrancisco et al., 1993). 
Besides inducing decidual secretion of stimulating factors, P4 also down-regulates 
PR expression in GE (Wang et al., 1998). First, it was believed that P4 directly 
promoted UTMP secretion by uterine glands, although this effect was only detectable 
after 14 days of treatment (Ing et al., 1989). Later it was demonstrated that down-
regulation of PR was actually needed to prevent inhibitory effects of P4 on UTMP 
secretion (Spencer et al., 2004). The stimulatory action of P4 is most likely achieved, 
indirectly, by induction of decidual PRL (Burton et al., 2007).  
Gland secretion diminishes in the late secretory phase of the menstrual cycle 
(McCluggage, 2011). By contrast, glycogen secretion increases until 6 weeks of 
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pregnancy (Burton et al., 2002). Besides CL-derived P4, factors released by the 
conceptus, seems to rescue the function of the endometrial glands. Indeed, 
embryonic signals are able to enhance uterine gland development and secretion in 
domestic animals (Spencer et al., 2004), and GE proliferation in early pregnancy has 
been demonstrated (Demir et al., 2002). Placental lactogen (PL) is a 
syncytiotrophoblast-secreted somatotropin that shares 67% sequence homology with 
PRL, and is able to bind and activate PRLR in GE (Burton et al., 2007). Intrauterine 
infusion of PL in ovine uteri increased the number of glands and induced expression 
of UTMP and SPP1 mRNA in GE (Noel et al., 2003). Chorionic gonadotropin (CG) is 
another hormone secreted by syncytiotrophoblast and with a role in endometrial gland 
function. The maximal expression of the hCG receptor (LHCGR) is observed in LE 
and GE, during the secretory phase (Reshef et al., 1990). Human endometrial gland 
cells increased the expression of PTGS2, encoding COX2, and the secretion of PGE2 
upon exposure to hCG (Zhou et al., 1999). Female baboons exhibited up-regulation 
of glycodelin expression in the uterine glands, when treated with exogenous hCG 
(Hauserman et al., 1998).  
A positive feedback mechanism is suggested between the endometrial glands and 
the conceptus. EGF secreted by the glands stimulates release of hPL and hCG by 
the syncytiotrophoblast. These peptide hormones induce secretory activity by GE 
(Burton et al., 2007). 
In view of these observations, it can be conclude that endometrial gland function in 
pregnancy is regulated by coordinated roles of P4, the decidualized stroma and the 
conceptus (Figure 1.6).  
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Figure 1.6 Regulation of endometrial gland secretion during pregnancy. Gland 
secretory activity, during pregnancy is regulated by the decidualized stroma, the 
corpus luteum, the embryo and by the endometrial glands themselves.  
 
1.6 Missed Miscarriage 
1.6.1 Spontaneous Miscarriage 
According to the Royal College of Obstetricians and Gynaecologists, miscarriage is 
the spontaneous loss of pregnancy before foetal viability, meaning losses until 24 
weeks of gestation. This concept tends to change over time, as survival of earlier 
babies is reported (Lawn et al., 2014). The terminology for the various types of 
miscarriage is controversial, with discrepancy and overlapping being found between 
the different nomenclature systems (Farquharson et al., 2005, Bottomley and Bourne, 
2009, Kolte et al., 2014). 
1.6.2 Epidemiology of Miscarriage 
Approximately 15 % of all clinical pregnancies are lost, 98 – 99 % occurring within the 
first trimester (Regan and Rai, 2000). Risk increases with age. Miscarriage rate of 9% 
at 20 - 24 years old rises to 51 % in women aged 40-44 years (Andersen et al., 2000).  
β-subunit of hCG (βhCG) transcripts were identified as early as the two-cell stage of 
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human embryo development (Jurisicova et al., 1999). Extremely sensitive tests allow 
detection of βhCG in urine and serum 1 day after the implantation, engendering a 
new entity, the occult biochemical or pre-clinical pregnancy. In this scenario, an early 
positive βhCG test is not associated with clinical gestational symptoms, or even a 
positive ultrasound scan (Annan et al., 2013). Some of these women experience 
embryonic loss, before exhibiting an overt pregnancy. The real incidence of total 
miscarriages is difficult to estimate. Some women suffer the loss at home, without 
seeking for medical assistance. Others attend to different medical facilities. 
Furthermore, in many cases, the event presents too early to be distinguished from a 
normal menstrual bleeding or a slight delay in the menses. Nevertheless, when the 
pre-clinical losses are included, the incidence of total miscarriages can reach as high 
as 60% (Macklon et al., 2002).  
Recurrent miscarriage is defined as 3 or more consecutive pregnancy losses before 
foetal viability. It affects 1% of couples, although the incidence rises to 1-5% if the 
definition adopted by many clinicians of 2 or more losses is considered (Rai and 
Regan, 2006). 
1.6.3 Causes of Miscarriage 
Numerous risk factors for miscarriage have been reported. However, establishing a 
real cause and the exact mechanism leading to the foetal loss, has been proven much 
more laborious. Several confounding factors may be involved, making it difficult to 
weigh the real contribution of a specific condition for the aetiology of the miscarriage. 
For example, polycystic ovary syndrome is frequently associated with insulin 
resistance, obesity and hyperprolactinemia (Bahceci et al., 2003). Some factors may 
be associated with recurrent miscarriage, whereas others can only justify sporadic 
cases. Infectious diseases, for instance, are usually associated with occasional, 
rather than repetitive pregnancy complications (Giakoumelou et al., 2015).  
Chromosome abnormalities are described as the major cause of miscarriage, 
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accounting for almost half of the cases (Goddijn and Leschot, 2000). Interestingly, 
the incidence of aneuploidies and structural aberrations in recurrent and sporadic 
miscarriages is the same (Stephenson et al., 2002, van der Berg et al., 2012).  
Despite the plethora of putative pathologies associated with pregnancy loss, 40 - 50% 
of couples with recurrent miscarriage lack a diagnosis after the initial clinical 
investigation. In Table 1.3 some frequently described miscarriage risk factors are 
displayed with their possible causality. 
 
Table 1.3 Risk factors for miscarriage and their causalities 
Risk factor Causality  Reference 
Chromosome 
abnormalities 
~45% of all losses.  
Similar incidence in recurrent 
pregnancy losses (RPL). 
Stephenson et al., 
2002 
van der Berg et al., 
2012 
Parental balanced 
translocation 
50% risk.  
Similar prognosis as other RPL 
causes recommends against 
PGD. 
Treff et al., 2013 
  
Franssen et al., 2006 
Thrombophilias  
- Antiphospholipid 
syndrome (APS) 
- Deficiency of protein C 
- Deficiency of protein S 
- Factor V Leiden 
- Factor II mutation 
 
Increased risk in APS.  
Not clear in congenital 
thrombophilias and no clear 
benefit for heparin and 
aspirin. 
 
McNamee et al., 2012 
  
de Jong et al., 2014 
Endocrine 
- Hypothyroidism 
 
 
- PCOS 
 
 
  
- LPD 
  
  
- Higher risk even with 
elevated autoantibodies 
and normal TSH. 
- Higher risk. No clear benefit 
with metformin in normal 
glucose tolerance.  
 
- Controversial diagnosis. 
Benefits with P4 for RM. 
  
Marai et al., 2004 
  
Zolghadri et al., 2008 
  
 Haas and Ramsey, 
2014 
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- Hyperprolactinemia 
 
  
- Diabetes 
- Higher risk. No clear benefit 
with dopamine agonists. 
 
- Higher risk, only if not 
properly controlled. 
 Pluchino et al.,  2014 
Chen et al., 2016 
Gutaj et al., 2013 
  
Infection Higher risk in malaria, 
brucellosis, CMV, HIV, dengue 
fever, influenza, bacterial 
vaginosis, rubella and syphilis. 
Not clear in Chlamydia, 
toxoplasmosis, HPV, HSV, 
parvovirus B19 and Hepatitis B 
Giakoumelou et al., 
2015 
Life style 
- Alcohol 
- Coffee 
  
- Smoking 
- Obesity 
  
- Higher risk 
 
- Increased risk with high 
doses 
 
- Higher risk 
 
- Higher risk 
  
Andersen et al., 2012 
Bech et al., 2005 
Weng et al., 2008 
Pineles et al., 2014 
Talmor et al., 2015 
Uterine malformations Higher risk in septate, 
bicornuate and unicornuate 
uteri. Higher risk of second 
trimester loss with arcuate 
uterus. No clear benefit with 
metroplasty.  
Chan et al., 2011 
  
Kowalik et al., 2011 
Vitamins and 
oligoelements 
  
No association with a specific 
vitamin or oligoelement 
deficiency detected. 
Multivitamins and iron 
supplements reduce risk for 
stillbirth. 
Balogun et al., 2016 
Natural killer cells No increased risk. 
Heterogeneity in methods 
used to measure number or 
density of the cells.  
Tang et al., 2011 
Sperm DNA fragmentation Higher risk. Robinson et al., 2012 
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1.6.4 Missed Miscarriage 
Missed miscarriage, also known as delayed miscarriage or silent miscarriage, is 
defined as a non-viable < 20 weeks pregnancy, and absence of uterine activity to 
expel the products of conception (Farquharson et al., 2005). Amongst some reported 
risk factors are folic acid deficiency, lack of physical exercise, hypoventilation and 
environment factors, such as ionizing radiation, pesticides, polycyclic aromatic 
hydrocarbons and phthalates (Zhang et al., 2011). A remarkable 13 - 24 fold increase 
in the incidence has been observed in China between 2002 and 2012, concomitant 
with escalating levels of industrial pollutants in the air (Yi et al., 2016).  
The condition is found in 2.8 % of couples at 10-14 week pregnancy (Pandya et al., 
1996). Besides the unexpected ultrasound finding in asymptomatic patients, there are 
cases of women with a mild first trimester bleeding and a long closed cervix, or the 
report of bad premonition, after the ceasing of pregnancy symptoms (Jansson and 
Adolfsson, 2010). The final diagnosis is usually achieved by serial ultrasound scans 
and common echographic signs include: 
 Persistent empty gestational sac (GS) (Kolte et al., 2015).  
 Small GS for pregnancy age calculated by the last menstrual period (LMP), 
also called early oligohydramnios (Odeh et al., 2010). 
 Absence of foetal heart activity after 6 weeks of pregnancy or crown-rump 
length (CRL) ≥ 5 mm (Farquharson et al., 2005). 
 Failure of CRL to progress in one week (Bottomley and Bourne, 2009). 
 CRL small for gestational age, calculated by LMP (Farquharson et al., 2005). 
 Foetal bradycardia (Makrydimas et al., 2003). 
 Abnormalities in yolk sac: large, small, unusual shape, calcification, or early 
regression (Cho et al., 2006). 
58 
 
For the purpose of this thesis missed miscarriage was considered as first trimester 
intrauterine visualized losses and empty sacs. Ectopic pregnancies and pregnancies 
of undetermined location were also excluded.  
1.6.5 Etiopathogenesis of Missed Miscarriage 
There are no defined specific conditions associated with missed miscarriages, but 
some mechanisms have been suggested. Several studies addressing this type of 
foetal loss direct the main focus on the discovery of diagnostic markers, thereby not 
being possible to discriminate whether the finding is rather a cause than a 
consequence of the pregnancy failure.  
There is no precise estimate for the incidence of chromosome abnormalities in missed 
miscarriage cases. Nevertheless, some studies coupling embryoscopy with 
karyotyping suggest a higher frequency when compared to general miscarriages. 
Philipp and Kalousek (2001) found 9 (60 %) abnormal karyotypes in 15 embryos. In 
a larger series, the same group demonstrated 70 % of chromosome errors in 37 cases 
of missed miscarriage (Philipp et al., 2002). Ferro et al (2003), after analysing 55 
karyotypes of direct embryo biopsies, detected 37 (67.3 %) chromosome 
abnormalities. An even higher incidence of abnormal karyotypes was observed again 
by Philipp et al. (2003). These authors identified 165 (75 %) chromosome errors 
amongst 221 missed miscarriage cases. A remarkable finding in all of these studies 
was the frequency of morphologically abnormal embryos with a normal karyotype that 
varied from 18 % to 35.7 %. In another study, 177 (65 %) abnormal karyotypes were 
encountered in 272 curettages of missed miscarriages, 58 % amongst empty sacs 
and 68 % amongst retained embryos (Lathi et al., 2007). Askerov (2016), 
investigating 59 cases of anembryonic pregnancies, detected 71.4 % of chromosome 
abnormalities in spontaneous pregnancies, whereas between the pregnancies after 
assisted reproduction techniques, the incidence was 55.3 %. However, even 
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considering the high incidence of chromosome errors, 25–40 % of missed miscarriage 
cases may occur due to other aetiologies.   
Angiogenesis is crucial for the development of functional chorionic villi. The hypoxic 
environment of the maternal-placental interface in the first trimester induces the 
expression of several angiogenic factors and their inhibitors (Charnock-Jones et al., 
2004). Impaired angiogenesis has been implicated in the genesis of missed 
miscarriages. Reduced serum levels of the angiogenic placental growth factor (PlGF) 
and the VEGF inhibitor serum fms-like tyrosine kinase 1 (sFlt1) were associated with 
missed miscarriage, and were postulated to occur as a consequence of decreased 
local hypoxia (Daponte et al., 2011, Martinez-Ruiz et al., 2014). Precocious increase 
in oxygen levels in IVS, would disturb placental angiogenesis. Lower serum levels of 
angiopoietin 1 and 2 were also verified in delayed miscarriage cases (Daponte et al., 
2013a). The main issue with these investigations on angiogenesis is the focus on the 
discovery of markers to discriminate between normal pregnancy and missed 
miscarriage or even between missed miscarriage and ectopic pregnancy. Fang et al. 
(2013) demonstrated dysregulation of the hypoxia induced factor 1α 
(HIF1α)/VEGF/sFlt1/delta-like ligand 4 (Dll4)/Notch 1 pathway in placental villi of 
missed miscarriages. The authors suggested that excessive hypoxia would 
disarrange this system, resulting in reduced expression of the Notch 1 ligand, Dll4, 
an essential factor for establishment of vascular endothelial cell fate.  
Placental apoptosis has essential roles in early pregnancy, ensuring maternal 
immune tolerance to the implanting embryo, and steering trophoblast remodelling 
(Jersak and Bischof, 2002). However, excessive villous apoptosis may increase the 
risk for early pregnancy complications (Rull et al., 2013). Cells from amniotic and 
coelom fluid acquired from missed miscarriages exhibited higher expression of FAS 
and FAS ligand. These are main factors that control apoptosis. Furthermore, the 
same samples and trophoblast samples from the same patients harboured a higher 
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number of cells stained positive for terminal deoxynucleotidyl transferase (TdT) dUTP 
Nick-End Labeling (TUNEL) (Kaponis et al., 2008). TUNEL is a method for detecting 
apoptotic cells that undergo extensive DNA degradation (Kyrylkova et al., 2012). 
Gene associated with retinoid-interferon mortality 19 (GRIM19) is an anti-apoptotic 
gene essential for the assembly of mitochondrial complex 1 (Huang et al., 2004). 
Expression of GRIM19 was downregulated in trophoblast from missed miscarriage 
patients. The expression of P53 was up-regulated and the number of TUNEL+ cells 
was higher when compared with normal pregnancies. In addition, the expression of 
HIF1α was increased, and that of VEGF was reduced (Chen et al., 2015). P53 is a 
pivotal mediator of apoptosis in response to DNA damage. Human double minute 2 
(HDM2) is induced by P53 and is a key inhibitor of P53 activity. A specific combination 
of gene polymorphism for P53 and HDM2 was observed in association with recurrent 
miscarriage (Fang et al., 2011). The authors suggested that this gene-gene 
polymorphism interaction would blunt the apoptotic process in the placenta. Thereby 
the clearance of DNA damaged cells would be impaired, resulting in foetal demise. 
These data underscores the importance of a fine balanced control of apoptosis in the 
human placenta.   
Decidua- and placenta-derived cytokines are critical to ensure maternal immune 
tolerance to the foetus and a successful pregnancy (Mor et al., 2011). Imbalance in 
the secretion of the various members can lead to pregnancy disorders (Raghupathy 
and Kalinka, 2008). A shift from an anti-inflammatory Th2-type cytokine response (i.e. 
secretion of IL4 and IL10) to a pro-inflammatory Th1-type cytokine response (i.e. 
secretion of interferon γ [IFNγ], IL2, sIL2R, IL12, IL15, TNFα) has been indicated as 
a possible cause for missed miscarriage. Plevyak et al., (2002) observed decreased 
expression of IL10 and no changes in IFNγ and immune cells in decidua from missed 
miscarriage patients. Daponte et al., (2013b) detected increased serum levels of IL15 
and no changes in anti-C1q in patients with delayed early pregnant loss. Increased 
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serum levels of IL12 and sIL2R were also described in cases of missed miscarriage, 
when compared to normal pregnancy and even threatened miscarriage (Paradisi et 
al., 2003). In a more recent study, increased serum levels of IFNγ and reduced IL4 
and peripheral Treg cells were verified in missed miscarriage cases (Cao et al., 2014). 
Based on the additional observation of decreased E2 serum concentrations, the 
authors suggested a positive correlation of the low levels of T reg cells and IL4 with 
the low concentration of that sex steroid. 
Metabolomics is the study of endogenous low-molecular-weight metabolites that 
could serve as disease-specific biomarkers, or provide insights into mechanisms of a 
disorder (Zhang et al., 2012). In a recent paper, this approach was used in an attempt 
to define biomarkers for missed miscarriage (Fei et al., 2016). Thirty-seven differential 
plasma metabolites that discriminate between normal pregnancies and missed 
miscarriages were detected. Using metabolic impact analysis, two metabolic 
pathways were identified: tryptophan and sphingolipid metabolism. Lower level of 
tryptophan and their metabolites were observed (Fei et al., 2016). Tryptophan 
degradation is essential for maternal immune tolerance to the foetus via growth arrest 
of T cells (Mellor and Munn, 2001). This amino-acid is also crucial for foetal growth 
and development during the organogenesis period (Badawy, 2015). It is also a 
precursor of serotonin, and placenta-derived serotonin is involved in foetal brain 
development (St-Pierre et al., 2016). As regards the sphingolipid metabolism, higher 
plasma levels of sphingosine and reduced levels of sphingosine 1-phosphate (S1P) 
were detected in cases of missed miscarriage (Fei et al., 2016). Sphingosine inhibits 
proliferation and induces apoptosis and inflammation, whereas S1P has anti-
apoptotic, anti-inflammatory and angiogenic properties (Gomez-Muñoz et al., 2016). 
Sphingolipid metabolism pathway is also critical for prevention of foetal rejection by 
regulation of innate immunity at the feto-maternal interface (Mizugishi et al., 2015). In 
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addition, S1P was demonstrated to play a role in the maintenance of the corpus 
luteum in mice (Hernandez et al., 2009).  
 Oxidative stress has been implicated in RPL (Gupta et al., 2007). Elevated serum 
levels of lipid peroxidation and reduced levels of reduced glutathione, GPX, vitamin 
A, vitamin E and β-carotene have been observed in patients who suffered recurrent 
miscarriages (Şimşek et al., 1998). Decreased plasmatic levels of the antioxidants α-
tocopherol, vitamin C and erythrocyte glutathione and total thiols were also 
associated with repeated miscarriages (Vural et al., 2000). Sata et al. (2003) reported 
increased risk for RPL in glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) 
gene polymorphism carriers. These enzymes are important free radical scavengers 
(Hayes and Strange, 2000). Based on the findings of Nelen et al. (2000) associating 
homocysteinemia and RPL, Gupta et al. (2007) postulated that the pro-oxidant 
property of homocysteine would be the mechanism responsible for the pregnancy 
failures. Up-regulated expression of the oxidative stress markers hsp 70 and 
nitrotyrosine, alongside with increased lipid peroxidation in placental specimens were 
described in missed miscarriage (Hempstock et al., 2003). Sugino et al. (2000), 
compared oxidative stress in decidua from normal early pregnancies, missed 
miscarriages and spontaneous miscarriages with vaginal bleeding. Total SOD 
activity, Cu,Zn-SOD activity and mRNA where decreased, and lipid peroxidase and 
PGF2α were increased in spontaneous miscarriage with bleeding. By contrast, there 
were no differences between normal pregnancies and retained conceptuses. The 
authors proposed that the elevated ROS levels would induce PGF2α synthesis in 
miscarriages with spontaneous expulsion of conceptus. This phenomenon would be 
abrogated in missed miscarriages. However, in the study it was not possible to 
ascertain if the stress response was a cause or a consequence of the increased 
uterine activity. More recently, a study showed a decrease in SOD and HIF1α 
expression, and increased ROS levels in trophoblasts from missed miscarriage 
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patients, indicating a possible mechanism for foetal demise through disturbed 
angiogenesis (Zhu et al., 2014).  
Although most knowledge on this type of pregnancy loss is derived from serum, 
placenta and, in a lesser proportion, decidua analysis, no investigation on endometrial 
glands has been hitherto performed. Furthermore, as previously mentioned, all these 
studies have been performed during the miscarriage time-frame, thereby not being 
possible to determine if the conditions were cause or consequence. Considering the 
crucial role of uterine glands in providing nutrients and growth factors for the embryo 
in the early pregnancy, it is rational to presume that glandular defects could lead not 
only to inadequate foetal nutrition, but also to impaired organogenesis and eventually 
foetal death. The result would be a malformed foetus or an empty sac with a normal 
karyotype. Indeed several papers have described structurally abnormal foetuses at 
embryoscopy as well as empty sacs with normal karyotypes (Phillipp and Kalousek, 
2002, Ferro et al., 2003, Lathi et al., 2007).   
 
 
 
 
 
 
 
 
 
 
64 
 
1.7 Research justification and aims 
The role of endometrial glands in the implantation process and early pregnancy 
remains poorly understood. A major hurdle is the inability to successfully propagate 
and differentiate primary HEECs in culture, which contributes to the paucity of studies 
focusing on glands in the endometrial field. Hence, the overall aim of my project is to 
develop efficient methods for isolation, culturing and differentiation of primary HEECs 
in vitro. The specific goals are: 
 To establish 2D and 3D models to study of primary HEECS and human 
endometrial glands in culture, respectively.  
 To study the effect of ovarian steroids, embryo-derived signals and stromal 
decidua cues on HEEC cultures. 
 To investigate the role of uterine glands in the pathophysiology of recurrent 
missed miscarriages.  
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Chapter 2 
 
Materials and methods 
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2.1 Materials and Recipes 
2.1.1 List of Materials 
Table 2.1 Materials used in the experiments, supplier and catalog numbers. 
Material Supplier Catalog number 
β-actin antibody  Mouse  Abcam AB8224 
β-estradiol  Sigma-Aldrich E2758 
 
β-mercaptoethanol    Sigma-Aldrich M3148 
 
3T3 swiss albino mouse 
embryo fibroblasts (cell line)  
Sigma-Aldrich 85022108 
 
8-Bromoadenosine 3',5'- 
cAMP 
Sigma-Aldrich B7880 
 
6x DNA gel loading dye      Thermo Scientific R0611 
 
6 well plates  Corning 3598 
 
12 well plates  Corning 3513 
 
24 well plates  Corning  3506 
 
96 well plates  Corning  3599 
 
Acrilamide, 30%  Bio-Rad Laboratories      161-0158 
 
Adenine - Sigma-Aldrich   A2786  
 
Advanced DMEM/F12      Life Technologies 12634010 
 
ALK-4, -5, -7 inhibitor, A83-
01  
Sigma-Aldrich SML0788 
 
Ammonium persulfate 
(APS)   
 
Sigma-Aldrich   A3678 
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Antibiotic/antimycotic 
(Penicilin, streptomycin, 
amphotericin B)  
Gibco 15240-062 
 
B27 supplement minus 
vitamin A      
Life Technologies 12587010 
 
Black 96-well plate for 
fluorescence     
Appleton Woods 611F96BK 
BSA  
 
–Sigma-Aldrich      A2153 
Cell Recovery Solution   Corning 354253 
 
Cell scrapers     Corning 3010 
 
Cell strainer, 40 µm  Fisher Scientific 22363547 
 
Charcoal Sigma-Aldrich  Sigma-Aldrich C9157 
 
Chloroform  VWR    100034Q 
 
Cholera toxin   Sigma-Aldrich C8052 
 
Cleaning agent for 
removing RNAse (RNAzap)  
Sigma-Aldrich R2020 
 
Collagenase  Sigma-Aldrich C9891 
 
Cytokeratin 18 antibody  
Mouse     
Abcam AB668 
 
DNAse I for tissue digestion  Roche 11284932001 
 
Dextran 70   Sigma-Aldrich 1179741 
 
DL-dithiothreitol (DTT)   Sigma-Aldrich   D9779 
DPX mounting medium   Leica 3808600E   
Dulbecco’s modified Eagle 
medium (DMEM)/F12 
Gibco 31330-638 
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nutrient (Ham) (1:1) 
medium with red-phenol  
Dulbecco’s modified Eagle 
medium (DMEM)/F12 
nutrient (Ham) (1:1) 
medium with red-phenol  
 
Gibco 11039-021 
E-cadherin antibody Rabbit  Cell Signaling    3195 
 
ECL Western-blotting 
analysis system    
GE Healthcare RPN2232 
ENaCα antibody  Sigma     Sigma-Aldrich HPA012743 
 
ENaCβ antibody  Sigma-Aldrich HPA015612 
 
ENaCγ antibody          Proteintech 13943-1-AP 
 
Eosin Y   Sigma-Aldrich          HT110132 
 
Epidermal growth factor 
(EGF)   
Peprotech    AF100-15 
 
Eppendorf tubes 1.5 ml    Starlab  E1415-1500 
 
Eppendorf tubes 0.6 ml    Starlab E1405-0600 
 
Ethanol  Fisher Chemical    E/0650DF/17 
 
Falcon tubes  14 ml   
 
Greiner Bio-one 188261 
Falcon tubes  50 ml   
 
Greiner Bio-one 227270 
 
Fetal bovine serum (FBS)  Gibco 10500-64  
 
FGF10     Peprotech 100-26 
 
Filter paper     Whatman   3001-861 
 
Formaldehyde, 4%      VWR 9713 
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Frostbite freezing spray    Leica 3803100EE 
Gel cassettes   Novex   NC2015 
 
Glass-bottom Petri-dishes   Mat tek      P35GCol-1.5-10-C 
 
Glass Pasteur pipettes  Fisher Scientific 1156-6963 
Glass slides       
 
Thermo Scientific BS7011/2 
Gloves  Kimtech Science      90626 
 
Glycogen         Invitrogen 10814-010 
 
Hanging Drop plates   Sigma Aldrich HDP1096 
 
hepatocyte growth factor 
(HGF)    
Peprotech 100-39 
 
Human chorionic 
gonadotropin (hCG)   
 
Sigma-Aldrich C0434 
Histone H3-MeK9 antibody  
Rabbit  
Abcam AB8898 
 
HMGB2 antibody  Rabbit    Abcam AB672282 
 
Hydrocortisone   
 
Sigma-Aldrich   H0888   
Hyper ladder V     
 
Bioline BIO-33031 
Insulin   Sigma-Aldrich 91077C 
 
Isopropanol (2-Propanol)   Sigma-Aldrich     24137 
Isolation caps with diffuser 
for LMD  
Molecular Machines 
Industries 
50202 
 
Lamin B1 antibody Mouse  Abcam  
 
AB8982 
LDS buffer NuPAGE     Invitrogen NP0008 
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L-glutamine   Gibco 25030-024 
 
Matrigel  
 
Corning 354230 
Medroxiprogesterone 17-
acetate  
Sigma-Aldrich   M1629 
 
Membrane slides  
 
Molecular Machines 
Industries    
50103 
Methanol  
 
Fisher Chemical    M/4000/17 
Microtome blade      
 
Leica R-35 
N2 supplement   Life Technologies 17502048 
 
N-acetyl-L-cysteine     
 
Sigma-Aldrich A9165 
Nicotinamide    Sigma-Aldrich N0636 
 
N, N, N’,N’-
tetramethylethylenediamine 
(TEMED)  
Sigma-Aldrich     T9281 
 
Noggin    Peprotech 120-10C 
 
Nonfat dried milk powder   Panreac AplliChem A0830 
 
Nuclease-free water       Ambion AM9932 
 
OCT cryoembedding matrix     
 
VWR 36160E 
P16 antibody Rabbit       Abcam AB108349 
 
P53 antibody  Mouse       Dako M7001 
 
Parafilm     Bemis PM-996 
 
PBS  Fisher Scientific 102092521X-PBS 
 
PCR plates  FAST      Applied Biosystems 4346906 
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PCR plates  non-FAST   
 
Applied Biosystems    N8010560 
PCR plate sealing film   Excel Scientific      TS-RT2-100 
 
Petri-dish 92 x 16 mm  Sarstedt   821473 
 
Pipette tips 10 µl Alpha Laboratories ZP1010S 
 
Pipette tips 40 µl Alpha Laboratories ZP1204S 
Pipette tips 100 µl Alpha Laboratories ZP1200S 
Pipette tips 300 µl Alpha Laboratories ZS3300S 
Polyvinylidene Fluoride 
(PVDF) blotting membranes  
GE Healthcare 10600023 
 
Prestained protein ladder   Thermo Scientific    26619 
 
Progesterone   Sigma-Aldrich P7556 
 
Prolactin  Peprotech 100-07 
 
Protease inhibitor    Roche 11836170001 
 
Protein assay dye reagent   Bio-rad    5000006 
 
RTCA plates (E-plate)   ACEA Biosciences 05469813001 
 
R-spondin 1   Peprotech 120-38 
 
RIPA buffer   Upstate Cell Signalling 
Solutions 
20-188 
 
Scalpels   Swann-Morton 0501  
 
Secondary antibodies HRP 
anti-mouse  
Dako   P0447 
 
Secondary antibodies HRP 
anti-rabbit      
Dako P0448 
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Secondary antibody, anti-
mouse alexa-fluor 488 
Molecular Probes      A11088 
 
Secondary antibody, anti-
mouse alexa-fluor  
Molecular Probes      A21424 
 
Serological pipettes 5 ml   Greiner Bio-one    606 180 
 
Serological pipettes 10 ml Greiner Bio-one    607 180 
 
Serological pipettes 25 ml Greiner Bio-one    760 180 
 
Sodium dodecyl sulphate 
(SDS)  
Sigma-Aldrich      75746    
 
Sponge pad for blotting  Novex   EI9052 
 
STAT-60   AMS Biotechnology   CS-502 
 
Sybr green      Applied Biosystems 4367659 
 
Syringes 20 ml   BD Plastipak 300613 
 
Syringes 50 ml   BD Plastipak 300865  
 
Syringe filter   Sartorius Stedim Biotech 16534-K 
 
Transwell cell culture 
inserts  
BD Falcon 353095 
 
Triton X-100  Sigma-Aldrich     T9284 
 
Trypsin Sigma-Aldrich T4799 
 
Trypsin-EDTA 0.25%  Gibco 25200-056 
 
Tween 20  Fisher Scientific    EC500-018.3 
 
Vectashield mounting 
medium with DAPI  
Vector Laboratories H-1500 
Vimentin antibody Mouse   Cell Signalling 3390 
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Y-27632   Abcam AB120129 
 
Xylene   Fisher Chemicals      X/250/17 
 
Gel extraction/purification 
of DNA  
Qiagen 28704 
Glycogen assay Kit    Abcam AB169558 
 
Immunohistochemistry  Leica   RE7150-K 
 
Laser microdissection 
staining kit     
Ambion AM1935 
On-column DNAse I 
digestion set   
Omega Bio-Tek   E1091 
PGE2 ELISA kit   Thermo Scientific EHPGE2 
 
Reverse transcription kit     Qiagen 205314 
 
RNAqueous Micro Kit Ambion AM1931 
 
Senescence-associated 
beta galactosidase 
activity kit (fluorometric 
format)    
Cell Biolabs CBA-231 
Senescence-associated 
beta galactosidase 
staining kit  
Cell Signaling     98605 
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2.1.2 Recipes 
2.1.2.1 Blocking Buffer for Blotting 
5% Skimmed milk powder (w/v) in TBS-T 
2.1.2.2 Blocking Buffer for Immunofluorescence: 
1% BSA (w/v) in PBS  
2.1.2.3 Running Buffer (10 X)   
250 mM Tris base 
192 mM Glycine 
1% (w/v) SDS 
2.1.2.4 Transfer Buffer (10 X) 
250 mM Tris base 
192 mM Glycine 
20 % (v/v) Methanol 
2.1.2.5 DNA Loading Buffer 
0.3 % (w/v) Bromophenol blue 
40% (v/v) Glycerol 
0.25 M EDTA, pH 8.0 
2.1.2.6 Tris-Borate EDTA (TBE) Buffer (10 X) 
0.9 % Tris-borate 
2 mM EDTA, pH 8.0 
2.1.2.7 Tris-Buffered Saline (TBS) (10 X) 
130 mM NaCl 
20 mM Tris 
Adjust pH to 7.8 
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2.1.2.8 TBS-T 
0.1 % Tween 20 in 1X TBS 
2.1.2.9 Tris-EDTA Elution (TE) Buffer 
10 mM Tris-HCl pH 8.0 
1 mM EDTA  
2.1.2.10 Citrate Buffer 
Sodium citrate 10 mM 
0.05 % Tween 20 
2.1.2.11 Whole Cell Extraction Buffer (WEB buffer) 
20 mM Hepes 0.5% NP-40  
0.5 % NP-40 
15 % glycerol 
0.3 M NaCl 
0.5M EDTA 
1 mM Na3VO4 
10 mM NaF 
1 mM DTT 
2 mM leupetin 
1.5 mM pepstain 
150 µM aprotinin 
0.6 mM phenylmethylsufonyl fluoride (PMSF) 
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2.1.2.12 10% dextran-coated charcoal (DCC) Medium 
500 ml DMEM/F12 with phenol red   
50 ml DCC                                                  
2 mM L-Glutamine                                    
5 ml Antibiotic-Antimycotic solution (100 X) 5 ml 
2 µg/ml Insulin  
1 nM Oestradiol                  
 
2.1.2.12 Conditioned Reprogramming of Epithelial Cell Medium 
(CRC Medium) 
500 ml DMEM/F12 with phenol red   
50 ml DCC                                                  
2 mM L-Glutamine                                    
5 µg/ml Insulin 
5 ml Antibiotic-Antimycotic solution (100 X) 5 ml 
8.4 ng/ml Cholera toxin  
10 ng/ml EGF 
0.4 µg/ml hydrocortisone 
24 µg/ml Adenine 
10 µM/l Y-27632 
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2.1.2.13 Organoid Expansion Medium  
500 ml Advanced DMEM/F12  
5 ml N2 supplement (100 X) 
10 ml B27 supplement minus vitamin A (50 X) 
5 ml Antibiotic-antimycotic solution (100 X) 5 ml 
1.25 mM N-acetyl-L-cysteine 
2 mM L-glutamine 
50 ng/ml EGF 
100 ng/ml Noggin 
500 ng/ml R spondin-1 
100 ng/ml FGF10 
50 ng/ml HGF 
500 nM ALK-4, -5, -7 inhibitor 
10 mM Nicotinamide 
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2.2 Methods 
2.2.1 Cell culture 
2.2.1.1 Procurement of Endometrial Tissue 
Endometrial tissue was acquired from women attending the Implantation Clinic at 
University Hospitals Coventry and Warwickshire National Health Service Trust, after 
obtaining written consent. The study was approved by the NHS National Research 
Ethics Committee of Hammersmith and Queen Charlotte’s Hospital NHS Trust. 
Endometrial biopsies were collected under ultrasound guidance, using a Wallach 
Endocell sampler (Wallach Surgical Devices, Trumbull, CT, USA), and were timed to 
the mid-secretory phase of the menstrual cycle. LH surge was self-assessed by the 
patients through a home urine ovulation test. None of the women were using 
hormones for at least three months prior to the tissue collection. A fragment of the 
tissue was put in 10 % DCC medium for immediate isolation of endometrial cells. 
Another fragment was immediately snap frozen in liquid nitrogen and kept at - 80 ºC 
until its use for laser microdissection. 
 
2.2.1.2 Preparation of Dextran-Coated Charcoal Treated Stripped 
Foetal Bovine Serum (DCC) 
Foetal bovine serum (FBS) was stripped of several small molecules, including 
endogenous hormones, by treatment with dextran-coated charcoal. Here, 1.25 g 
charcoal and 125 mg dextran were added to 500 ml FBS and incubated at 56 oC for 
2 hours with intermittent shaking. The mixture was centrifuged at 1100 g for 30 
minutes, before the supernatant was filtered to remove the charcoal, and aliquoted 
and stored at - 20 ºC.  
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2.2.1.3 Isolation of Endometrial Stromal Cells (HESC) 
The endometrial tissue was minced for 5 minutes with a scalpel, and digested in an 
enzymatic solution (composition: 0.1 mg/ml DNAse I and 0.5 mg/ml collagenase in 
10 ml phenol red-free DMEM/F12) for one hour at 37 ºC with intermittent shaking. 
After 1 hour, collagenase was neutralized by addition of 10 ml 10 % DCC medium 
and centrifugation at 280 g for 5 minutes. The cell pellet was re-suspended in 10 % 
DCC medium and seeded into tissue culture flasks. Blood and epithelial cells in 
suspension were removed by changing media after 3 hours and within 18 hours. 
Media were changed every other day until the cells were confluent.  
2.2.1.4 Isolation of Human Endometrial Epithelial Cells (HEEC) 
The endometrial tissue was minced using a scalpel, for 5 minutes, and digested in an 
enzymatic solution with 0.1 mg/ml DNAse I and 0.5 mg/ml collagenase in 10 ml 
phenol red-free DMEM/F12 for one hour at 37 ºC, with intermittent shaking. After one 
hour, the solution was filtered through a 40 µm cell strainer. Stromal cells passed 
through the filter and the endometrial gland clumps were retained. The strainer was 
backwashed with 20 ml DMEM/F12 and centrifuged at 280 g for 5 minutes. The cell 
pellet was re-suspended in 1 ml 0.25 % tripsin-EDTA and incubated at 37 ºC for 10 
minutes, to allow dissociation of the glandular clumps. After 10 minutes, 10 ml 10 % 
DCC medium were added to stop the enzymatic process and the solution was 
pipetted up and down several times to physically dissociate the gland clumps. Cell 
suspension was centrifuged at 280 g for 5 minutes, and the pellet re-suspended and 
seeded in tissue culture dishes. The first media change were undertaken after 60 
hours to allow the epithelial cells to attach to the dish. Subsequent media changes 
were carried out every other day until the cells were confluent.  
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2.2.1.5 Cell Passage 
Cells were washed with phosphate buffered saline (PBS) lifted with 0.25 % Trypsin-
EDTA, and incubated for 5 minutes at 37 ºC. The flask was gently agitated and cell 
detachment checked intermittently on the microscope. In order to stop trypsin 
digestion, 10% DCC medium was added and the cell suspension was centrifuged at 
280 g for 5 minutes. Cells were re-suspended, and seeded in tissue culture dishes.  
2.2.1.6 Cell Freezing 
Once the cells were separated (see ‘Isolation of endometrial stromal cells’ and 
‘Isolation of endometrial epithelial cell’), the cell pellets were re-suspended in 900 µl 
DCC. 900 µl of a 20 % (v/v) DMSO in DCC solution was added dropwise with 
continuous mixing of the solutions. The solution was mixed by pipetting up and down 
several times and transferred to a cryovial. Cells were frozen at a rate of 1 ºC/minute 
in a freezing container (Nalgene, Mr. Frosty) with isopropanol, and kept overnight, at 
- 80 ºC before transfer to liquid nitrogen the following day. 
2.2.1.7 Cell Thawing 
The cryovial was transferred from liquid nitrogen to dry ice. The cryovial was thawed 
at 37 ºC for 4 minutes, and cells were immediately added into a 50 ml Falcon tube 
with 10 ml pre-heated 10 % DCC media. The solution was centrifuged at 280 g for 5 
minutes before thel pellet was re-suspended and seeded into a tissue culture dish. 
2.2.1.8 Culture of 3T3 Swiss Albino Mouse Fibroblasts 
Cells were supplied as frozen cryovial stock. Cells were submitted to the same 
method described in ‘Cell thawing’, and were seeded into a T75 flask using 
DMEM/F12 supplemented with 10 % (v/v) FBS, 1 % (v/v) antibiotic-antimycotic and 2 
mM L-glutamine. Media were changed every other day. Cells were passaged when 
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90 % confluent, using the same method described in ‘Cell passage’, and were split in 
one T75 and four 100 mm Petri-dishes. The cells in the Petri-dishes were used for 
irradiating with UVC light.   
2.2.1.9 Irradiation of 3T3 Swiss Albino Mouse Fibroblasts 
Cells were irradiated when they reached 60 - 70 % confluency. Media were removed 
and saved. 10 ml of PBS was added to the Petri-dish and next aspirated. The Petri-
dish was irradiated with a 100 J/m2 dose of ultraviolet C light (254 nm), using a CX-
2000 UVC crosslinker (UVP, Upland, CA, USA). Saved media was added to the cells, 
and after 3 days, the supernatant was harvested and stored at - 20 ºC.  
2.2.1.10 Differential Trypsinization for Separation of Feeder Layer 
and HEEC 
Cells were washed with PBS, and incubated in 1 ml 0.25 % trypsin-EDTA for 1 -2 
minutes under phase microscopy monitoring. Once the fibroblasts started to detach 
dishes were gently tapped and the floating feeder cells were removed. Remaining 
cells were washed in PBS, and 1 ml 0.25 % trypsin-EDTA was added again for the 
dissociation of HEEC for another 5-7 minutes. Floating HEEC were transferred to 14 
ml Falcon tubes and 9 ml 10% DCC medium were added to stop trypsin digestion. 
Cells were centrifuged at 280 g for 5 minutes, re-suspended in conditioned 
reprogramming of cell (CRC) medium and seeded in fresh dishes. 
2.2.1.11 Decidualization of HESC 
Only HESCs between passages 1 and 3 were used for decidualization. The cells were 
cultured in 10 % DCC media until 90 % confluent. Cells were down-regulated 
overnight in 2 % DCC phenol red-free DMEM/F12 and the decidualization was carried 
out the following day. The cells were treated with 0.5 mM 8-bromoadenosine 3’,5’-
cyclic adenosine monophosphate (cAMP) and 1 µM medroxyprogesterone acetate 
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(MPA) in 2% DCC  phenol-free DMEM/F12. Decidualizing medium was changed 
every other day.  
2.2.1.13 Co-culture of HESC and HEEC 
HESC and HEEC were isolated as previously described. Cells were counted with a 
Luna Automated Cell Counter (Logos Biosystems – South Korea). HESC were 
seeded into the bottom of 24-well plates at a density of 0.5 x 105 cells/well. HEEC 
were plated on a 0.4 µm pore membrane of a transwell cell culture insert at a density 
of 3 x 105 cells/insert. Different cell types were cultured in separate wells until 90 % 
confluency. Transwell inserts with the HEEC were placed inside the wells with HESC 
for co-culture experiments.  
2.2.1.14 HEEC Spheroids in Hanging Drops 
HEEC were isolated as previously described. Cells were counted. A suspension with 
2 x 105 cells/ml in CRC medium supplemented with 2.5 % (v/v) Matrigel was prepared, 
and 45 µl/well were seeded in a hanging drop plate. The reservoirs in the hanging 
drop plates were filled with 1 % agarose gel. 10 µl media were added to each well 
every two days. The spheroids were transferred after 4 days, by simple pipetting, into 
96-well plates containing 50 µl ice cold Matrigel/well for treatment. The plates were 
placed in the incubator at 37 ºC for 45 minutes for the Matrigel to set and 100 µl CRC 
medium was added into the wells.  
2.2.1.15 HEEC Organoids in Matrigel and HGF Supplemented 
Medium 
Isolated cells were counted with a Luna Automated Cell Counter (Logos Biosystems 
– South Korea), and 0.1 x 105 cells in 50 µl of ice-cold Matrigel were seeded in 96-
well plates. Plates were placed in the incubator at 37 ºC for 45 minutes for the Matrigel 
to set and 100 µl CRC medium supplemented with 50 ng/ml HGF was added. 
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2.2.1.16 HEEC Organoids in Matrigel and Expansion Medium 
HEEC were isolated as previously described. The final cell pellets were suspended 
in ice cold Matrigel at a ratio of 1:20 (v:v), and 20 µl drops/well of the Matrigel-cell 
suspension were plated into 24-well plates. Matrigel was allowed to set at 37 ºC for 
45 minutes and then 350 µl organoid expansion medium was added. Media were 
changed every other day.  
2.2.1.17 HEEC Organoid Formation Efficiency  (OFE)Assay 
Frozen HEEC were thawed as previously described. Live cells were counted using 
Trypan Blue. A suspension with 1,000 live cells per 5 µl ice cold Matrigel was 
prepared, and 5 µl drops were plated into 96-well plates. The drops were allowed to 
set at 37 oC for 45 minutes and 100 µl organoid expansion medium supplemented 
with 10 µM Rock inhibitor Y-27632 was added. Media were changed every 3 days 
and the number of organoids per well was manually counted after 10 days. At least 3 
wells per sample/group were counted and averaged. Organoid forming efficiency was 
calculated using the formula  
OFE (%) = 
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑜𝑟𝑔𝑎𝑛𝑜𝑖𝑑𝑠 
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑒𝑒𝑑𝑒𝑑 𝑐𝑒𝑙𝑙𝑠
 𝑥 100. 
2.2.1.18 Culture of HEEC in Scaffolds 
Triacrylate scaffolds cut into 200 µm thick and 10 mm diameter discs were developed 
in Warwick Chemistry Department by Prof. Neil Cameron and Dr. Ahmed Eissa. The 
discs were placed in 24-well plates, disinfected with 100 % ethanol, rendered 
hydrophilic with 70 % ethanol, and washed twice with sterile PBS. The scaffolds were 
coated to improve cell adherence. To coat the scaffolds, a 0.33 mg/ml fibronectin in 
PBS solution was used. After the second wash, PBS was aspirated, and 300 µl 
fibronectin solution was added. The scaffolds were left in the fibronectin for at least 1 
hour before cell seeding. HEEC were isolated as previously described and counted. 
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A suspension of 2.5 x 105 cells in 50 µl CRC media was carefully added onto the 
centre of each scaffold disc and incubated for 1 hour at 37 ºC. After the incubation, 2 
ml CRC medium was added to the wells. Media were changed every other day.  
2.2.2 Cell and Tissue Staining 
2.2.2.1 Scaffold Haematoxylin-Eosin (H&E) Staining  
Media were aspirated from the wells. Discs were washed twice with 2 ml PBS and 
transferred to a flask with 4 % formaldehyde. Formaldehyde fixed discs were 
processed and embedded in paraffin and 5 µm sections were obtained with a 
microtome. Sections were mounted on a glass slide and left to dry at 60 ºC overnight. 
Slides were re-hydrated by a sequence of 3 baths of xylene for 5 minutes each, 
followed by 2 baths of 100 % isopropanol for 2 minutes each. Next, slides were dipped 
in 70 % isopropanol for 2 minutes and rinsed in distilled water for 2 minutes. Slides 
were incubated with filtered haematoxylin for 1 minute and rinsed with warm running 
tap water for 15 minutes. They were placed in distilled water for 30 seconds and in 
95% ethanol for 30 seconds. Cells were counterstained with eosin-Y for 1 minute. To 
dehydrate and clear the sections, slides were immersed in a sequence of 2 baths of 
95% ethanol, 2 bath of 100% ethanol and 2 baths of xylene (2 minutes each). 
Distyrene/plasticizer/xylene (DPX) mounting medium was employed for mounting the 
slides with coverslips.  
2.2.2.2 Scaffold Immunostaining  
Formaldehyde fixed discs were processed and embedded in paraffin and 5 µm 
sections were obtained with a microtome. Sections were mounted onto glass slides 
and left to dry at 60 ºC overnight. Slides were re-hydrated by a sequence of 3 baths 
of xylene for 5 minutes each, followed by 2 baths of 100 % isopropanol for 2 minutes 
each. Next, slides were dipped in 70 % isopropanol for 2 minutes, rinsed in distilled 
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water for 2 minutes, dipped in 10 mM citrate buffer pH 6.0, and placed in an epitope 
retriever unit for 2 hours. For immunostaining, Novolink Polymer Detection System 
(Leica) was used.  Peroxidase Block is added for 5 minutes, and 0.05 % polysorbate 
20 (Tween 20) in tris buffered saline (TBS-T) was used twice for washing. Sections 
were incubated overnight at 4 ºC in primary antibodies diluted in 0.05 % TBS-T.  The 
slides were again rinsed twice with TBS-T and incubated with Post Primary Block for 
30 minutes. Two more 0.05 % TBS-T washes were carried out and the slides were 
incubated for 30 minutes with Novolink Polymer Solution. Slides were rinsed with 0.05 
% TBS-T, incubated for 5 minutes with Diaminobenzidine Chromogen and rinsed with 
water for 5 minutes. Slides were counterstained with haematoxylin. 
2.2.2.3 Immunofluorescence 
Cell monolayers were grown in glass-bottom Petri-dishes until 90 % confluent. 
Organoids in Matrigel were cultured for 7 days. Culture media were aspirated, cells 
were washed in PBS and fixed in 4 % formaldehyde. Formaldehyde was aspirated 
and washed clear with PBS 5 minutes. Cells were permeabilized with 0.1 % Triton X-
100 for 1 hour at room temperature, washed with PBS for 5 minutes and incubated in 
1% BSA / PBS (v/v) for 1 hour to block nonspecific binding of antibodies. Cells were 
incubated overnight with primary antibodies diluted 1/100 in 1% (w/v) BSA/PBS at 4 
ºC, washed with 1% BSA/PBS and incubated with secondary antibodies diluted 1/200 
in 1 % BSA/PBS at 4 ºC for 2 hours in the dark. A new 1% BSA / PBS wash was 
carried out, and cells were coverslipped with mounting medium containing DAPI for 
nuclear counterstaining. The cells and organoids were imaged with a confocal 
microscope.  
2.2.3 xCELLigence Real-Time Cell Analysis (RTCA) 
An xCELLigence RTCA DP system (ACEA Biosciences, San Diego, CA, USA) was 
used for proliferation assays.  This system employs microelectrodes integrated into 
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the bottom of microwell plates (E-plates) to measure electric impedance. A current 
between the negative and positive electrodes pass through an electrically conductive 
solution (culture medium). Adherent cells at the electrode-solution interface hinder 
the electron flow. The impedance increases proportionally to the number of attached 
cells and is displayed as cell index values. This index provides an estimative of cell 
proliferation and attachment. The instrument is placed inside a humidified incubator 
at 37 ºC with 5% CO2. 
The instrument was set-up for data acquisition parameters: impedance recording 
intervals and duration of the experiment. Cells were isolated as previously described. 
Wells were loaded with 10,000 cells in 200 µl of the indicated culture media. E-plates 
were placed in the RTCA system and allowed to settle for 15 minutes before running 
the experiment. Treatment/cell type groups were loaded in duplicates. Cell index 
values were plotted against time (hours) for producing the graphs. 
2.2.4 Glycogen Measurement in Endometrial Gland Organoids 
A colorimetric assay (Abcam) was used for measuring the glycogen levels in 
endometrial gland organoids in 24-well plates. In this assay, glycogen is hydrolysed 
into glucose, which is oxidised. Oxidised glucose renders a colourless probe to a 
coloured compound with strong absorbance at 450 nm.  
Media from organoids in Matrigel were removed. Organoids were washed twice with 
500 µl/well of PBS and 400 ml/well of Cell Recovery Solution (Corning) was added. 
Plates were placed in the fridge for 1 hour to melt the Matrigel. Organoids in Cell 
Recovery Solution were transferred to 14 ml Falcon tubes and 10 ml of ice-cold PBS 
was added. Tubes were centrifuged at 280 g for 5 minutes and another PBS wash 
was performed to remove residual Matrigel. PBS was removed and 50 µl/well of 
Glycogen Hydrolysis Buffer was added. Cells were homogenised for 10 minutes on 
ice. Lysates were transferred to Eppendorf tubes and centrifuged at 16,000 g for 10 
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minutes. Supernatants were collected and 5 µl added to 45 µl of Glycogen Hydrolysis 
Buffer in a 96-well clear flat bottom plate (1/10 dilution samples). Glycogen standards 
containing 0, 0.4, 0.8, 1.2, 1.6, and 2 µg/50 µl were prepared in the same plate. 
Standards and samples were loaded in duplicate. Background control samples were 
set using pooled samples. 2 µl Hydrolysis Enzyme Mix were added to standards and 
samples and the plate was incubated at room temperature for 30 minutes. A master 
mix containing 44 µl of Glycogen Development Buffer, 2 µl of Development Enzyme 
Mix and 2 µl of Probe per sample was prepared, and 48 µl were added to standards 
and samples. A master mix containing 46 µl of Glycogen Development Buffer, 2 µl of 
Development Enzyme Mix and 2 µl of Probe per sample was prepared, and 50 µl was 
add to background control wells. The plate was incubated at room temperature for 30 
minutes and was read at 450 nm with a microplate reader. A standard curve was 
generated and used to calculate the amount of glycogen in the samples. The amount 
of glycogen in µg was normalized to the total protein content in the samples 
(measured by Bradford assay).  
2.2.5 mRNA Analysis 
2.2.5.1 Primer Design 
Primers were initially designed using online tools such as Roche Universal Probe 
Library and Primer-Blast or Primer3. Corrections were made to fit the primers within 
the following parameters, wherever possible: 
a) Spanning intron amplicon  
b) Amplicon length between 65 and 125 base pairs.  
c) Melting temperature between forward and reverse primer ≤ 1 degree. 
d) At least two C or G amongst the last five bases at the 3’ end.  
e) No more than 4 of the same base in a run. 
f) Primer length between 18 - 24 base pairs 
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Primer specificity was tested using the online tool Basic Local Alignment Search Tool 
(BLAST). Secondary structure were checked using the online tool OligoAnalyzer 3.1. 
Links: 
Roche Universal Probe: 
https://lifescience.roche.com/shop/CategoryDisplay?catalogId=10001&tab=Assay+
Design+Center&identifier=Universal+Probe+Library&langId=-1  
Primer-Blast: 
 http://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi?LINK_LOC=BlastHome  
Primer3: http://biotools.umassmed.edu/bioapps/primer3_www.cgi 
Basic Local Alignment Search Tool (BLAST): 
http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&PAGE_TYPE=BlastSearc
h&LINK_LOC=blasthome 
OligoAnalyzer 3.1: 
https://www.idtdna.com/calc/analyzer  
2.2.5.2 Primer Optimization 
Primers pairs were first tested by melt curve analysis. Pairs were used to amplify 
random cDNA by RT-qPCR at a 300 nM concentration. Melting curves were analysed 
for primer dimer and amplicon melting temperature. Amplified cDNA was saved and 
used for agarose gel analysis. Gels (3 %) were prepared dissolving 3 g agarose 
powder in 100 ml boiling TBE and 2 µl ethidium bromide. Gels were transferred to 
casting plates inserted with combs while still liquid, and allowed to set. Combs were 
removed, and plates were placed into the electrophoresis tank with TBE. 20 µl cDNA 
was mixed with 4 µl DNA loading dye (6x) and 10 µl cDNA-dye solution and 3 µl Hyper 
Ladder V (Bioline) were applied into the wells. Gels were run at 100 V untill halfway 
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line. Purified products were visualized in a G:Box (Syngene, Cambridge, UK) and 
amplicon sizes were confirmed. 
 
Table 2.2 Primers utilized in experiments  
Gene Forward primer Reverse primer 
ALKBH7 agacgctgagccgagaact 
 
gacttctctgtctctcggaag 
 
ESR1 ggctacatcatctcggttcc 
 
cttcagggtgctggacagaa 
 
F2RL1 atcctgctagcagcctctc gtgggatgtgccatcaacctt 
 
FAM89A cgctgctccgcaaagagat 
 
aggctgtacagttggcagag 
 
LHCGR tgcctttgacaacctcctcaat 
 
gctccgggctcaatgtatct 
 
MFAP4 ggcgtgtacctcatctacc 
 
gagccattgaatctcttctgga 
 
NID2 tggctggctctttgctttagaa 
 
atgggtaaaggcagcacctg 
 
PAEP gagcatgatgtgccagtacc 
 
tgatgaatccctgcatgatctc 
 
PGR ctggcatggtccttggag 
 
ttcatttggaacgcccactg 
 
PRL aagctgtagagattgaggagcaaac tcaggatgaacctggctgacta 
PTGS2 ccagcacttcacgcatcagt 
 
gggtggacttaaatcatatttacggt 
 
SCNN1A catccctggaggaggaca 
 
tggtggaagtgagagtaattcg 
 
SCNN1B caccaatatcaccctgagcag 
 
gagagcagccagacgatgt 
 
SCNN1G gagtgacgtgccaatcagg 
 
tgtctggaagcatgaatgaagg 
 
TERT cggtgtgcaccaacatcta 
 
gcacacatgcgtgaaacct 
 
TIMP3 gctggaggtcaacaagtacca 
 
cacagccccgtgtacatct 
 
ZNF319 acctcatgctgccacaaagtg 
 
aaggctctgcctacaggaca 
 
L19 gcggaagggtacagccaat gcagccggcgcaaa 
 
 
2.2.5.3 DNA Gel Extraction of PCR Amplified Products  
PCR products from tested primers were extracted from 1 % agarose gel to generate 
standard curves. Gels were prepared dissolving 1 g agarose powder in 100 ml boiling 
TBE and 2 µl ethidium bromide. Gels were transferred to casting plates inserted with 
combs while still liquid, and allowed to set. Combs were removed, and plates were 
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placed into electrophoresis tanks with TBE. 80 µl cDNA was mixed with 16 µl DNA 
loading dye (6 x).  3 µl Hyper Ladder V (Bioline) were applied into one of the wells 
and cDNA-dye solution was split in the remaining wells. Gels were run at 100 V till 
half line. Purified products were visualized in a UV cabinet and excised with scalpels.  
For DNA extraction, a gel extraction kit (Qiagen) was used. Gel slices were weighed, 
after the addition of 3 volumes of Buffer QG, they were incubated at 50 ºC for 10 
minutes to dissolve gels. 1 gel volume of isopropanol was added, solutions were 
mixed, and applied to Qiagen columns. Columns were centrifuge at 17,000 g for 1 
minute. Flow-through were discarded, and 500 µl Buffer QG were applied to the 
columns. Columns were centrifuged at 17,000 g for 1 minute and 750 µl Buffer PE 
added. After a further 17,000 g centrifugation for 1 minute the columns were 
transferred to fresh 1.5 ml microcentrifuge tubes. To elute DNA, 30 µl Elution Buffer 
was applied to the centre of column membranes, incubated at room temperature for 
1 minutes and centrifuged at 17,000 g for 1 minute. Final DNA concentrations were 
measured using a spectrophotometer.  
2.2.5.4 Primers Standard Curves for Calculation of Efficiency 
Gel extracted cDNA was serially diluted from 100 pg/µl to 10 ag/µl using serial 1/10 
dilutions, before amplification in triplicate by RT-qPCR with test primers. To generate 
the standard curve, the log of the concentrations of cDNA were plotted against the 
average Ct value from triplicates. The following formula was used to calculate primers 
efficiency:   
Primer efficiency = 10
−1
𝑔𝑟𝑎𝑑𝑖𝑒𝑛𝑡 𝑜𝑓 𝑡ℎ𝑒 𝑙𝑖𝑛𝑒  
2.2.5.6 RNA Isolation from Cells in Culture 
Cells in culture were washed with PBS, and harvested by scraping, after the addition 
of phenol-guanidinum thiocyanate monophasic solution (Stat-60). Homogenates 
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were transferred to RNAse-free Eppendorf tubes, and 20 % volume of ice cold 
chloroform added before vigorously vortex for 15 seconds. Tubes were centrifuge at 
16,000 g at 4 ºC for 30 minutes to separate the upper aqueous phase, where the RNA 
remains, from the organic phase at the bottom, where DNA and protein stay. The 
aqueous phase was transferred to RNAse-free Eppendorf tubes containing half of the 
original STAT-60 volume of ice-cold isopropanol and 20 µg glycogen. Tubes were 
thoroughly vortexed and stored at - 80 ºC for at least 30 minutes (maximum 24 hours) 
to precipitate the RNA. Tubes were thawed on ice and centrifuged at 16,000 g at 4 
ºC for 15 minutes. RNA pellets were washed twice with 500 µl of 75 % (v/v) ethanol 
in RNAse free-water, and allowed to dry for 2 minutes, before resuspension in TE 
buffer pH 8.0. RNA concentration and purity were measured using a 
spectrophotometer. RNA purity was considered satisfactory when the absorbance 
ratio at 260/280 ≥ 1.8. 
2.2.5.7 RNA Isolation from Cells in Matrigel 
This method was used for spheroids and organoids in 3D culture. Culture media were 
removed and wells were washed twice with PBS. Ice cold Cell Recovery Solution 
(Corning) was added to wells and plates were stored at 4 ºC for one hour to melt the 
Matrigel. Suspensions containing the cells were transferred to 14 ml Falcon tubes 
containing ice-cold PBS. Wells were examined at the microscope for remaining 
spheroids or organoids and if necessary were scraped. Tubes were centrifuged at 
280 g at 4 ºC for 5 minutes. Two more washes with ice-cold PBS were carried out. 
400 µl Stat-60 were added to the pellets and tubes were placed on the shaker at room 
temperature for 10 minutes. Homogenates were transferred to RNAse-free Eppendorf 
tubes, 20 % volume of ice cold chloroform was added, and tubes were vigorously 
shaken for 15 seconds. Tubes were centrifuge at 16,000 g at 4 ºC for 30 minutes to 
separate the upper aqueous phase, where the RNA remains, from the organic phase 
at the bottom, where DNA and protein stay. The aqueous phase was transfer to 
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RNAse-free Eppendorf tubes containing half of the original STAT-60 volume of ice-
cold isopropanol and 20 µg glycogen. Tubes were thoroughly vortexed and stored at 
- 80 ºC for 30 minutes to precipitate the RNA. Tubes were thawed on ice and 
centrifuged at 16,000 g at 4 ºC for 15 minutes. RNA pellets were washed twice with 
500 µl 75 % (v/v) ethanol in RNAse free-water. Pellets were allowed to dry for 2 
minutes and were re-suspended in TE buffer pH 8.0. RNA concentration and purity 
were measured using a spectrophotometer. 
2.2.5.8 RNA Isolation from Organoids in Organoid Forming 
Efficiency Assay 
RNA was isolated using a kit (Ambion). Media from organoids were aspirated and 
100 µl Lysis Buffer were added. Plates were shaken at room temperature for 10 
minutes, and lysates were collected into RNAse-free Eppendorf tubes. Half volume 
of 100% ethanol was added to lysates, mixtures were briefly vortexed, loaded onto 
Micro Filter Cartridge Assemblies, and centrifuged for 15 seconds at 16,000 g. 
Collection Tubes were emptied, 180 µl Wash Solution 1 were added, and Micro Filter 
Cartridge Assemblies were centrifuged for 15 seconds at 16,000 g. 180 µl Wash 
Solution 2/3 were added and Micro Filter Cartridge Assemblies were centrifuged for 
15 seconds at 16,000 g. A second 180 µl aliquot of Wash Solution 2/3 was added and 
centrifuged for 15 seconds at 16,000 g. Collection Tubes were emptied, and the 
assemblies were centrifuged for 1 minute at 16,000 g to remove the residual fluid. 
Micro Filter Cartridges were transferred to Elution Tubes, 10 µl Elution Solution at 75 
ºC were applied to the centre of filters, and assemblies were stored at room 
temperature for 1 minute. Assemblies were centrifuged for 30 seconds at 16,000 g to 
elute RNA from filters. A second 10 µl aliquot of Elution solution was added, and after 
one minute at room temperature assemblies were centrifuged again for 30 seconds 
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at 16,000 g. Eluates were transferred to RNAse-free Eppendorf tubes and frozen at - 
80 ºC. 
2.2.5.9 Complementary DNA (cDNA) Synthesis from mRNA 
A reverse transcription kit (Qiagen) was used for cDNA synthesis. 1µg of template 
RNA, 2 µl of 7 x gDNA Wipeout Buffer and nuclease-free water to complete 14 µl 
were mixed in pre-chilled RNAse-free Eppendorf tubes. Tubes were vortexed, 
centrifuged briefly and incubated at 42 ºC for 2 minutes to remove the genomic DNA. 
4 µl RT Buffer (5 x), 1 µl RT Primer Mix and 1µl Quantiscript Reverse Transcriptase 
were added to each tube, vortexed, and briefly centrifuged. Control sample without 
the reverse transcriptase were prepared, using 1 µl of water instead of the enzyme. 
Tubes were incubated at 42 ºC for 30 minutes. To inactivate the reverse transcriptase 
tubes were incubated at 95 ºC for 3 minutes. Final cDNA was diluted 1/5 by adding 
80 µl nuclease free-water. Samples were assayed immediately or stored at – 20 ºC. 
2.2.5.10 Real-time Quantitative Polymerase Chain Reaction (RT-
qPCR) 
A real-time PCR instrument (7500 Real-Time PCR System, Applied Biosystems, CA, 
US) was used for amplification and quantification of genes of interest. Primers at 300 
nM concentration, 10 ng cDNA template and a  ready-made master mix (SYBR green 
I) containing deoxynucleotides, magnesium, DNA polymerase and a fluorescent dye 
was added at a volume of 20 µl / well in 96-well optical PCR plates. Plates were 
centrifuged at 1,100 g for 3 minutes. cDNA samples were tested in triplicates. Non-
template controls were used, replacing the cDNA by 1 µl nuclease free-water. A 
housekeeping (RPL19) gene was always used to normalize between the different 
samples. For amplification the instrument was set-up for the following thermocycling 
sequence: 
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a) 95 ºC for 10 minutes (pre-cycling stage) 
b) 95 ºC for 15 seconds 
c) 60 ºC for 1 minute 
A fluorescent signal is released when the SYBR green is incorporated into the DNA 
double strand and it is measured by the instrument in each cycle. As the amplified 
DNA accumulates the fluorescence increases. Therefore an amplification curve is 
generated by the instrument. A threshold is assigned within the exponential phase to 
define a cycle threshold (Ct) value. A Ct value is the number of cycles required for 
the curve to cross the given threshold.  
For the dissociation curve the sequence was: 
a) 95 ºC for 15 seconds 
b) 60 ºC for 1 minute 
c) 95 ºC for 30 seconds 
d) 60 ºC for 15 seconds 
The Pfaffl method was chosen for the analysis (Pfaffl, 2001). This method compares 
the difference between Ct values with PCR reaction efficiency correction. The formula 
used for this method is: Expression value = E-∆Ct 
2.2.6 Protein Analysis  
2.2.6.1 Protein Extraction and Quantification (Bradford assay) 
A 1x radioimmunoprecipitation assay (RIPA) lysis buffer solution with protease 
inhibitor was prepared and stored in ice. Culture medium was aspirated and cells 
were washed with ice-cold PBS, before addition of RIPA buffer. Cells were scraped 
and lysates were transferred to sterile microcentrifuge tubes. Tubes were centrifuged 
at 16,000 g for 10 minutes at 4 ºC to eliminate cell debris. Supernatants were 
transferred to sterile microcentrifuge tubes and stored at - 80 ºC. For nuclear proteins, 
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the RIPA buffer was replaced by whole cell extraction buffer also with protease 
inhibitor.  
Protein concentration was determined by the Bradford method (Bradford, 1976). A 10 
mg/ml bovine serum albumin (BSA) stock solution was prepared and was used for 
protein standard dilutions. The BSA dilutions were 0, 0.5, 1, 2, 4, 6, 8 and 10 µg/ml. 
Tested protein samples were diluted 1/400 (v/v) in distilled water. A protein dye 
reagent concentrate containing Coomassie Brilliant Blue dye was added to the 
standard dilutions and to tested samples at a ratio of 1/5. This dye binds the proteins, 
forming a complex that absorb light at 594 nm. Tubes were incubated at room 
temperature for 15 minutes, vortexed and loaded in duplicates into a 96-well assay 
plate. Plates were read at 595 nm. Standard curves were generated from the optical 
density of the BSA standards and were used to calculate the protein concentration of 
tested samples.  
2.2.6.2 Polyacrylamide Gel Electrophoresis  
The percentage of acrylamide in the resolving gels depended on the protein size. For 
proteins ranging from 14 kDa to 200 kDa, 12 % gel were chosen. Stacking gels 
contained 4 % acrylamide were prepared to pH 6.8. Resolving gels were prepared to 
pH 8.8.  Disposable cassettes were used for gel preparation. 
Tetramethylethylenediamine (TEMED) and 10 % ammonium persulfate (APS) were 
applied to induce polymerisation. Resolving gels were added into the cassettes and 
coated with isopropanol. Once gels were set, the isopropanol was removed, stacking 
gels were added, and combs inserted.    
A mixture containing 20 ug total protein, 10 % dithiothreitol and 25 % 4 x lithium 
dodecyl sulphate (LDS) buffer was prepared and heated to 95 ºC for 10 minutes to 
denature the protein of interest, giving the antibody access to its epitope.  
96 
 
Gels were placed into electrophoresis tanks and covered with running buffer. Protein 
mixtures and a pre-stained protein ladder were loaded into the wells. The current was 
set to 230 mA and run at 125 V until the ladder reached the bottom of the gels. 
Separated proteins were subjected to membrane transfer.  
2.2.6.3 Western-Blotting 
Proteins run in gels were transferred to a polyvinylidene fluoride (PVDF) membrane. 
Membranes were activated with a 30 second methanol rinse. Gels and membranes 
were sandwiched between filter papers and blotting pads on each side and stacks 
were placed between plate electrodes in electrophoresis tanks. Tanks were filled with 
transfer buffer, and were run at 230 mA and 125 V for 2 hours.  
After the transfer, membranes were dried, reactivated with methanol, rinsed with tris-
buffered saline (TBS) and blocked in 5 % milk in TBS for one hour. Next, membranes 
were incubated with primary antibodies diluted in milk at 4 ºC with constant 
movement. Incubations with β-actin antibody lasted 2 hours. Incubations with all the 
other antibodies were carried out overnight (Table 2.1) 
Membranes were rinsed with 0.2% TBS-T, followed by one 15 minute and three 5 
minute washes in 0.2% TBS-T. Membranes were then incubated with secondary 
antibodies for 1 hour at room temperature. Secondary antibodies conjugated to 
horseradish peroxidase (HRP) and matching the species of primary antibodies were 
chosen. Another round of TBS-T washes (15 minutes, 5 minutes and 5 minutes) was 
performed and TBS was used for the final wash. Chemiluminescent detection of 
antigens conjugated to HRP labelled antibodies was accomplished with an enhanced 
chemiluminescence (ECL) detection system and using a G:Box (Syngene, 
Cambridge, UK). 
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Table 2.3 Primary antibodies and dilutions utilized in experiments 
Primary antibodies  Dilutions 
Cytokeratin 18 1/1,000 
Vimentin 1/1,000 
p53 1/3,000 
p16 1/1,500 
Lamin B1 1/1,000 
HMGB2 1/500 
Hist3meK9 1/1,000 
Β-actin 1/20,000 
 
2.2.7 Senescence Measurement 
2.2.7.1 Senescence-Associated β-Galatosidase (SAβgal) staining  
A commercially available kit (Cell Signaling) was used for SA-β-gal staining. Cells 
were cultured until 90 % confluent. Media were removed and cells were washed with 
PBS. Fixative solution was added into the dishes and were incubated at room 
temperature for 10 minutes. Dishes were rinsed twice with PBS. An X-gal stock 
solution (20 x) was prepared dissolving 20 mg of X-gal in 1 ml dimethylformamide. β-
gal staining solution was prepared according to the following recipe: 
Distilled water: 837 µL 
10 x staining solution: 93 µL 
Staining supplement A: 10 µL 
Staining supplement B: 10 µL 
X-gal stock solution (20 x): 50 µL 
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Dishes were incubated overnight with β-gal solution at 37 ºC in a dry incubator (no 
CO2). Cells were imaged in the following day or were stored in 70 % glycerol at 4 ºC. 
2.2.7.2 Senescence Associated β-gal Activity Measurement 
A commercially available fluorometric format kit (Cell Biolabs) was used for SAβ-gal 
activity measurements. Lysis Buffer was prepared immediately before use and 
proteinase inhibitor added. Assay Buffer (2 x) was prepared by adding 0.704 µl β-
mercaptoethanol in 1000 µl 2 x Reaction Buffer, and then adding 50 µl 20 x SA-β-gal 
Substrate in 950 µl of this solution (2 x Reaction Buffer containing β-
mercaptoethanol).  
Cells were seeded in 24-well plates. Culture media were aspirated and cells were 
washed with cold PBS. After aspirating the PBS cells were incubated with Lysis Buffer 
at 4 ºC for 5 minutes. Lysates were transferred to microcentrifuge tubes and 
centrifuged at 4 ºC for 10 minutes to remove debris. Supernatants were collected and 
stored at - 80 º C. Total protein concentration of lysates were determined by Bradford 
assay. 50 µl of cell lysates were transferred to 96-well plates, 50 µl 2 x Assay Buffer 
were added to the wells, and plates were incubated at 37 ºC for 1 hour in the dark, 
without CO2. Negative controls were set up replacing cell lysates for 50µl Lysis Buffer. 
50 µl of the reaction mixture were removed from the wells and transferred in duplicate 
to black 96-well plates in duplicate. To stop reactions, 200 µl Stop Solution was added 
into the wells. Fluorescence was read at 360 nm excitation and 465 nm emission. 
Fluorescence intensity units (FU) of the duplicates were averaged, the value was 
divided by the negative control, and were normalized dividing the result by sample 
total protein amount (mg).  
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2.2.8 Enzyme-Linked Immunosorbent Assay (ELISA) 
2.2.8.1 Prostaglandin E2 (PGE2)  
A competitive immunoassay kit for quantitative determination of PGE2 (Thermo-
Fisher) in cell culture supernatant was utilized. PG2 amount in standard dilutions or 
samples compete with an alkaline phosphatase conjugated PGE2 (PGE2-AP) for the 
specific primary antibody. The plate is supplied covered with the secondary antibody. 
Unbound antigen is removed by washing the plate. A chromogenic substrate is added 
and PGE2-AP cleaves this substrate triggering a chromogenic signal. As the 
competitive binding is concentration dependent the signal output is inversely 
correlated with the amount of antigen in the sample.  
Cell culture supernatant was retrieved and centrifuged to remove debris and stored 
at - 80 ºC until use. Eight standard dilutions were prepared using 2% DCC medium: 
5,000; 2,500; 1,250; 625; 313; 156; 78.1 and 39.1 pg/ml. Cell culture supernatant 
samples were diluted 1/2. Standards and supernatant samples (100 µl/well each) 
were loaded into the wells in duplicate. PGE2-AP and PGE2 antibody (50 µl/well each) 
were added and plates were incubated at room temperature on a plate shaker for 2 
hours at 500 rpm. Plates were washed 3 times with 400 µl Washing Buffer and 200 
µl Substrate Solution. Plates were incubated at room temperature for 45 minutes and 
50 µl Stop Solution were applied to stop the reaction. A plate reader was used at 405 
nm with correction at 541 nm for determining the optical density. A standard curve 
based on the standard dilutions optical density was generated. The concentration of 
PGE2 in the samples were calculated using the standard curve. The concentration of 
PGE2 in pg/ml was normalized to the total protein content in the samples (measured 
by Bradford assay).  
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2.2.9 Laser Microdissection (LMD) 
2.2.9.1 LMD of Endometrial Glands  
Snap-frozen human endometrial biopsies from secretory phase were used for LMD. 
The frozen samples were embedded in optimal cutting temperature compound 
(OCT), and 10 µm sections were obtained with a cryostat. The sections were mounted 
on polyethylene naphthalate membrane slides and stained with cresyl-violet and 
eosin-Y. The slides were immersed in 95 % (v/v) ethanol in nuclease-free water for 
30 seconds. A mixture of 70 % cresyl-violet and 30 % eosin-Y (v/v) was used to stain 
for 40 seconds. The slides were sequentially immersed in 95 % ethanol for 30 
seconds, 100 % ethanol for 30 seconds and xylene for 5 minutes. A vacuum 
desiccator was employed to dry the slides.  
Capture of endometrial glands was carried out for no more than 30 minutes, to avoid 
excessive RNA degradation. Membrane slides were overlaid by a glass slide so that 
the tissue section was interposed between the glass and the membrane. Endometrial 
glands were dissected with a laser microdissection unit coupled to an inverted 
microscope and a 3-CCD camera. Glands were retrieved by isolation diffuser caps.  
2.2.9.2 RNA Isolation, DNAse I Digestion and Assessment of Laser 
Capture Samples 
An RNA isolation kit for LMD (Ambion) and an on-column DNAse I digestion (Omega 
Bio-tek) kits were used. The captured samples were stored in the provided Lysis 
Solution at - 80 ºC, until the RNA isolation. DNAse I digestion solution was prepared 
by mixing 1.5 µl DNAse I (20 Kunitz/µl) with 73.5 µl Digestion Buffer for each sample. 
Caps were thawed on ice and incubated at 42 ºC for 30 minutes. After vortexing and 
briefly centrifuging to collect the fluid at the bottom of the cap, 3 µl LCM Additive and 
129 µl 100 % ethanol were added. Lysate/ethanol mixtures were loaded onto 
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prepared Micro Filter Cartridge Assemblies (columns) and centrifuged at 10,000 g for 
1 minute. The DNAse I digestion solution (75 ul/sample) was added into the columns 
which were incubated at room temperature for 15 minutes. 180 µl Wash Solution 1 
were added and columns were centrifuged at 10,000 g for 1 minute. 180 µl Wash 
Solution 2/3 were added and columns were centrifuged at 16,000g for 30 seconds. A 
further wash with 180 µl of Wash Solution 2/3 was performed and flow through was 
discarded. Columns were replaced into the same collection tubes and centrifuged at 
16,000 g for 1 minute to remove residual fluid. Columns were transferred to Micro 
Elution Tubes, 10 µl Elution Solution at 95 ºC were applied to the centre of the filters. 
A 5 minute incubation at room temperature was followed by a centrifugation at 16,000 
g for 1 minute. Another 10 µl Elution Solution at 95 ºC was applied to the centre of 
the filters. After a 5 minute incubation at room temperature, another centrifugation at 
16,000 for 1 minute was performed. The eluted RNA was transferred to a nuclease-
free tube and stored at - 80 ºC until the RNA assessment.  
RNA integrity and concentration analysis were performed by the Warwick Genomics 
Facility at Warwick Life Sciences School using a 2100 Bioanalyzer instrument 
(Agilent, CA, USA) and an Agilent RNA 6000 Pico chip. RNA integrity number (RIN) 
and the concentration were determined by the Bioanalyzer 2100 Expert software 
(Agilent, CA, USA). RNA samples with a RIN ≥ 6 and RNA ratio [28s/18s] ≥ 1.0 were 
deemed suitable for sequencing.  
2.2.10 RNA Sequencing 
2.2.10.1 Library Preparation 
Library preparations were performed by Warwick Genomics Facility. Ovation RNA-
Seq System V2® (Nugen Technologies) was used for cDNA synthesis and 
amplification. First strand cDNA was prepared using a DNA/RNA chimeric primer mix 
and reverse transcriptase.  This resulted in cDNA/mRNA hybrid molecules containing 
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a RNA sequence at the 5’ end of the cDNA strand. Priming sites for DNA polymerase 
were created by fragmenting the mRNA within the cDNA/mRNA complex, in order to 
synthesise a second DNA strand. Next the cDNA was amplified using DNA/RNA 
chimeric SPIA primers and DNA polymerase. RNA in the 5’ end of the cDNA strand 
was removed from the hybrid molecule by RNAse H.  
Libraries were produced using Ovation Ultralow System V2 1-16 (Nugen 
Technologies) in four steps: fragmentation of cDNA double strand, end repair to 
generate blunt ends, ligation of the adapters with barcoding of libraries and 
amplification by PCR.  
2.2.10.2 RNA Sequencing 
The libraries were sent to Wellcome Trust Centre for Human Genomics – High  
Throughput Genomics (Oxford, UK) for double end next generation sequencing using 
Illumina HiSeq and with a reading length of 100 base pairs, producing 150 million pair 
reads.  
2.2.10.3 RNA Sequence Data Analysis 
Data analysis was carried out in collaboration with Dr. Pavle Vrljicak. Transcriptomic 
maps of single-end reads were generated using Bowtie-2.2.3, Samtools-0.1.19, and 
Tophat-2.0.12 against the University of California Santa Cruz (UCSC) hg19 reference 
transcriptome (2014) from the Illumina Genomes resource using the fr-firststrand 
setting. Transcript counts were assessed by HTSeq-0.6.1 using the reverse strand 
setting and intersection non-empty mode and counts were assigned to gene IDs. 
Transcripts per million were calculated using the method described by Wagner et al. 
(2012). Count data from the TopHat-HTSeq pipeline were analyzed using DESeq2.  
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2.2.11 Data Mining 
Databases from GEO Datasets were mined for expression of several genes for 
comparisons with our RNA sequencing findings. The utilized databases were: 
GSE4888 – Molecular phenotyping of human endometrium 
GSE6364 – Gene profiling of endometrium reveals progesterone resistance and 
candidate genetic loci in women with endometriosis 
2.2.12 Statistical Analysis 
GraphPad Prism 6 software (GraphPad Software, CA, USA) was used for statistical 
analysis. Two-tailed paired or two-sample t-tests were applied for comparisons 
between two groups. One-way analysis of variance (ANOVA) with Holm-Sidak test 
correction was applied for comparisons between more than two groups. Gaussian 
distribution was verified with D’Agostinho-Pearson and Shapiro-Wilk test. Kruskal-
Wallis test (non-paired groups) and Friedman test (paired groups) were chosen for 
more than two groups with non-parametric distributions. Mann-Whitney U test was 
used for comparing two unpaired groups and Wilcoxon signed-rank test test for paired 
groups. P-values < 0.05 were considered statistically significant. 
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3.1 Introduction 
The culture of HEECs allows for studying the function of this compartment in the 
implantation process, as well as the effect of the endocrine and paracrine cues, 
coming from the underlying stromal cells, the ovary and the implanting blastocyst. 
However, since the first attempts to culture isolated HEECs, researchers have 
struggled to maintain long term functional cells that mimic the in vivo responses to 
differentiation and proliferation signals (Liszczak et al., 1977, Kirk et al., 1978, Bongso 
et al., 1988). Once in culture, HEECs rapidly undergo proliferation arrest and become 
senescent (Kyo et al., 2003, Valentijn et al., 2015). Furthermore, like most epithelial 
cells, they lose their specialized properties when cultured as monolayers, due to a 
process known as dedifferentiation, and become unresponsive to ovarian steroid 
hormones (Kleinman et al., 1983, Classen-Linke et al., 1997).  
During the secretory phase of the menstrual cycle, increasing levels of P4 inhibit 
proliferation of HEECs, counteracting the mitogenic effects of E2 (Pierro et al., 2001). 
In addition to being anti-mitogenic, P4 is also responsible for inhibiting telomerase 
activity in the endometrium. Tanaka et al. (1998) demonstrated that the lowest 
endometrial telomerase activity occurs in the late secretory phase, when compared 
to proliferative phase. Using in situ RNA hybridization, these authors also identified 
the endometrial glands as the main source of telomerase. The highest expression 
was detected in GE during the proliferative phase. This may explain the lack of 
proliferation of HEECS derived from secretory phase when compared to proliferative 
phase (Fleming, 1999). Taken together, these data reflect the hurdles of culturing 
HEECS isolated from biopsies taken during the secretory phase of the menstrual 
cycle.  
An alternative approach is to adopt cell lines derived from endometrial cancers to 
study HEECs. There are relatively cheap commercially available options. These cells, 
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such as Ishikawa cells, HEC-1A, HEC-1B, HES, RL-92, ECC-1 are easy to culture, 
fast growing, provide an endless source of cells, and are ease to replace in case of 
contamination. However, this approach comes with some risks. Frequent genotypic 
and phenotypic drift during continuous culture has been described (Burdall et al., 
2003). Cell lines are susceptible to contamination by several pathogens, especially 
mycoplasma (Burdall et al., 2003). Selection of subpopulations of cells within the 
cultures have been described. Several concerns have been manifested in recent 
years, including the contamination, misidentification and redundancy in cell lines 
(Burdall et al., 2003). It has been reported that wrong cell lines have been used by 
researchers (Geraghty et al. 2014). This problem also affects endometrial cell lines 
(Korch et al.,  2012). Nichida (2002) has already raised this issue regarding Ishikawa 
cells. But the main disadvantage of these models is the lack of knowledge on the 
differences between cell lines and primary cells. Therefore I opted not to use 
endometrial epithelial cell lines.  
The inability to passage and expand adult epithelial cells that retain lineage 
commitment, and keep normal growth and differentiation capacity, led to the 
development of methods for cell immortalization. The use of oncogenes such as SV40 
large T antigen (Merviel et al., 1994) or E6/E7 proteins from oncogenic human 
papillomavirus (Kyo et al., 2003), although successfully avoiding premature 
senescence of the cultured cells, results in defects in p53 and Rb regulatory 
pathways. Somatic cells have been reprogrammed into induced pluripotent stem cells 
(iPSC), prolonging their life span (Saha et al., 2009). Unfortunately the method has 
been shown inefficient, and is dependent on the transfection of exogenous gene, 
which could induce changes in genome and antigenicity (Lister et al., 2011, Taylor et 
al., 2011). A technique using a feeder-layer of irradiated fibroblasts and a Rho-
associated kinase inhibitor (ROCK) inhibitor rapidly achieved immortalization of 
human keratinocytes, which maintain their original karyotypes (Liu et al., 2012). The 
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use of feeder layers of lethally irradiated mouse fibroblasts for epithelial cell culture 
was developed by Rheinwald and Green (1975) and has been widely used for serial 
culturing many types of epithelial cells. The cells in the feeder layer release growth 
factors, cytokines and extracellular proteins into the culture medium, promote 
attachment, and remove toxic or inhibitory factors from the culture medium (Lhames 
et al., 2015). Nevertheless, the method engenders some problems. Synchronization 
of the feeder layer with the seeding of the target cells can be laborious. Ionizing 
radiation is not widely available, brings professional risks, and demands a dedicated 
tissue culture facility. There is also the risk of infection of the target cells with mouse 
retrovirus, or the transmission of damaged genetic material (Amit et al., 2003). The 
separation of the feeder layer from the target cells can be cumbersome. A more 
recent study has indicated that media conditioned by irradiated mouse fibroblasts has 
the same effect on epithelial cells as co-culture with irradiated feeder layers 
(Palechor-Ceron et al., 2013).   
This chapter explores culturing of primary HEECs and its limitations. Here I report on 
a feeder-free method for conditionally reprogramming HEECs and investigate the 
responses of these cells to some signals from the ovaries, the endometrial stroma 
and the implanting blastocyst.  
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3.2 Results 
3.2.1 Isolation of HEECs and HESCs from Mid-Secretory 
Endometrium 
To isolate purified HEECs and HESCs, I used a method that involved mincing the 
endometrial tissue, followed by digestion in collagenase and DNAse solution, and 
filtering of the digested tissue through a mesh sieve, and backwash of the sieve. 
Stromal cells in the flow-through were pelleted, re-suspended, and seeded. Retained 
glandular clumps were retrieved by backwashing the sieve, and were seeded into the 
dishes. Unfortunately, this approach often resulted in floating glandular clumps and 
very few attached cells. To solve this problem, I added a further dissociation step with 
trypsin-EDTA for 10 minutes to dissociate the glandular clumps. Using this method, it 
was possible to produce single cell solutions and HEEC cultures that reached 
confluence, when seeded in a high density (Figure 3A). To test the purity of the 
cultures, I analysed the protein expression of an epithelial marker (cytokeratin 18; 
CK18) and a mesenchymal marker (vimentin) in the cell lysates, using Western-blot. 
The expression of CK18 was marked in HEEC cultures and undetectable in HESC 
cultures. Conversely, vimentin was highly expressed in HESC cultures and was not 
observed in HEEC cultures Figure 3B). In order to further assess purity, the cells were 
fixed and stained with CK18 and vimentin. Confluent Ishikawa cells were also fixed 
and stained for CK18 to serve as a positive control for HEECs. Using a fluorescent 
second antibody and a nuclear stain (DAPI), the cells were analysed on a confocal 
microscope (Figure 3C). Using DAPI as reference, 200 cells were counted in each 
culture. In HEEC cultures 95 % of cells showed positive staining for CK18. In HESC 
cultures 97 % of cells were stained by vimentin and less than 1% for CK18. Using 
IHC, Norwitz et al. (1991) showed co-staining of cytokeratin 18 and vimentin in 
endometrial gland cells during the whole menstrual cycle. In our HEEC samples, less 
than 1 % of cells showed vimentin expression.  
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Therefore, a simple method to achieve highly purified HEEC and HESC cultures can 
be established from mid-secretory endometrial phase. 
 
Figure 3.1 Characterization of purified cultures of primary HEECs and HESCs 
isolated from secretory endometrium. Paired HESC and HESC cultures from 3 
patients were propagated for 7 days. (A) Bright field microscopy images of confluent 
HEECs and HESCs cultures (B) Western-blot analysis of CK18 and vimentin in cell 
lysates of paired HEECs. (C) Immunofluorescence of CK18 and vimentin in cultured 
HEECs, HESCs and Ishikawa cells (epithelial cell positive control) counterstained 
with DAPI. Less than 1 % of HEEC were vimentin positive (not shown).  
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3.2.2 Responses of HEECs to Trypsin 
Trypsin-like serine proteases are released by the embryo and are known to have a 
role in blastocyst hatching (Sharma et al., 2006). It has been suggested that trypsin 
is an important molecule used by the embryo to signal to the uterine epithelium. In 
mice, this enzyme triggers decidualization through activation of epithelium sodium 
channels in luminal cells, leading to secretion of PGE2 (Ruan et al., 2012). In humans, 
it was suggested that embryo-derived trypsin could be used by the HEECs for 
maternal recognition of the embryo quality (Brosens et al., 2014). To investigate 
whether trypsin induces secretion of PGE2 in HEECs, I first treated several cultures 
with trypsin in a single pulse lasting 10 minutes, harvested total RNA 1, 3, 6 and 12 
hours later, and measured the relative expression of PTGS2. Three HEEC cultures 
were used for each time-point. No PTGS2 induction was observed at any time-point 
(Figure 3.2A). Since it was not possible to establish the time after trypsin exposure 
when PTGS2 would have its highest induction, I decided to measure PGE2 secretion 
in tissue culture supernatant, collected 24 hours after trypsin treatment. Different 
trypsin doses were applied and heterogeneous responses were obtained. One culture 
showed the highest induction of PGE2 secretion with 10 nM trypsin. Increased 
secretion was observed with 50 nM and 150 nM trypsin in a second culture. And no 
response was detected in a third culture (Figure 3.2B), suggesting that cultured HEEC 
show variable responses to trypsin exposure.  
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Figure 3.2 Variable responses of cultured HEECs treated with trypsin. (A) 
Normalized expression of PTGS2 after the treatment with 10nM trypsin. mRNA was 
harvest at indicated time-points. Three HEEC samples were used for each time-point. 
Data are presented as mean ± SD. P > 0.05. (B) PGE2 secretion in culture 
supernatant of three HEEC samples, 24 hours after treatment with different doses of 
trypsin in a single pulse lasting 10 minutes. Data are presented as secretion 
normalized to total protein ± SD. P = non-significant (ns). P values were calculated 
using a non-parametric test (Friedman test). 
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3.2.3 In vitro HEECs Do Not Respond to Differentiation Cues  
PAEP is the gene that encodes the different isoforms of glycodelin. Glycodelin-A is a 
marker of endometrial gland differentiation (Seppala et al., 2002). P4 induces 
glycodelin-A secretion by endometrial glands (Seppälä et al., 1987). hCG is also 
known to stimulate glycodelin-A (Uchida et. al., 2013). To test the effects of ovarian 
sex hormones and hCG in HEEC differentiation, I treated the cells with different 
combinations of E2, MPA and hCG, for 24 hours (Figure 3.3, top panel) and measured 
PAEP relative expression using RT-qPCR. No changes is PAEP expression were 
observed with any combination of hormones.  
I also examined the effect of the same hormones on HEEC expression of PTGS2 
(Figure 3.3, bottom panel). No significant induction or inhibition of PTGS2 expression 
was detected in HEECs treated with ovarian sex steroids or hCG, contradicting 
expected results. These findings suggest that HEECs change their behaviour in vitro, 
rendering them unresponsive to various differentiation stimuli.  
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Figure 3.3 Unresponsiveness of cultured HEECs to differentiation cues.  
Normalized expression of PAEP and PTGS2 in confluent HEECs treated with different 
combinations of 10 nM E2, 1 µM MPA and/or 1 IU/ml hCG for 24 hours. Their 
presence or absence in the medium is shown by + or – in each column (n = 3). Data 
are presented as mean ± SD. P = ns. P values were calculated using a non-
parametric test (Friedman test). 
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3.2.4 Expression of Hormone Receptors and Protease Activated 
Targets in HEECs 
Sex steroid hormones act through activation of their cognate nuclear receptors. hCG 
acts through its membrane bound G-protein coupled receptor, LHCGR. Trypsin 
cleaves epithelium sodium channels (ENaCs) on plasma membrane, increasing their 
open time probability (PO). The enzyme also activates special G-protein couple 
receptors, named protease activated receptors (PAR), through cleavage. I 
interrogated if the variable responses of HEECs to ovarian steroids and trypsin could 
be explained by heterogeneity in the expression of related receptors and ion 
channels. To test this hypothesis, I harvested mRNA from 7 primary HEEC cultures 
and measured the expression of ERα (ESR1), progesterone receptor (PGR), hCG 
receptor (LHCGR), ENaCα,(SCNN1A), ENaCβ (SCNN1B), ENaCγ (SCNN1G) and 
PAR2 (F2RL1), which is the main PAR activated by trypsin. Apart from PAR2, all the 
other receptors and the ion channels showed considerable variability in genomic 
expression between primary cultures (Figure 3.4A). To further investigate the variable 
effect of trypsin in HEECs, I performed fluorescent immunolocalization of ENaCα, β 
and γ in HEEC cultures, which revealed the staining confined to cells at the periphery 
of HEEC islands (Figure 3.4B). These data uncover a possible explanation for the 
heterogeneous response of HEEC when in monolayer culture. 
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Figure 3.4 Heterogeneous expression of steroid hormone receptors and 
protease activated ion channels in HEECs. Seven HEEC cultures were grown for 
8 days. (A) HEEC mRNA expression of selected genes. Results were normalized to 
the housekeeping gene (L19) expression. Data are presented as individual a.u. (B) 
Immunofluorescence of epithelial sodium channels HEEC cultures counterstained 
with DAPI (representative of n = 7).  
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3.2.5 Proliferation of Primary HEECs in Culture 
HEECs soon lose their proliferative capacity when in culture, whereas HESCs can be 
easily cultured for longer periods (Kyo et al., 2003). E2 stimulates epithelial 
proliferation in vivo. By contrast P4 counteract the mitogenic effects of E2. 
Proliferative effects of E2 in HEECs are mediated by stromal ERα while inhibition of 
oestrogen-driven epithelial proliferation are mediated by epithelial and stromal PR 
(Vasquez and DeMayo, 2013). In order to investigate the growth rate of HEECs and 
HESCs, proliferation in purified cultures were monitored by an xCELLigence real-time 
cell analyser. HESCs continuously grew, maintaining their proliferative capacity for 
over 72 hours. By contrast, HEECs showed a highly restricted growth, with minute 
change after 72 hours (Figure 3.5A). 
To determine the effects of E2 and P4 on proliferation of isolated in vitro HEECs, an 
xCELLigence real-time cell analyser was used for monitoring the growth of HEECs 
either untreated or treated with E2 or P4 or the combination of both. No effect on 
HEEC growth was detected over 60 hours (Figure 3.5B). This confirms that HEECs 
undergo growth arrest when cultured under standard conditions.  
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Figure 3.5 Growth arrest of HEECs in culture. Ten thousand cells were seeded into 
0,2 cm2 wells. (A) Real-time cell analysis of attachment and growth of HESCs (n = 6) 
and HEECs (n = 6) measured by electrical impedance, using an xCELLigence 
analyser for 72 hours. (B) Real-time cell analysis of attachment and growth of HEECs 
for 60 hours. The cells were either untreated, or treated with 10 nM E2 or 1µM P4 or 
the combination of both (n = 3).  
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3.2.6 Purified HEECs from Mid-Luteal Biopsies Exhibit Acute 
Senescence in Culture 
HEECs derived from the secretory phase of the menstrual cycle develop senescence 
in culture after few days (Valentijn et. al., 2015). To corroborate this previous 
observation, I compared the senescence in paired HESCs and HEECs from mid-
secretory phase. Cellular aging results in accumulation of toxic by-products and 
macromolecules in lysosomes. The activity of β-galactosidase reflects increased 
lysosomal mass (Matjusaitis et al., 2016). Using senescence associated β-
galactosidase (SA-β-gal) staining, it was possible to detect marked presence of the 
senescence dye in HEECs, whereas few spots were observed in HESCs (Figure 
3.6A). SA-β-gal activity was also compared between the two cell types, using a 
fluorometric assay. Activity in HESCs was approximately 80 % lower than in HEECs 
(Figure 3.6D). Using Western-blot analysis of senescence markers (Binet et. al., 
2009, Freund et al., 2012, Guerreiro and Gil, 2016) in HESCs and HEECs, I 
demonstrated a typical profile of senescence in HEECs, exemplified by higher 
expression of P53, P16 and histone H3, and lower expression of lamin B1 and high 
mobility group box family member 2 (HMGB2) compared to HESCs (Figure 3.6B). 
Immunohistochemistry of mid-luteal endometrial biopsy (LH+9) demonstrated 
predominance of P16-positive cells in both GE and LE compared to stroma (Figure 
3.6C). Taken together the data corroborate the observation that HEECs from mid-
secretory phase develop acute senescence when isolated and cultured. 
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Figure 3.6 Acute senescence of cultured HEECs derived from the secretory 
phase of the menstrual cycle compared to HESCs from the same period. (A) 
SA-β-gal staining of paired HESCs and HEECs cultured for 9 days (representative of 
n = 3). (B) Western-blot analysis of senescence markers in three paired HESC and 
HEEC samples in culture for 7 days (C) IHC of Mid-secretory human endometrium 
stained for P16 (representative of n = 3). (D) SA-β-gal activity in HEECs (n = 9) and 
HESCs (n = 9) cultured for 7 days, measured by fluorometric assay. Data are 
presented as percentage of reduction of SA-β-gal activity in relation to HEEC activity 
± SD. ** P = 0.007. P values were calculated using a non-parametric test (Wilcoxon 
signed-rank test). 
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3.2.7 Conditional Reprogramming of Primary HEECs Using an 
Irradiated Feeder Layer and a Rho-Associated Kinase (ROCK) 
Inhibitor 
In an attempt to reverse the senescence-associated cell cycle arrest of HEECs in 
culture, I used a combination of a feeder layer of irradiated 3T3 swiss albino mouse 
embryo fibroblasts (3T3 SAFs) and a ROCK inhibitor (Y-27632) to conditionally 
reprogramme HEECs. This method has been employed for keratinocytes and non-
keratinocyte epithelial cells (prostate cells and mammary cells) (Liu et al., 2012), but 
not for HEECs. In previous studies, the feeder layers were gamma-irradiated for 
growth arrest (Liu et al., 2012, Yuan et al., 2012).  Due to the unavailability of a 
suitable ionizing radiation source and the requirement of a dedicated tissue culture 
room to work with radioactive cells, I opted for irradiating the 3T3 SAFs with ultraviolet 
C light (UVC). This short wave ultraviolet light (254 nm), at doses above 50 J / m2, 
triggers DNA damage, cell cycle arrest and apoptosis (Gentile et. al., 2003). Some 
studies have suggested that apart from inducing growth arrest, irradiation of feeder 
layer increases the release of soluble factors that are crucial for cell reprogramming 
(Li et al. 2010, Palechor-Ceron et al., 2013). 3T3 cells were cultured until 70 % 
confluence, and were irradiated with 100 J / m2 dose of UVC. HEECs were seeded 
on top of the feeder layer, and cultured with medium supplemented with 7.5 uM / l Y-
27632 (CRC medium) (Figure 3.7A). Once confluent, cultures were differentially 
trypsinized and passaged onto fresh dishes. The technique is based on the 
differences in cell attachment. Fibroblasts from feeder layer detach first, whereas 
HEECs are more tightly adherent, thus taking longer in trypsin-EDTA solution to 
dissociate (see ‘Methods’). A frequently faced problem with these cultures is 
contamination of the passaged reprogrammed HEECs with fibroblasts from the 
feeder layer (Figure 3.7B). Despite most of the 3T3 SAFs being eliminated with the 
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differential tripsinization, the presence of few viable cells resulted in overgrowth of the 
feeder layer at the expense of the HEECs.  
 
 
Figure 3.7 Conditional reprogramming of HEECs using a feeder layer of 
irradiatied 3T3 SAFs and a ROCK inhibitor. (A) Cartoon representing the use of a 
3T3 SAF feeder layer in combination with a ROCK inhibitor (Y-27632), for conditional 
reprogramming of HEECs. (B) Culture of conditionally reprogrammed HEECs with a 
feeder layer of irradiated 3T3 SAFs and 7.5 µM / l Y-27632 at P0 (left panel), and 
conditionally reprogrammed HEECs at P1 for 7 days after the differential 
trypsinization to remove the feeder layer, exhibiting contamination with 3T3 SAFs 
(right panel).   
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3.2.8 Conditioned Medium from UVC Irradiated 3T3 SAF 
Substitutes for Feeder Layers in the Conditional Reprogramming of 
HEECs 
Due to the contamination of HEECs with cells from the feeder layer and the difficulty 
of synchronising the irradiation of 3T3 SAFs with the isolation of HEECs, I explored a 
feeder-free method for conditional reprogramming of primary cultures. It has been 
demonstrated that soluble factors in the conditioned medium from irradiated 3T3 
SAFs could substitute for feeder layers in conditional reprogramming of epithelial cells 
(Palechor-Ceron et al., 2013). The same authors showed that media from irradiated 
3T3 SAF was most effective when collected 48-72 hour after the irradiation. This 
period correlated with apoptosis of feeder layers, as demonstrated by caspase 3 and 
7 activity. Using conditioned medium from irradiated 3T3 SAF (CMi), in combination 
with a ROCK inhibitor, I developed a method for conditionally reprogram HEECs 
without the requisite of feeder layers. Seventy percent confluent 3T3 SAFs were 
irradiated with a 100 J/m2 UVC dose, and culture supernatants were harvested 3 days 
later. CMi was mixed with CRC medium in a 1/4 ratio and the resulting mixture (final 
CRC) was used as culture medium for HEECs (Figure 3.8A). The resulting cultures 
were pure and morphologically indistinguishable from un-reprogrammed HEECs 
cultures (Figure 3.8B). To test whether the reprogrammed cells retained their 
epithelial phenotype, and to demonstrate the purity, three HEEC cultures were 
immunostained for CK18 and vimentin (Figure 3.8D). More than 97% of cells were 
positive for CK18, whereas less than 3% were vimentin positive. Next, I tested the 
proliferation capacity of reprogrammed HEECs using xCELLigence real-time cell 
monitoring. The use of CMi or ROCK inhibitor moderately increased proliferation of 
HEECs, but the combination of both considerably improved growth (Figure 3.8C). 
These findings demonstrate that conditional reprogramming of HEECs can be 
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successfully achieved without ionizing radiation or the need of co-culturing with a 
feeder layer.  
 
 
 
Figure 3.8 Conditional reprogramming of HEECs using conditioned medium 
from irradiatied 3T3 SAFs and a ROCK inhibitor. (A) Cartoon showing the 
conditional reprogramming of HEECs using CMi in combination with a RI. (B) Bright 
field images of confluent cultures of paired naive HEECs and conditionally 
reprogrammed HEECs. (C) Real-time cell xCELLigence analysis of attachment and 
growth of HEECs. The cells were either untreated, or treated with CMi or 10 µM/l 
ROCK inhibitor or the combination of both, for 60 hours (n = 4) (D) 
Immunofluorescence of CK18 and vimentin in conditionally reprogrammed HEECs 
cultured for 7 days, counterstained with DAPI. 
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3.2.9 Impact of Conditional Reprogramming in Expression of 
Hormone Receptors, Protease Activated Targets and PAEP 
Cell reprogramming can affect cell phenotype of the resulting derivatives 
(Suprynowicz et al., 2012). In order to test if conditional reprogramming with CMi and 
ROCK inhibitor changes the phenotype of HEECs, and the reversibility of this effect, 
I measured mRNA expression of trypsin-activated ion channels, PAR2 (F2RL1), ERα, 
PR and PAEP in naive and reprogrammed HEECs; and upon reprogramming 
withdrawal. One group of cells was kept in standard culture conditions for 5 days. 
Another group was conditionally reprogrammed for 5 days. A third group was initially 
reprogrammed for 5 days, followed by reprogramming withdrawal for 48 hours. 
Except for LHCGR and F2RL1, all the other genes were up-regulated upon 
conditional reprogramming (Figure 3.9). This may suggest that the cells were more 
differentiated. More important was the fact that reprogramming withdrawal restored 
the basal phenotype of HEECs, proving that it is possible to transiently induce 
proliferation. Arguably, it may also be possible that the reprogramming phenotype is 
closer to the one observed in vivo. 
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Figure 3.9 Expression of protease activated targets, hormone receptors and 
PAEP in conditionally reprogramed HEECs. Paired HEECs were either kept in 
standard culture for 5 days (N), or were conditionally reprogrammed (R) for 5 days, 
or were reprogrammed for 5 days, followed by reprogramming withdrawal for 48 hours 
(RW). Data are presented as individual a.u. (n = 7). P values were calculated using a 
non-parametric test (Friedman test).  
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3.2.10 Reversal of Cellular Senescence upon Conditional 
Reprogramming of HEECs 
To determine the effect of conditional reprogramming on HEEC senescence, I 
measured cellular senescence by SA-β-gal staining and activity. Naive HEECs 
exhibited more intense SA-β-gal staining after 11 days in culture when compared to 
reprogrammed HEECs (Figure 3.10A). For the SA-β-gal activity, HEECs were 
maintained for 5 days in standard culture, then conditionally reprogrammed for 5 
days, or reprogrammed for 5 days followed by reprogramming withdrawal for 48 
hours. SA-β-gal activity was approximately 50 % lower in reprogrammed HEECs, but 
was restored upon withdrawal of CMi and ROCK inhibitor (Figure 3.10B). Loss of 
telomerase activity is the main feature of cellular replicative senescence (Campisi and 
Fagagna, 2007). To test if this enzyme is affected by conditional reprogramming, I 
measured the mRNA expression of reverse transcriptase telomerase (TERT) in cells 
maintained in standard culture for 5 days, in cells reprogrammed for 5 days, and upon 
withdrawal of the reprogramming cues for 48 hours. A 376 % increase in TERT 
expression was observed, with return to basal levels upon reprogramming withdrawal 
(Figure 3.10D). To further corroborate the findings, I analysed the expression of 
senescence markers in naive and reprogrammed HEECs using Western-blot (Binet 
et. al. 2009, Freund et al., 2012, Guerreiro and Gil, 2016). Decreased expression of 
P53, P16 and histone H3 in reprogrammed HEECs was observed along with an 
increase in lamin B1 and HMGB2 expression, which indicates reduction in 
senescence upon reprogramming (Figure 3.10C).  
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Figure 3.10 Reversal of HEEC senescence upon conditional reprogramming. 
(A) SA-β-gal staining of paired un-reprogrammed and conditionally reprogrammed 
HEECs in culture for 11 days. (B) SA-β-gal activity of paired naive HEECs, 
conditionally reprogrammed HEECs (R), and of HEECs in which conditional 
reprogramming was withdrawn (RW). Dotted line indicates SA-β-gal activity in naive 
HEECs. Data are presented as percentage of increase/decrease of SA-β-gal activity 
in relation to the activity in naive HEECs ± SD (n = 3). *P = 0.013. (C) Western-blot 
analysis of senescence markers in paired conditionally reprogrammed and naive 
HEECs from three HEEC samples. (D) Normalized HEEC expression of TERT in 
paired naive, R and RW HEECs. Dotted line indicates mRNA expression of naive 
HEECs. Data are presented as percentage of induction/inhibition in relation to the 
naive HEEC mRNA expression ± SD (n = 7) *P = 0.03. P values were calculated using 
a non-parametric test (Friedman test). 
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3.2.11 Conditionally Reprogrammed HEECs Remain 
Unresponsive to Differentiation Cues or Trypsin 
My data suggested that reprogrammed HEECs acquire a more differentiated 
phenotype, with higher expression of ovarian steroid receptors. Therefore, I decided 
to investigate the effect of E2 and P4 on reprogrammed HEEC proliferation. The 
growth and attachment of these cells were monitored through real-time cell analysis 
using an xCELLigence system (Figure 3.11A), and final CRC medium was 
supplemented with E2, P4 or the combination of both. No effect on HEEC proliferation 
was detected indicating that reprogrammed HEECs, like their naive counterparts 
(Figure 3.5B) are not responsive to either E2 or P4. Next I tested if the expression of 
two differentiation markers, PAEP and PTGS2, could be induced in reprogrammed 
cells treated with E2, MPA or hCG alone or in combination. No significant changes in 
PAEP or PTGS2 (Figure 3.11B) were observed. I have demonstrated that mRNA 
expression of the three ENaC variants were also up-regulated upon reprogramming. 
To test if this remodelling would bestow the cells the ability to respond to serine 
proteases, I treated reprogrammed HEECs with trypsin in a single pulse lasting 10 
minutes, and harvested the culture supernatant 24 hours later. No increment in PGE2 
secretion into the culture medium was observed (Figure 3.11C). These data 
demonstrated that conditional reprogramming does not modify the capacity of HEECs 
to respond to differentiation cues from the ovary or the implanting blastocyst.  
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Figure 3.11 Unresponsiveness of conditionally reprogrammed HEECs to 
differentiation cues and embryonic signals. (A) 105 cells / well were seeded. Real-
time xCELLigence monitoring of conditionally reprogrammed HEEC proliferation. The 
cells were either untreated (Control), or treated with 10 nM E2 or 1 µM P4 or the 
combination of both, for 24 hours (n = 3). (B) Normalized expression of PAEP and 
PTGS2 in reprogrammed HEECs treated with different combinations of 10 nM E2, 1 
µM MPA and 1 UI/ml hCG, for 24 hours (n = 3). Their presence or absence in the 
medium is shown by + or – in each column. Data are presented as mean ± SD. P = 
ns. P values were calculated using a non-parametric test (Friedman test). (C) 
Secretion of PGE2 in reprogrammed HEEC culture supernatant, 24 hours after a 
single 10 nM trypsin pulse lasting 10 minutes. Data are presented as mean secretion 
normalized to total protein in cell lysates ± SD (n = 3) P = ns. P values were calculated 
using a non-parametric test (Wilcoxon signed-rank test).    
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3.2.12 HEEC Differentiation in Response to Conditioned Medium 
from Decidualized HESCs 
A fine balanced cross-talk between the epithelial and the stromal compartments of 
the endometrium is crucial to create a receptive environment for the implanting 
embryo (Pawar et al., 2014). Paracrine factors regulated by oestrogen and P4 
mediate this dialogue. For example, the oestrogen-driven proliferation of the epithelial 
cells is mediated by stromal ER (Cooke et al., 1997) and anti-mitogenic effects of 
progesterone in the epithelial compartment are regulated by PR in the stromal cells 
(Hantak et al., 2014). Furthermore, factors like Wnt5a, Wnt4, HOXA10 and HOXA11, 
expressed by the endometrial stromal compartment, are critical for development of 
endometrial glands (Mericskay et al., 2004, Zhang and Yan, 2015). The highest 
expressions of gland differentiation markers such as glycodelin and dipeptidyl 
peptidase-4 (DPP4) are observed during the mid-secretory phase, concurring with 
the highest levels of P4 and the stromal decidualization (Imai et al., 1992, Seppälä et 
al., 2002). Gland differentiation could be induced directly by P4, which was not verified 
in my previous experiments (Figure 3.3A and figure 3.11C), or it could be indirectly 
triggered by soluble factors derived from the decidualized stroma. This phenomenon 
has been already demonstrated. In other species, PRL, which is an important protein 
expressed by the stroma upon decidualization, can induce uteroglobin expression in 
endometrial glands (Spencer, 2014). Uteroglobin, encoded by SCGB1A1, is mostly 
secreted in the uterine lumen during the receptive phase in human uterus (Müller-
Schöttle et al., 1999).  
To investigate the effect of decidualized HESCs in gland differentiation, I used 
conditioned media from pooled HESCs from 5 biopsies. The supernatant was 
collected from undifferentiated HESCs and from cells decidualized with cAMP and 
MPA for either 4 or 10 days. The medium was refreshed 24 hours before collection, 
to remove cAMP and MPA. Confluent cultures of reprogrammed HEECs were treated 
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with unconditioned medium and with conditioned medium from decidualized and 
undecidualized HESCs. mRNA was harvested 24 hours later (Figure 3.12A). 
Significant up-regulation of PAEP was observed with conditioned medium from 
HESCs decidualized for 4 and 10 days. (Figure 3.12B, left). PTGS2 expression in 
HEECs was also measured to investigate whether the decidualized HESCs released 
factors that further enhance epithelial differentiation in a paracrine manner. No 
response was detected when compared to HEECs cultured in standard medium 
(Figure 3.12B, right).  
Since PRL is a major secretory product of human decidua, I speculated if this protein 
was the effector of the previous results observed in the HEECs treated with the 
decidualized HESC conditioned medium. To test this hypothesis, I treated HEEC 
cultures with 20 ng / ml PRL for 24 hours and measured PAEP expression. However, 
the treatment did not induce any response (Figure 3.12C). 
These observations suggest that soluble factors released by the decidualized 
endometrial stromal compartment induce differentiation in uterine glands. The 
factor(s) responsible for this effect are undetermined.   
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Figure 3.12 HEEC differentiation by soluble cues from decidualized HESCs. (A) 
Cartoon showing HESC decidualization with 0.5 mM cAMP and 1 µM MPA, and the 
retrieval of conditioned medium after 0, 4 and 10 days of treatment. The medium was 
refreshed 24 hours before the supernatant harvesting to remove cAMP and MPA. (B) 
Normalized expression of PAEP and PTGS2 in HEECs that were either untreated 
(C), or treated for 24 hours with medium from undecidualized HESC (D0), or HESC 
decidualized for 4 (D4) or 10 (D10) days (n = 6). P values were calculated using a 
non-parametric test (Friedman test). (C) Normalized expression of PAEP in HEECs 
treated with 20 ng / ml PRL for 24 hours. Data are presented as individual a.u. (n = 
3). P values were calculated using a non-parametric test (Wilcoxon signed-rank test). 
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3.2.13 Induction of HEEC Differentiation and HESC 
Decidualization upon Co-Culture of the Two Cell Types 
To further validate the observations that the endometrial stromal compartment 
induced glandular differentiation in HEECs, I established a co-culture system of 
HESCs and HEECs, using transwell inserts with permeable porous membranes 
(Figure 3.13A, top). A pool of HESCs from 5 different patients was cultured in 24-well 
plates and decidualized with cAMP and MPA. Reprogrammed HEECs were cultured 
on the membrane of transwell inserts in separate wells until confluence was reached. 
After 4 days of HESC decidualization, cAMP and MPA were withdrawn, and the 
inserts with HEECs were placed into the wells with decidualized HESC for 24 hours. 
mRNA from HEECs was harvested, and subjected to RT-qPCR. Up-regulation of 
PAEP was observed when compared to non-cocultured HEECs (Figure 3.13C).  
The presence of the endometrial glands has been proven essential for 
decidualization. In mice lacking uterine glands, decidualization is totally abolished and 
implantation does not occur (Lejeune et al., 1981, Filant & Spencer, 2013). Some 
factors expressed by endometrial glands have been suggested as potential 
candidates for this stromal decidualization role. Lif and Spink3 are the most promising 
(Cheng et al., 2000; Cheng et al., 2010). However, the dependency of decidualization 
on uterine glands in humans has not been demonstrated yet. To investigate if HEECs 
have any impact on stromal decidualization, I applied the same co-culture system. 
The pool of HESCs was seeded in 24-well plates, and HEECs from three different 
endometrial biopsies were cultured in transwell inserts. HESCs were cultured in 2 % 
DCC medium, for 8 days, with or without HEEC inserts (Figure 3.13A, bottom). mRNA 
from HESC was harvested, and PRL was measured. A significant induction of PRL in 
HESCs co-cultured with HEECs (S/E) was detected when compared to HESCs in 
monocultures (S) (Figure 3.13D). 
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These data confirm the influence of decidualized HESCs in endometrial gland 
differentiation and suggest that, as is the case in mice, signals emanating from 
glands, such as PGE2, contribute to differentiation of HESCs into decidual cells.  
 
Figure 3.13 Induction of differentiation in HEECs and decidualization in HESCs 
when the two cell types are co-cultured. (A) Cartoon showing the system for co-
culture of HEECs with decidualized HESCs, using transwell inserts with microporous 
membrane (top) and the system for co-culturing HEECs and HESCs (bottom). (B) 
Normalized expression of PAEP and PTGS2 in HEECs co-cultured for 24 hours with 
decidualized HESCs (n = 6). Transwell inserts with confluent reprogrammed HEECs 
were placed into the wells with HESCs decidualized for 4 days, and were co-cultured 
for 24 hours in 2% DCC. (C) Normalized expression of PRL in HESCs after 8 days in 
co-culture with HEECs. Data are presented as individual a.u. (n = 6). P values were 
calculated with a non-parametric test (Wilcoxon signed rank test). 
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3.2.14 Proliferation and Partial Reversal of Senescence in HEECs 
Exposed to Conditioned Medium from Decidualized HESC 
As aforementioned, raising levels of P4 during the luteal phase inhibit the mitogenic 
effects of E2 in the epithelial compartment (Pierro et al., 2001, Chen et al., 2005). At 
the same time, senescence of HEECs peaks at mid-secretory phase, coinciding with 
the highest serum concentrations of P4 (Williams et al., 2001). Endometrial gland 
function must be safeguarded to provide histiotrophic support to the implanting 
blastocyst. I examined if decidualized HESCs, through secretion of soluble factors, 
could rescue the gland cells from growth arrest and acute senescence.    
Using xCELLigence real-time cell monitoring, I analysed the effects of conditioned 
medium from HESC decidualized for 4 days, ROCK inhibitor, and the combination of 
both in HEEC proliferation. HEEC growth was discretely enhanced with the use of 
conditioned medium from decidual HESCs. Proliferation of HEECs was even further 
increased with the addition of ROCK inhibitor (Figure 3.14A).  
As previously discussed, senescence in the endometrial epithelial compartment 
peaks at mid-secretory phase, coincident with the highest levels of P4. To test if P4 
affects the senescence in HEECs in an indirect paracrine way through inducible 
soluble factors from stromal compartment, I treated HEECs for 24 hours with 
conditioned medium from HESCs decidualized for 4 days and measured SA-β-gal 
activity. Strikingly, a mean reduction of 24% was observed (3.14B).  
This suggests that decidualized HESCs induce proliferation and partially reverse 
senescence in HEECs. 
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Figure 3.14 Proliferation and reversal of senescence in HEECs treated with 
conditioned medium from decidualized HESCs. (A) Real-time xCELLigence 
analysis of HEEC attachment and growth for 40 hours.  HEECs were either untreated 
(control), or treated with 7.5 µM Y-27632 (RI) or conditioned medium from HESCs 
decidualized for 4 days or the combination of both (n = 4). (B) SA-β-gal activity in 
HEECs either untreated (control) or treated for 24 hours with conditioned medium 
from HESCs decidualized for 4 days. Data are presented as percentage of reduction 
of SA-β-gal activity in relation to the control ± SD (n = 4). *P = 0.03. P values were 
calculated using a non-parametric test (Wilcoxon signed-rank test ). 
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3.3 Discussion 
Isolation and culture of HEECs are pivotal for understanding the implantation process 
and its disruptions. Primary HEECs are hard to culture, and the problem is further 
exacerbated when they derive from mid-secretory phase endometrium. One possible 
explanation for this refractoriness is the proportion of progenitor, transit amplifying 
and terminally differentiated cells in the tissue. Chan et al. (2004) demonstrated that 
0.22 % of HEEC population was comprised of progenitor cells in contrast with 1.25 % 
of HESC. The cells were isolated from hysterectomy specimens, which included the 
basal and the functional layers of the endometrium. It has been suggested that the 
majority of the epithelial progenitor cells reside in the gland segments of basalis 
(Nguyen et al., 2012, Valentijn et al., 2013). Therefore it is reasonable to postulate 
that the percentage of human endometrial epithelial progenitor cells would be even 
lower in Endocell Sampler biopsies.  
Conditional reprogramming rescued the cells from acute senescence and improved 
in vitro proliferation. The exact mechanism by which this was achieved is yet to be 
uncovered, although many explanations can be inferred from the current knowledge. 
The effect of irradiated feeder layers and their soluble factors on telomerase activity 
has been demonstrated (Liu et al., 2012, Palechor-Ceron et al., 2013). The up-
regulated expression of TERT upon reprogramming was observed in my study 
(Figure 3.10C). Chapman et al. (2010) observed an increased expression of avian 
myelocytomatosis viral oncogene homolog (MYC) in human foreskin keratinocytes 
treated with ROCK inhibitor. MYC induces transcription of TERT through promoter e-
boxes.  Yu et al. (2012) verified that a ROCK inhibitor increased cyclin-dependent 
kinase 4 (CDK4) and Cyclin D1 expression in astrocytes. The complex Cyclin 
D1/CDK4 induces cell cycle progression from G1 phase to S phase through 
phosphorylation of Rb. As a consequence I conjectured that inhibition of ROCK would 
induce phosphorylation of Rb, overcoming CDK4 inhibition by P16. Furthermore, in 
138 
 
my experiments, P16 expression was decreased upon reprogramming. ROCK 
regulates cytoskeleton function by inhibition of myosin phosphatase. The activity of 
the latter de-phosphorylates the myosin light chain, an important component of the 
cytoskeleton. Inhibition of ROCK promotes myosin phosphatase activity leading to 
cytoskeleton remodelling (Wettschureck and Offermanns, 2002). These cytoskeleton 
changes promotes proliferation (Provenzano and Keely, 2011). Supranowicz et al. 
(2012) showed increased protein expression of many adult stem cell markers in 
primary human ectocervical cells reprogrammed with ROCK inhibitors in combination 
with feeder layers of irradiated fibroblasts. Some of these markers were integrins α6 
and β1, p63, CD44, β-catenin, Notch-1, delta like canonical Notch ligand 1 (DLL1). 
The authors also measured the expression of markers of pluripotent stem-cells (SRY 
box 2 [SOX2], Nanog homeobox [NANOG] and octamer-binding protein 4 [OCT4]) 
and did not observed up-regulation, suggesting that the reprogrammed cells were 
committed to an epithelial lineage. Although the issue of limited in vitro proliferation 
of HEECs was circumvented, reprogramming did not render the cells responsive to 
various differentiation stimuli. 
No changes in proliferation and differentiation induction in HEECs with ovarian steroid 
hormone treatment were observed. An increased proliferation with E2, an inhibition 
of proliferation with P4 and even a further reduction in proliferation with the 
combination of both was expected, since progesterone has an anti-proliferative effect, 
and E2 induces synthesis of PR by action on an oestrogen response element in the 
promoter region (Kaster et al., 1990). Naive HEECs presented an arrested 
proliferation, therefore it would be hard to notice any inhibitory effect, considering the 
already low rate of growth of untreated cells. However, the unresponsiveness was 
also observed with reprogrammed HEECs. One possible reason for that, could be the 
observed variability in ovarian steroid receptors expression in HEECs. However, 
normal expressions of ER and PR were detected in cultured HEECs by ligand binding 
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assay (Zhang et al., 1995) and by immunocytochemistry (Hombach-Klonisch et al., 
2005). Another explanation could be the need of the stromal compartment for the 
ovarian steroid hormones to enhance or reduce proliferation in the epithelial cells.  It 
has been demonstrate in mice that oestrogens induce proliferation in the epithelial 
compartment of the endometrium through ER in the stromal cells (Cooke et al., 1997). 
In turn, P4 would inhibit epithelial growth by binding to its cognate receptor PRA in 
the endometrial stroma (Hantak et al., 2014).  
Progesterone and hCG have been shown to induce glycodelin-A secretion in 
endometrial glands (Sepälla et al., 2002). There is no evidence for glycodelin 
regulation by oestrogen (Seppälä et al., 2002). However, no up-regulation of PAEP 
with P4 or hCG was observed in my experiments. My results suggest that the 
decidualized endometrial stromal compartment also regulates epithelial 
differentiation. Which decidual soluble factors stimulate epithelial differentiation is still 
elusive. PRL was a rational candidate, but no response was detected with its use. 
Arnold et al. (2001) showed induction of glycodelin secretion by HEECs when co-
cultured with undecidualized HESC, but the effect was only attained when the cells 
were seeded in Matrigel. This may indicate that HEECs need to be allowed to 
polarize, to respond to differentiation signals.  
Conditioned medium from decidualized HESCs induced proliferation of HEECs. I 
speculate that this effect could be explained by PR isoform specific roles. While 
stromal PRA would only regulate epithelial proliferation by counteracting oestrogen-
driven mitogenic effects (Vasquez and DeMayo, 2013), PRB would stimulate 
epithelial proliferation in an oestrogen-independent manner. Indeed, Mulac-Jericevic 
et al. (2000) demonstrated that specific ablation of PRA in mice led to progesterone- 
induced epithelial proliferation through PRB. Another plausible explanation for this 
effect and the partial reversal of senescence would be that the decidualized HESCs 
provided soluble growth factors for HEECs, in a similar way that feeder layers do for 
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embryonic stem cell cultures (Llames et al., 2015). As a matter of fact, decidualization 
triggers apoptosis in the stromal compartment as irradiation does in the fibroblasts of 
the feeder layer (Akcali et al., 2003). The main focus of the studies was on the 
mechanisms of apoptosis. The extrinsic pathway is involved, through translocation of 
TNF receptors and FAS receptors from the Golgi apparatus to the plasma membrane, 
and increasing levels of FASL and TNF during the mid-secretory phase (Boeddeker 
and Hess, 2015). The intrinsic pathway is also affected by decrease of anti-apoptotic 
B-cell lymphoma 2 (BCL2), increase of pro-apoptotic BCL2 associated X, apoptosis 
regulator (BAX) and release of cytochrome C from mitochondria (Tao et al., 1997). 
Despite the several studies of the decidual transcriptome and proteome (Popovici et 
al., 2000, Brar et al., 2001, Garido-Gómez et al., 2014, Gellersen and Brosens, 2014), 
the factors released by the apoptotic decidual cells that reverse epithelial senescence 
and induce proliferation of gland cells are yet undetermined.   
Up-regulation of PTGS2 was not observed, and induction of PGE2 secretion was 
inconsistent in HEEC upon trypsin exposure. Ruan et al. (2012) showed a 3 fold 
induction in PGE2 secretion and up-regulation of PTGS2 in mouse endometrial 
epithelial cells treated with trypsin. Furthermore, the authors could inhibit these 
responses using amiloride, an ENaC inhibitor. In my study, ENaC expression was 
only observed in the borders of the HEEC monolayers, which could explain the 
blunted and inconsistent responses to the serine protease. ENaCs were identified in 
the apical membrane of HEECs (Enuka et al., 2012). Taken together these data 
suggest the need for epithelial polarity for these ion channels to function and be 
appropriately expressed in HEECs.  
Mouse decidualization depends on embryo’s presence (Lee et al. 2007), not occurring 
spontaneously. In humans, decidual differentiation occurs independently of 
pregnancy, in every ovulatory cycle, by the influence of P4 and cAMP (Gellersen et 
al., 2007). This physiologic difference may account for the unresponsiveness of 
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HEECs to trypsin. This role for serine proteases would not have been conserved, 
once the decidual control shifted from the embryo to the mother.  
The luminal epithelium is the main uterine sensor for the embryonic signals, besides 
being the site for blastocyst attachment (Zhang et al., 2013). Structural differences 
between human luminal epithelium and endometrial glands are well described (Demir 
et al., 2002), and distinct transcriptome has been detect in mice (Niklaus and Pollard, 
2006). In my study, the isolated HEECs derived from the dissociation of glandular 
clumps, conferring on them a specific phenotype. I conjecture that trypsin-triggered 
PGE2 secretion could be a property of the luminal epithelium, which forms the first 
maternal embryo interface. Glandular cells would not retain this capacity. 
Epithelial cells polarize to differentiate between the interior of the organism and the 
external environment. The apical membrane is exposed to the organ lumen and the 
basolateral membrane is in contact with the interior. A complex of adhesion molecules 
and organelles (adherent junctions, tight junctions, gap junctions and desmosomes) 
take part in this polarization process (Kaplan et al., 2009). G protein-coupled 
receptors, such as PARs and LHCGR, and ion channels, such as ENaCs, are bound 
to the apical membrane, while proteins involved in cell-to-cell communications reside 
in the basolateral membrane. The transport of molecules produced in the cells is also 
organized in a mode that some are secreted to the lumen and some are release to 
the underlying compartment, usually stroma (Nelson, 2009). This way, the epithelial 
cells can perform the roles by which they were differentiated for. Cells in monolayers 
develop a flat morphology that compromises polarity and, as a consequence, 
function. Several authors have reported dedifferentiation of endometrial cells in two 
dimensional (2D) cultures, limiting functional studies (Zhang et al., 1995, Classen-
Linke et al., 1997, Arnold et al., 2001). That could be a reason for the dampened 
responses of the epithelial cells in monolayer cultures. On that account, the next 
logical step is the development of three dimensional (3D) culture systems for HEECs. 
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Establishing Endometrial Gland Organoids 
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143 
 
4.1 Introduction 
In vivo, epithelial cells reside in a 3D environment that enables contact with 
extracellular matrix (ECM) and neighbouring cells. They are organized in a manner 
to allow for interaction with the exterior, through the lumen, and with the interior of the 
tissue through cross-talk with the underlying cells. This system requires cellular 
polarity. This is a complex process involving several players, such as partioning 
defective proteins (Par proteins), Crumbs proteins (CRB), Scribble proteins (SCRIB), 
Rho GTPases, lipids, and signal pathways, e.g. Notch, Wnt and Hippo (Rodriguez-
Boulan & Macara, 2014, Bayraktar et al., 2006). This arrangement facilitates efficient 
secretion of target molecules, relaying signals to the external environment through 
the apical membrane and to the underlying compartments across the baso-lateral 
membrane. At the same time, cues from the organ lumen are delivered to the cells 
onto the apical domain, and messages from neighbouring cells are sensed by the 
basolateral domain (Vreede et al., 2014).  
In monolayer cultures, the cells are attached to the rigid flat surface of the dish, 
changing their shape and spreading. Interact with the ECM, and the contact with the 
adjacent cells are restricted (Pampaloni et al., 2007). These limitations are associated 
with loss of function and differentiation, altering the responses in different situations 
(Antoni et al., 2015). In fact, cells can regain their differentiated phenotype in vitro 
when embedded in a 3D environment. This has been demonstrated with 
chondrocytes and mammary cells (Petersen et al., 1992, Caron et al., 2012, Sokol et 
al., 2016). In anticancer drug discovery, 95% of the compounds, first selected based 
on the effects observed in cell line 2D cultures, fail to be licensed due to poor 
responses in animal experiments or in clinical trials (Hutchinson and Kirk, 2011). The 
same problems associated with dedifferentiation have been described in endometrial 
epithelial cell cultures (Classen-Linke et al., 1997, Chitcholtan et al., 2012). For 
example, Arnold et al. (2001) demonstrated that HEECs could only respond to 
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differentiation signals from HESCs, when both cell types were cultured in Matrigel. 
This reconstituted basement membrane preparation is extracted from the Engelbreth-
Holm-Swarm mouse sarcoma. It is compound of approximately 60% laminin, 30% 
collagen IV, and 8% entactin. It also contains heparan sulfate proteoglycan, TGFβ, 
EGF, IGF1, FGF, nerve growth factor (NGF), PDGF, and tPA, in variable 
concentrations (Kleinman et al., 1986, Vukicevic et al., 1992). 
3D endometrial gland models can help us to understand the roles of these structures 
in implantation and early pregnancy. Endocrine and paracrine interactions with other 
components of the reproductive system, namely the ovaries, the endometrial stromal 
compartment and the implanting embryo, could be assessed in vitro, in a rather more 
physiologic context than in 2D cultures.  
The establishment of gland-like organoids has been described frequently in the last 
decade due to their pivotal role in cancer research. Prostate, intestine, colon, gastric, 
and mammary cell organoids are some of the recently described gland-like structures 
(Karthaus et al., 2014, Sato et al., 2011, Bartfeld et al., 2015, Sokol et al., 2016). 
These organoids were developed in well-defined culture conditions, combining basal 
membrane extract with medium containing factors that stimulate proliferation of 
progenitor cells (R-spondin 1, Noggin), de-differentiate transit amplifying cells into 
progenitor cells (EGF), and avoid cellular senescence (nicotinamide), along with 
molecules that induce organ-specific gland differentiation. FGF10 and HGF are 
expressed by the endometrial stroma, and are key factors in endometrial gland 
morphogenesis (Gray et al., 2001). One study described the establishment of 
fallopian tube organoids by modulation of Wnt pathway, and also suggested a role for 
Notch in cell fate determination (Kessler et al., 2015).  
One of the main roles of endometrial glands is to provide histiotrophic support to the 
embryo, until the haemochorial placenta is established, around 12 weeks of 
pregnancy (Burton et al., 2002).  
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Missed miscarriage is characterized by foetal demise, without expelling of the 
products of conception. It is usually suspected when the symptoms and clinical signs 
of pregnancy are regressing, and the diagnosis is confirmed by an ultrasound scan 
(Griebel et al., 2005). The exact incidence of chromosomal abnormalities in these 
cases is undetermined. Karyotype studies of the products of conception detected 60-
75 % of chromosome errors in isolated cases of missed miscarriage (Phillipp and 
Kalousek, 2001, Ferro et al., 2003, Phillipp et al., 2003, Lathi et al., 2007). 
Considering that only 2–4% of the couples suffering recurrent miscarriage are carriers 
of balanced translocations, the real burden of the chromosomal defects might be even 
smaller in recurrent missed miscarriage. So, 25 – 40 % of the missed miscarried 
embryos present normal karyotypes, indicating that other causes may be involved in 
the aetiology. I postulate that defects in endometrial glands impair histiotrophic 
support for the genetically normal embryo, eventually leading to demise.   
This chapter explores the options for endometrial epithelium 3D culture, the 
establishment of a method for culture of endometrial gland-like organoids, and 
investigates the responses of these epithelial structures to differentiation signals. I 
also suggest that endometrial gland clonogenicity is disturbed in recurrent missed 
miscarriage cases.    
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4.2 Results 
4.2.1 HEEC Spheroids  
My first attempt to establish a 3D model for HEECs was through spheroid formation. 
Spheroids are aggregates of mutually adherent cells that do not attach to culture 
substrate, and adopt a spherical-like shape (Fennema et al., 2013). These cell 
clusters can mimic in vivo solid tumours, being a useful choice for studying anticancer 
therapy sensitivity and resistance (Adcock et al., 2015). The potential use in 
regenerative medicine has widened the interest in non-cancerous cell organoids. 
Recent studies with hepatocytes, thyrocytes and chondrocytes have been published 
(Bell et al., 2016, Wang et al., 2016, Bartz et al., 2016).  
A specific plate designed for hanging drop culture was used (Figure 4.1A) and 104 
primary isolated HEECs / well were seeded in 45 µl of final CRC medium 
supplemented with 2.5 % Matrigel. The cells started to organize in sphere-like 
structures within 48 hours (Figure 4.1 C). Spheroids were transferred to 96-well plates 
containing Matrigel, after 4 days, for treatment. To test if organoid formation would 
render the HEECs responsive to differentiation cues I treated them with different 
combinations of  E2, MPA and hCG for 24 hours. No induction of PAEP was observed 
(Figure 4.1B).  
Next I examined the effect of the decidualized stromal compartment on spheroid 
differentiation. After being transferred to Matrigel, the spheroids were cultured for 24 
hours in conditioned medium from HESC decidualized for 4 days. No significant 
induction of PAEP was detected (Figure 4.1D). The data indicate that, although 
organized in a 3D arrangement, the HEEC spheroid do not respond to various 
differentiation signals.  
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Figure 4.1 Unresponsiveness of HEEC spheroids to differentiation cues. (A) 
Cartoon showing the culture of HEEC spheroid in hanging-drop and its transfer to cell 
culture microplate containing Matrigel. (B) Bright field image of a compact HEEC 
spheroid in a hanging drop, 2 days after seeding of 104 cells / well of a hanging drop 
plates. (C) Normalized expression of PAEP in HEEC spheroid treated with different 
combinations of 10 nM E2, 1 µM MPA and/or 1 IU / ml hCG for 24 hours (n = 3). Their 
presence or absence is shown by + or – in each column. P = ns (Friedman test) (D) 
Normalized expression of PAEP in paired HEEC spheroids cultured for 24 hours with 
or without (control) conditioned medium from HESC decidualized for 4 days (n = 4). 
Data are presented as mean ± SD. P = ns (Wilcoxon signed-rank test). 
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4.2.2 Endometrial Gland Organoids Established by the Use of 
Matrigel and HGF Supplemented Medium  
A variety of methods for creating human endometrial gland organoids have been 
reported (Rinehart et al., 1988, Classen-Linke et al., 1997, Bläuer et al., 2005, 
Valentijn et al., 2015), all of them based solely on the use of Matrigel. The efficiency 
rate of organoid forming is not described and the performance on functional assays 
was diverse.  
Sugawara et al. (1997) developed human endometrial gland-like organoids using 
Matrigel and HGF from three different biopsies. Using a similar method, I attempted 
to establish gland organoids. Ten thousand primary isolated HEEC / well mixed in 50 
µl Matrigel were seeded in 96-well plates. The cells were overlaid by final CRC 
supplemented with 50 ng/ml HGF. HGF is an endometrial stroma derived factor and 
is involved in uterine gland morphogenesis in ovines (Taylor et al., 2001). The cells 
initially clustered and, gradually, some of them showed central lumen formation. The 
organoids were mostly round, with a central lumen (Figure 4.2A). However, only 
27.3% (3/11) of the cultures formed gland-like structures after 7 days.  
To examine the response of these 3D cell formations to differentiation cues, the 
organoids were treated with different combinations of E2, MPA and  hCG for 24 hours, 
and no induction of PAEP was verified (Figure 4.2B).  
To investigate the effect of cues from the decidualized stroma, the organoids were 
cultured for 24 hours in conditioned medium from HESCs decidualized for 4 days. 
Once more, despite a trend of higher expression on treated organoids, no significant 
PAEP up-regulation was observed, suggesting that, in addition to the low efficacy for 
forming the gland organoids with this method, this 3D arrangement do not confer on 
HEECs the ability to respond to differentiation signals from diverse sources (Figure 
4.2C).  
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Figure 4.2 Unresponsiveness of HEEC organoids in Matrigel and HGF 
supplemented medium to differentiation cues. (A) Bright field images of 
endometrial gland organoids in Matrigel for 5 days. Ten thousand cells / well were 
seeded into a 96-well plate with 50 µl Matrigel / well, and the culture medium was 
supplemented with 50 ng / ml HGF (representative of n = 3). (B) Normalized 
expression of PAEP in endometrial gland organoids treated with different 
combinations of 10 nM E2, 1 µM MPA and / or 1 IU / ml hCG for 24 hours (n = 3). 
Their presence or absence in the medium is shown by + or – in each column. P = ns 
(Friedman test) (C) Normalized expression of PAEP in endometrial gland organoids 
cultured for 24 hours with or without (control) conditioned medium from HESC 
decidualized for 4 days (n = 3). Data are presented as mean. ± SD.  P = ns (Wilcoxon 
signed-rank test). 
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4.2.3 Cell Scaffolds for HEEC 3D Cultures 
In vivo, the epithelial cells lie in an intricate 3D fibrous meshwork of collagen and 
elastic fibres, the ECM. The combination of chemical composition and nanostructure 
supports biochemical and biophysical roles, such as transport of soluble molecules 
and absorption of mechanical stress (Lee et al., 2007). Scaffolds have been 
developed to emulate ECM functions, and generate 3D cell cultures. Intense research 
has been undertaken to improve the bulk material, pore size, nanoscale design and 
surface properties. One study described the development of a bovine endometrial 
construct, using a polyglycolide electrospun scaffold (Mackintosh et al., 2015). The 
scaffolds were populated with stromal and epithelial cells from bovine endometrium, 
and cells expressed vimentin and cytokeratin, besides accumulating prostaglandins 
in response to arachidonic acid, oxytocin and lipopolysaccharide.  
I used scaffolds developed at the University of Warwick Engineering School, by Prof 
Neil Cameron and Dr Ahmed Eissa. Well-defined macro-porous foam scaffold discs 
were produced by emulsion templating technique, whereby a highly porous polymer 
is created from a monomer (triacrylate), using water droplets (Figure 4.3A). The 
inability to monitor the cells growing in the scaffolds is a disadvantage of the method, 
so HEECs were initially seeded onto fibronectin coated scaffolds, cultured for 15 days 
in final CRC medium, and stained for haematoxylin/eosin (H&E) and CK18. The cells 
populated the discs, exhibiting a multilayer structure (Figure 4.3B). Another reported 
issue is the chance of the cells to flatten and spread in the scaffolds, behaving as 
though in 2D monolayer cultures (Stevens et al., 2005). To address this concern, I 
cultured paired HEECs in monolayers and in scaffolds, immunostained them for 
CK18, and acquired Z-stack images of single cells by confocal microscopy. The cells 
in monolayers had an overt flat shape, in contrast with the cell in scaffolds, which 
displayed a distinct 3D configuration (Figure 4.3C).  
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Once the 3D structure of the HEECs in the scaffolds was demonstrated, functional 
assays were performed. First, I tested the differentiation of HEECs in scaffolds 
compared to 2D cultures. Paired HEECs were seeded in flat dishes and scaffolds, 
and PAEP expression was measured after 3 and 7 days in culture. A trend of higher 
expression of PAEP in scaffold-grown HEECs was observed, but the differences were 
not statistically significant (Figure 4.4A). Next, the responsiveness of HEECs in 
scaffolds to E2 and P4 was tested, and the impact of the stromal compartment on 
these responses was also adressed. Three groups of paired HEECs were seeded in 
scaffolds and grown for 22 days. One group was mono-cultured, and was not treated. 
A second mono-cultured group was treated with E2 for 15 days, followed by the 
addition of P4, for 7 days. The third group was co-cultured with HESC and was also 
treated with E2 and P4. No difference in PAEP expression was detected upon E2 and 
P4 treatment, or upon co-culture with HESC (Figure 4.4B). To further explore the 
responses of scaffold-grown HEECs to differentiation cues, cells were grown on 
scaffolds for 15 days, then treated for 24 hours with conditioned media of HESC 
decidualized for 4 days. Although a trend of higher expression of PAEP in treated 
HEECs was again observed, statistical significance was not reached (Figure 4.4D). 
Inferring that the HEECs in scaffolds were polarized, and considering that polarization 
is pivotal for expression of apical domain proteins such as ENaCs, I investigated the 
effect of trypsin in this 3D model. HEECs were grown in scaffolds for 15 days, and 
were treated with trypsin. PGE2 concentration in the culture supernatant collected 24 
hours after the treatment was measured by ELISA. No enhancement in the 
prostaglandin secretion was detected (Figure 4.4C).  
The data indicate that, although HEECs grow in a 3D conformation in scaffolds, they 
remain unresponsive to differentiation signals using this model.  
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Figure 4.3 HEEC growth and population of thiol-acrylate cell scaffolds. (A) 
Pictures showing the microporous structure of the scaffold and the scaffold discs 
ready to be used. Discs were cut to 1 cm diameter, 200 µm thick and were placed 
inside 24-well plates for cell culture. (B) HEECs cultured in a scaffold for 15 days and 
stained with H&E (left) and CK18 (right panel). (C) Immunofluorescence of CK18 in 
HEECs cultured as monolayer, showing flat architecture (left panel), and in the 
scaffold exhibiting 3D conformation (right).  
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Figure 4.4 Responses of HEECs in scaffold to differentiation cues, and 
comparison with 2D culture. (A) Normalized expression of PAEP in HEECs in 
monolayers and in scaffolds. Paired HEECs were cultured in scaffolds and 
monolayers (n = 3). mRNA was harvested after 3 and 7 days. (B) Normalized 
expression of PAEP in paired HEECs cultured in scaffolds and either untreated or 
treated with 10 nM E2 for 14 days, followed by 10 nM E2 and 1 µM P4 for 7 days. 
One of the treated groups was co-cultured with HESCs (n = 3). (C) Secretion of PGE2 
by HEECs cultured in scaffolds and either untreated (control) or treated with 10 nM 
trypsin in single pulse lasting 10 minutes (n = 3). Culture supernatant was collected 
24 hours after the treatment. Data are presented as mean secretion normalized to 
total protein in cell lysates ± SD (n = 3). (D) Normalized expression of PAEP in HEECs 
cultured in scaffolds and either untreated (control) or treated for 24 hours with 
conditioned medium from HESCs decidualized for 4 days (n = 3). Data are presented 
as mean ± SD. P = ns. 
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4.2.4 Establishment of Endometrial Gland Organoids Using 
Matrigel and Modified Adult Stem-Cell Medium 
Since Matrigel and HGF were not sufficient to derive responsive endometrial gland-
like organoids efficiently, I decided to try another method to generate these gland-like 
structures. The use of factors that stimulate cell stemness has been recently reported 
for gastric- , intestine-, colon-, mammary gland- and prostate-like organoids (Karthaus 
et al., 2014, Sato et al., 2011; Bartfeld et al., 2015, Sokol et al., 2016). Specific factors 
to induce organ-specific gland differentiation were also deployed. HGF and FGF10 
have been demonstrated to be key factors in endometrial gland morphogenesis.  
Using Matrigel and culture medium supplemented with R-spondin 1, Noggin, EGF, 
nicotinamide, a TGFβ inhibitor (A83-01), HGF and FGF10, henceforth referred as 
expansion medium, it was possible to derive endometrial gland-like organoids from 
primary HEECs, with a 97.4% (38/39) efficiency. The organoids grew in culture, 
progressively increasing their number and size. Round shape was more often 
observed, but elongated organoids were also detected, depicting a feature that 
recapitulates in vivo endometrial glands (Figure 4.5A). The organoids were 
immunostained, and showed expression of CK18 and E-cadherin, a key component 
of adherens junctions (Figure 4.5B).  
To test the responsiveness to differentiation cues, organoids in expansion medium 
were treated with E2, P4,  cAMP, PRL or hCG for 8 days. A two-fold increase in PAEP 
expression was observed with cAMP (Figure 4.6A). To further address the issue, I 
treated organoids with different combinations of E2, P4, cAMP, PRL hCG, and 
observed that E2, P4 and cAMP in combination induced a 3 fold increase in PAEP 
expression. The addition of PRL or hCG did not further enhance the PAEP induction 
(Figure 4.6B). To explore the effect of differentiation signals from the endometrial 
stroma, organoids were cultured for 24 hours in conditioned medium from HESC 
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decidualized for 4 days. A trend of higher PAEP expression in treated cells were 
observed, but the difference was not statistically significant (Figure 4.6 C).  
Glycogen is a key component of endometrial gland histiotrophe, produced in high 
quantities during the secretory phase (Burton et al., 2011). Endometrial gland-like 
organoids were grown for 7 days, treated with E2, P4, cAMP, PRL and hCG for 8 
days. The organoids were lysed and cell glycogen levels were measured by a 
colorimetric assay. No differences were observed in organoid glycogen 
concentrations upon stimulation with differentiation signals (Figure 4.6 D). 
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Figure 4.5 Establishment of endometrial gland organoids using Matrigel in 
association with a modified adult stem cell medium. (A) Bright field image of 
endometrial gland organoids cultured in Matrigel and supplemented with expansion 
medium for 7 days. (B) Immunofluorescence of CK18 and e-cadherin in endometrial 
gland organoids, counterstained with DAPI. Organoids were cultured Matrigel for 7 
days, fixed and stained as a whole mount and the images were acquired with a 
confocal microscope.  
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Figure 4.6 Responses of endometrial gland organoids in Matrigel and 
expansion medium to differentiation cues. (A) Normalized expression of PAEP in 
paired organoids either untreated (control) or treated for 8 days with 10 nM E2, 1 µM 
P4, 0.5 mM cAMP, 20 ng / ml PRL or 1 IU / ml hCG (n = 3). Data are presented as 
mean. ± SD. *P = 0.047. (B) Normalized expression of PAEP in organoids treated for 
8 days with different combinations of 10 nM E2, 1 µM P4, 0.5 mM cAMP,  20 ng / ml 
PRL and 1 IU / ml hCG (n = 3). Their presence or absence is shown by + or – in each 
column. Different letters above error bars indicate that those groups are significantly 
different from each other. P = 0.3. (C) Normalized expression of PAEP in organoids 
cultured for 7 days, followed by treatment for 24 hours with or without (Control) 
conditioned medium from HESC decidualized for 4 days (n = 3). Data are presented 
as mean ± SD. P = ns. (D) Glycogen levels in organoids either untreated (Control) or 
treated with 10 nM E2, 1 µM P4, 0.5 mM cAMP, 20 ng/ml PRL and 1 IU/ml hCG for 8 
days. Data are presented as mean glycogen concentration in organoids, normalized 
to total protein in organoid lysates ± SD (n = 5). P = ns. 
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4.2.5 Reduction of Gland Clonogenicity in Recurrent Missed 
Miscarriage (RMM) Cases 
The histiotrophic support of the embryo during the first trimester of pregnancy is 
provided by the endometrial glands (Burton et al., 2002). In missed miscarriage 
cases, embryonic or foetal demise occurs with no associated uterine bleeding 
(Griebel et. al., 2005). Around 35% of these cases are not explained by chromosomal 
anomalies (Lathi et al., 2007). Based on those observations, I hypothesized that 
endometrial gland defects could account for a proportion of recurrent missed 
miscarriage cases (RMM), defined as 3 or more episodes of missed miscarriage.  
I set up organoid forming efficiency assays (OFE) for patients with and without 
recurrent missed miscarriage (Table 4.1). One thousand cells mixed in 5 µl Matrigel 
drops were plated in 96-well plates. The drops were left to set for 1 hour, and were 
overlaid with expansion medium supplemented with ROCK inhibitor to avoid anoikis 
(Koyanagi et al., 2008). OFE was calculated based on the percentage of formed 
organoids, after 10 days, in relation to the number of seeded cells (Figure 4.7A). The 
organoid forming efficiency was significantly decreased in the missed miscarriage 
sample derived organoids (Figure 4.7B). After the counting, the organoids in the OFE 
assay were either untreated or treated with differentiation medium (10 nM E2, 1 µM 
P4, 0.5 mM cAMP, 20 ng / ml PRL and 1 UI / ml hCG) for 8 days. mRNA was 
harvested, extracted, assessed by spectrophotometry, and was deemed eligible for 
PCR if ratio 260/280 ≥ 1.8. No difference in PAEP induction was observed between 
control individuals and missed miscarriage derived organoids. However, the induction 
of PAEP upon differentiation cues was markedly higher in both groups than that 
observed in the previous similar experiment (Figure 2.6B), reaching up to 58 fold 
change (Figure 4.7C).   
This confirms that the endometrial gland-like organoids established with expansion 
media are responsive to differentiation cues. The data also suggest that the 
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population of endometrial gland cells from recurrent missed miscarriage patients may 
have progenitor cell deficiency, being incapable to meet the demand for histiotrophic 
support of the first trimester pregnancy.    
 
 
Table 4.1. Clinical characteristics of patients from OFE assay.                      . 
Groups Control (n=9) RMM (n=9) P 
Age 34.5 (32-43) 32 (28-45) P = 0.7425 
BMI 20 (18-29) 25 (17-34) P = 0.2338 
Day of cycle LH+9 (7-10) LH+9 (7-11) P = 0.9536 
Miscarriage 1 (0-1) 6 (4-8) P < 0.0001 
Live birth  0 (0-1) 0 (0-1) P > 0.9999 
Data are presented as median (range). BMI: body mass index 
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Figure 4.7 Endometrial gland cell clonogenicity in missed miscarriage and 
induction of differentiation in gland-like organoids. (A) Bright field images of 
endometrial gland organoids seeded in low density (1,000 live cells in 5 µl Matrigel 
droplets) for organoid forming efficiency (OFE) assay, after 10 days. Left panel: 
control subjects; right panel: recurrent missed miscarriage cases (B) Organoid 
forming efficiency in control subjects and RMM cases (n = 9 in each group). *P = 
0.029 (two sample t student test). (C) Fold induction of PAEP in endometrial gland 
organoids in control subjects (n = 7) and RMM cases (n = 6). The organoids were 
grown in expansion medium for 10 days, and were either untreated or treated with 
differentiation medium for 8 days. Data are presented as fold change compared to 
untreated samples (dotted line). P = ns (two sample t student test). 
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4.3 Discussion 
In this chapter, I reported the strategies to establish a 3D model that recapitulated the 
endometrial gland phenotype in vitro.  Polarity is a pivotal property for gland cells to 
perform their roles efficiently. Although 3D cultures provide a more propitious 
environment for cells to emulate in vivo organization, every function may not be 
restored. The creation of a perfect artificial cell niche in culture dishes is a particularly 
challenging goal. Some variants can be partially controlled, but indeed, it is most likely 
that several required conditions are not uncovered yet.  
HEECs formed compact spheroids in hanging-drops that could be transferred to 
Matrigel for treatments, however these aggregates did not show expected responses 
to differentiation cues. One possible reason could be the inability of the molecules to 
diffuse, and reach the cells residing in the core of the spheroids. The lack of 
vascularity makes diffusion the only available mean to support oxygen and nutrient 
delivery, and CO2 and waste removal. Cells in different depths are in dissimilar 
nutritional state and, therefore, not at same stages of cell cycle (Edmondson et al., 
2014). This is actually beneficial when testing a new anticancer drug, since it mimics 
a solid tumour environment (Mehta et al., 2012). But for testing the global effect of an 
agent on a normally polarized cell type, it may represent a confusion factor. The cells 
in the centre of the spheroid are not exposed to the treatment, and could mask the 
effect obtained on their surface counterparts.  
The initial method for organoid deriving, using HGF only, proved to be highly 
ineffective. The only three endometrial samples that formed organoids were used for 
the assays, with no compelling results, so the method was set aside.  
Most of the knowledge on matrix culture derives from studies with cancer cell lines. 
These cells show a rapid growth in culture, being the ideal choice for scaffold cultures. 
After the optimization for some culture parameters (number of seeded cells, medium 
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volume for seeding, time to add medium after the initial seeding, scaffold covering), 
fixing, and staining, it was possible to grow primary HEECs in the polymer scaffolds. 
The cells populated the scaffolds and exhibited a 3D conformation. Nevertheless, no 
response to differentiation cues was observed either. One reasonable cause for this 
refractoriness would be the inability of the tested molecules to diffuse through the 
scaffold and reach the deeper cells, as previously postulated for the spheroids. 
Microfluidic devices have been proposed as effective systems for uniform distribution 
of the cells inside the scaffold and for controlled delivery of biochemical signals 
(Tehranirokh et al., 2013). Another possible explanation would be a deficiency in cell-
to-cell communication due to sub-optimal pore size. If the pores are too large, cells, 
even though in a 3D conformation, could not adhere to each other. Furthermore, 
another possible reason for the unresponsiveness of HEECs could be the inability to 
recapitulate the in vivo gland structure inside the macro-porous matrix.  In this sense, 
the scaffolds would be more appropriate for luminal epithelium models.  
Inhibition of TGFβ signalling enhances stem cell self-renewal in humans (Sakaki-
Yumoto et al., 2013). The canonical Wnt pathway, through the interaction of β-catenin 
with the transcript complex T-cell factor/lymphoid-enhancing factor (TCP/LEF), 
induces transcription of target genes involved in cell stemness (Van Camp et al., 
2014). Noggin inactivates bone morphogen protein 4 (BMP4), whereas A83-01 is an 
inhibitor of TGFβ receptors type I. R-spondin 1 is a Wnt/β-catenin agonist, binding to 
leucine-rich repeat-containing G-protein coupled receptors (LGR). EGF was 
demonstrated to convert transit amplifying cells into multipotent stem cells (Doetsch 
et. al., 2002). Nicotinamide prevents cell senescence by repressing P53, P21 and 
P16 and accelerating proliferation of pluripotent cells (Son et al., 2013). HGF and 
FGF10 are pivotal factor in endometrial gland morphogenesis (Taylor et al., 2001). 
Using a basement membrane extract (Matrigel), modulating the paracrine TGFβ and 
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Wnt pathways involved in the stem cell niche, and providing cell fate cues, polarized 
endometrial gland-like organoids were efficiently established from primary HEECs. 
The organoids initially showed modest gland differentiation responses that seemed 
to be exclusive to cAMP. Nevertheless, when the organoids in the forming efficiency 
assay were treated with a combination of differentiation cues, the response was 
considerably increased, with PAEP expression fold change of up to 58. This might be 
explained by the pronounced heterogeneity of the responses from sample to sample. 
Even in the OFE assays, some of the organoids produced only a moderate induction 
of PAEP. Attached HEECs, forming a monolayer underneath and at the border of the 
Matrigel drops, was often observed. This phenomenon was not observed in the OFE 
assays, most likely because the number of seeded cells was smaller, and therefore 
insufficient to establish a monolayer. This difference could be therefore accounted for 
the mild effect of differentiation signals on the organoids. It is possible that the 2D 
cells harvested along with the organoids masked the real response of the gland-like 
structures.  
Glycogen is broken down within the gland cells by glycogen phosphorylase, soon 
after synthesis, and it is further degraded into diffusible sugars by α-amylase, at the 
apical surface (Jones et al., 2015). Gland activity is additionally enhanced by 
placental signals, in order to make this sugars available for the embryo (Jones et al., 
2010).  Glycogen accumulation is actually identified in the placenta as well as the 
endometrial glands during the first trimester of pregnancy (Burton et al., 2011). These 
observations could justify the fact that the glycogen levels were not higher in 
differentiated organoids.  
Very little is known about missed miscarriage etiopathogenesis, and even less about 
recurrent cases. In this study, I detected differences in the OFE between recurrent 
missed miscarriage samples and control subjects. Based on this observation I 
postulate that endometrial glands of patients suffering recurrent missed miscarriage 
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have a deficiency of progenitor cells, compromising the ability to produce new gland 
cells through asymmetric division and thereby meeting the increased demand for 
uterine secretions in early pregnancy. 
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Chapter 5 
 
Transcriptome of Human Endometrial Glands 
in the Secretory Phase and in Recurrent 
Missed Miscarriage 
____________________________________ 
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5.1 Introduction 
Once I established a method for studying the endometrial glands in vitro, and 
demonstrated differences in gland cell clonogenicity between control subjects and 
women who suffered RMM, I decided to investigate these endometrial structures in 
vivo.   
During the implantation process the endometrium must shift to a receptive state in 
order to accommodate the blastocyst. The uterine luminal epithelium is the first cell 
layer that comes in direct contact with the blastocyst. It is considered a gatekeeper, 
only allowing the endometrium to be breached during the WOI. Modifications are 
observed in this specialized epithelium, in order to prepare for adhesion and invasion 
(Zhang et al., 2013a). At the same time, changes arise in the underlying stroma, to 
make it ready for the embryo arrival. Angiogenesis and increased vascular 
permeability, along with uNK cell influx and mesenchymal-to-epithelial transition of 
fibroblasts, comprise the main transformations identified in the decidualized stroma, 
in response to the rising levels of P4, and local production of cAMP (Aplin, 2010). 
A role for endometrial glands in the establishment of the WOI has been demonstrated 
in studies with mice and sheep. Animals were exposed to P4 or progestins in the 
neonatal period, which inhibited uterine epithelium proliferation, and as a 
consequence, adenogenesis. The animals were mated , and a common observation 
during  pregnancies was that fertilization occurred, but the conceptuses were unable 
to implant (Filant and Spencer, 2014).  P4 up-regulates expression of many genes in 
the glands, and some of the translated proteins could induce a receptive phenotype 
in the luminal epithelium. Which gland-derived factors are involved is still not fully 
elucidated, but LIF has been suggested, since Lif null mice present blastocyst 
implantation problems. In humans, uterine luminal fluid protein content changes along 
the menstrual cycle, and is altered in infertile women (Hannan et al., 2011).  
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Endometrial glands provide the histiotrophic support for the foetus during the first 
trimester of pregnancy (Burton et al., 2002). Defective endometrial gland function, 
described as luteal phase defect, is considered an underlying cause of early 
pregnancy loss (Burton et al., 2007). Incidence of chromosome abnormalities in 
sporadic miscarriages is around 50 %.  No increase is observed in cases of recurrent 
pregnancy loss (Stephenson et al., 2002). The exact incidence of these genetic errors 
in cases of recurrent missed miscarriage is undisclosed, although 60 % – 75 % of 
chromosome errors were detected in isolated cases of missed miscarriage (Phillipp 
and Kalousek, 2001, Ferro et al., 2003, Phillipp et al., 2003, Lathi et al., 2007). This 
means that a significant proportion of missed miscarriage cases (25-40 %) might 
present with another cause. Impaired secretion of angiogenic factors and shifting from 
a Th2 to a Th1 immune response during the pregnancy were suggested (Paradisi et 
al., 2003, Fang et al., 2013, Daponte et al., 2013, Zhu et al., 2014). However, all the 
studies measured plasma concentrations of the mediators after the diagnosis of 
missed miscarriage, aiming to find a biomarker for the condition. Therefore, it is not 
possible to assert if they were a cause or a consequence.  
Laser microdissection (LMD) is a technique that allows for the isolation of one cell 
type or microstructure within a complex tissue. The acquisition of pure samples is 
pivotal for characterization of expression profiles. Coupled with high throughput 
technology, LMD is a powerful tool for genomic, transcriptomic and even proteomic 
research (Curran et al., 2012). This procedure has been applied in the investigation 
of the endometrium physiology. Niklaus and Pollard (2006) used the method to 
uncover distinct molecular signatures for the luminal and glandular epithelium in mice. 
Yanaihara et al. (2004) compared the epithelial with the stromal compartment in 
human endometrium, using microarray gene analysis. Franchi et al. (2008) 
characterized the expression changes of specific genes (DAF, SPP1, IL15 and PGR) 
in endometrial glands and stroma, during the window of implantation, using RT-qPCR.  
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In this chapter, I compare the transcriptome of LMD captured human endometrial 
glands in the early, mid- and late secretory phase. A gene signature of these glands 
in the receptive phase was revealed, reinforcing the importance of this cellular 
compartment in the establishment of the WOI.  Next, I explore the differences in gene 
expression between mid-secretory endometrial glands from control subjects and 
women who suffered RMM. A strong mitochondria-related gene signature suggests 
that altered glandular bioenergetics is involved in the genesis of this form of 
miscarriage.  
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5.2 Results 
5.2.1 Temporal Changes in Endometrial Gland Transcriptome, 
During the Secretory Phase of the Menstrual Cycle 
Genomic modifications of the endometrium along the secretory phase have been 
extensively demonstrated (Riesewijk et al., 2003, Mirkin et al., 2005, Talbi et al., 2006, 
Haouzi et al., 2009, Díaz-Gimeno et al., 2011, Hu et al., 2014). It is logical to infer that 
the glandular compartment is responsible for several of these changes, since 
numerous of the DEGs are strongly expressed by endometrial glands. To confirm 
this, I used LMD coupled with RNA-sequencing to study the transcriptome of glands 
in the early, mid- and late secretory phase.   
Three LH surge-timed human endometrial biopsies were acquired from each time 
point: LH+5, LH+8 and LH+11, corresponding to early, mid- and late secretory phase 
respectively. Table 5.1 displays the clinical characteristics of the patients. The 
samples were flash-frozen in liquid nitrogen and were kept in - 80 °C until LMD. 
Frozen sections were obtained from the samples, and were mounted on membrane 
slides. Endometrial glands were captured by laser microdissection (Figure 5.1). 
mRNA was extracted, and integrity was assessed at the Genomics Research Facility, 
Warwick School of Life Sciences, using Agilent 2100 Bioanalyzer with a RNA 6000 
Nano chip. The samples were deemed suitable for sequencing if RNA integrity 
number (RIN) > 5.0 and 28S/18S rRNA ratio > 0.9 (Supplementary table 5.1). 
Complementary DNA synthesis and amplification were also performed by Genomics 
Research Facility, Warwick School of Life Sciences, using Ovation RNA-Seq System 
V2 (Nugen Technologies). Library preparation and sample barcoding were produced 
using the Ovation Ultralow System V2 1-16 (Nugen Technologies). The libraries were 
sent to the Wellcome Trust Centre for Human Genomics – High Throughput 
Genomics, Oxford, UK for 100pb paired sequencing on Illumina HiSeq 4000 system. 
Data were processed and analysed in collaboration with Dr Pavle Vrljicak.  
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Principal component analysis showed the libraries clustering separately according to 
the time-point of the secretory phase (Figure 5.2). A total of 702 DEGs in at least one 
pair-wise comparison were detected, using the online tool DESeq2 and Bonferoni 
correction. Between LH+5 and LH+8, 565 genes were differentially expressed. 
Between LH+5 and LH+11, there were 295 DEGs, and between LH+8 and LH+11, 
70 DEGs were identified.  
Using K-means cluster analysis, 5 different clusters were found representing the 
temporal expression pattern of the DEGs (Figure 5.3). The different patterns suggest 
a more pronounced change from early to mid-secretory phase than from mid- to late 
secretory phase.  
 
Table 5.1 Clinical characteristics of patients from LH-timed endometrial gland 
assay.  
Groups LH+5 (n=3) LH+8 (n=3) LH+11 (n=3) Statistical 
significance 
Age 36 (32-40) 38 (34-43) 33 (32-38) No 
BMI 26 (25-29) 24 (23-30) 23 (22-25) No 
Miscarriage 5 (1-15) 0 (0-1) 4 (2-5) No 
Live birth  0 0 0 (0-1) No 
 Data are presented as median (range) 
 
 
 
Figure 5.1 LMD of human endometrial glands. (A) Bright field image of a 10 µm 
section of human endometrium stained with cresyl violet and eosin-Y. (B) The same 
endometrial section from the previous image with a laser microdissected gland. 
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Figure 5.2 Principal component analysis of RNA-seq data from LH-timed laser 
microdissected endometrial glands in the secretory phase of the menstrual 
cycle. Principal component analysis of RNA sequencing data from human 
endometrial glands captured in the secretory phase of the menstrual cycle segregates 
the libraries according to the time-points in the secretory phase (LH+5, LH+8 or 
LH+11). (n = 9).  
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Figure 5.3 Cluster analysis of temporal expression patterns of DEGs in 
endometrial glands from different time-points in the secretory phase. DEGs in 
at least one pair-wise comparison using DESeq2 and subjected to K-means cluster 
analysis using MultiExperiment Viewer v4.9.0 (MeV) uncovered 5 temporal 
expression patterns.  
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5.2.2 Gene Ontology Analysis of Glandular Transcriptome, During 
the Secretory Phase 
DEGs in the temporal clusters were submitted to gene ontology (GO) analysis using 
DAVID Bioinformatics Resources 6.8. Only temporal clusters C and E showed 
significant GO categories (P < 0.05) after Benjamini multiple testing correction. The 
Identified GO categories in these clusters were compatible with processes arising 
during the acquisition of endometrial receptivity (Supplementary table 5.2 and 5.3). In 
cluster C, which include DEGs that peaked at the mid-secretory phase, categories 
such as adhesion, extracellular matrix, inflammation, cytokine signalling and vesicles 
emerged, and are directly connected to events taking place during embryo 
implantation (Figure 3.4, top panel). Most of the GO categories engendered from 
cluster E comprised events connected to cell division (Figure 3.4, bottom panel). The 
genes in this cluster are downregulated during the mid- and late secretory phases. 
The findings are consistent with the inhibition of endometrial epithelial proliferation in 
the period.  
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Cluster C 
 
Cluster E 
 
Figure 5.4 GO analysis of temporal clusters C and E.  GO terms were obtained by 
DAVID Bioinformatics Resources 6.8. REVIGO online tool was used to summarize 
GO categories. Clusters C and E showed significant results following multiple testing 
correction (Benjamini). Only GO terms with adjusted P < 0.05 were plotted.  Plot size 
indicates the frequency of the GO term in the underlying GOA database (Barrell et al. 
2009). 
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5.2.3 Validation of Glandular Transcriptome Profile 
To validate my data, I compared the results to two datasets available in GEO Datasets 
(https://www.ncbi.nlm.nih.gov/gds) that examined whole endometrial tissue, using 
microarray technology. The first study analysed gene expression in the proliferative, 
early secretory, mid-secretory and late secretory phases of the menstrual cycle 
(GSE4888, Talbi et al., 2006). The other compared proliferative, early secretory and 
mid-secretory phase in control women and in women with endometriosis diagnosis 
(GSE6364, Burney et al., 2007). For my comparisons, I excluded the data from 
endometriosis patients. The expression of the identified DEGs in the temporal clusters 
were assessed in both datasets and plotted as heat-maps (Figure 3.5). For each 
gene, the highest expression level was considered as 100%, and other gene 
expression levels were calculated based on this assumption. The changes from early 
to mid-secretory phase were remarkably consistent with our findings. When 
comparing GSE4888 dataset to our data, during the mid- to late secretory phase, 
similarities were more evident for clusters B and E. When I focused on specific genes, 
some of the most upregulated and highest expressed genes in the receptive phase 
in two previous studies were also significantly induced in my data (Supplementary 
table 5.4 and 5.5). These findings confirm the importance of the endometrial glands 
for promotion of a receptive endometrium.  
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Figure 5.5 Comparison of temporal clusters with external datasets. Heat maps 
displaying transcription of DEGS from the temporal clusters in two publicly available 
microarray datasets (GEO Profiles; ID: GSE4888, GSE6364) generated from 
endometrial tissue in different phases of the menstrual cycle. Transcript levels were 
expressed in percentage according to the colour bar on top of the heat-maps. The 
highest transcript levels were rated as 100% for each individual gene. PE: proliferative 
endometrium; ESE: early secretory endometrium; MSE: mid-secretory endometrium; 
LSE: late secretory endometrium.  
177 
 
5.2.4 The Endometrial Gland transcriptome in Recurrent Missed 
Miscarriage 
The most profound genomic modifications in endometrial glands were verified during 
the mid-secretory phase. Therefore, I chose glands from this phase to study the 
differences between control subjects and women who experienced RMM (Table 3.2). 
The glands were captured by LMD. Total mRNA was extracted, assessed for integrity 
(Supplementary table 5.6), amplified, and used for library preparation as previously 
described. The libraries were sent to the Wellcome Trust Centre for Human Genomics 
– High Throughput Genomics, Oxford, UK for 100pb paired end sequencing with 
Illumina HiSeq 4000 system. Data was processed and analysed in collaboration with 
Dr Pavle Vrljicak. Principal component analysis did not segregate the two groups: 
control subjects and patients who suffered RMM. Although the wide-genome profile 
did not show clear difference between the groups, using DESeq2 analysis it was 
possible to detect 2014 DEGs: 1063 up-regulated in recurrent missed miscarriage 
cluster, and 951 down-regulated in the same cluster. Gene ontology analysis of the 
DEGs, using DAVID Bioinformatics Resources 6.8, revealed 25 GO terms out of 60 
involved in mitochondrial activity (Figure 3.7; supplementary table 5.7). All the genes 
within those categories were up-regulated in the RMM group.  
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Table 5.2 Clinical characteristics of patients from RMM vs control endometrial 
gland RNA sequencing.  
Groups Control (n=8) Recurrent missed 
miscarriage (n=8) 
P 
Age 35.5 (33-42) 38.5 (29-41) P = 0.8592 
BMI 23.5 (21-36) 24 (22-31) P = 0.7371 
Day of cycle LH+9 (8-10) LH+8 (7-9) P = 0.1251 
Miscarriage 0 (0-2) 3.5 (3-8) P = 0.0002 
Live birth  1 (0-2) 0.5 (0-2) P = 0.8858 
  Data are presented as median (range) 
 
 
 
Figure 5.6 Principal component analysis of RNA sequencing data from control 
subjects and patients who suffered from recurrent missed miscarriage. 
Principal component analysis of RNA-seq data from control subjects (C) (n = 8) and 
patients who suffered from recurrent missed miscarriage (RMM) (n = 8) does not 
segregate the two groups.  
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Figure 5.7 Gene ontology (GO) analysis of the RNA sequencing data from 
control subjects and patients who suffered from recurrent missed miscarriage.  
GO terms were obtained by DAVID Bioinformatics Resources 6.8. REVIGO online 
tool was used to summarize GO categories. Only GO terms with adjusted P < 0.05 
were plotted.  Plot size indicates the frequency of the GO term in the underlying GOA 
database (Barrell et al. 2009). 
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5.2.5 Validation of RNA Sequencing for Recurrent Missed 
Miscarriage 
Two up-regulated genes (ALKBH7 and ZNF319) and four down-regulated genes 
(FAM89A, MFAP4, TIMP3 and NID2) in the recurrent missed miscarriage group were 
selected for validation of the RNA sequencing data. Independent endometrial glands 
from 3 control subjects and 3 patients who suffered from recurrent missed miscarriage 
were captured by LMD. Total mRNA was extracted and used for cDNA synthesis. 
Expression of the mentioned genes was measured by RT-qPCR. The two up-
regulated genes in the recurrent missed miscarriage group in the RNA sequencing 
data were also significantly up-regulated in the samples used for RT-qPCR. Two out 
of four of the down-regulated genes in the recurrent missed miscarriage (FAM89A 
and TIMP3) were also significantly down-regulated in the samples used for RT-qPCR. 
Other two genes (MFAP4 and NID2) were also down-regulated, but the differences 
between the two groups were not statistically significant. Variability in the expression 
of latter genes in the control group was high, which could account for the lack of 
significance (Figure 3.8). Genes encoded by mitochondrial DNA were not analysed 
separately.  
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Figure 5.8 Validation of RNA sequencing data from control subjects and 
patients who suffered from recurrent missed miscarriage. mRNA from 
endometrial glands from control subjects and patients who suffered from recurrent 
missed miscarriage was extracted and used for cDNA synthesis. Expression of two 
up-regulated genes (ALKBH7 and ZNF319) and four down-regulated genes 
(FAM89A, MFAP4, TIMP3 and NID2) in recurrent missed miscarriage group from 
RNA sequencing data was measured. P values were calculated using a non-
parametric test (Mann-Whitney U test). 
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5.3 Discussion 
This is the first analysis of the human endometrial gland transcriptome during the 
secretory phase, enabling the recognition of a genomic signature for these structures 
during the receptive period. Our findings were strikingly similar to previous data sets 
using whole endometrial tissue, suggesting that the most drastic rearrangements 
during the window of implantation are due to changes in the endometrial glands and 
not in the luminal epithelium, as is often asserted. The fold change of genes in the 
mid-secretory phase was strikingly higher in my data, when compared to previous 
studies. The use of endometrial glands instead of whole endometrium may explain 
this contrast. In the whole tissue analysis the expression of regulated genes in the 
glands would be masked by the global expression in the endometrium and its other 
cell types. The use of microarray and different methods for analysis could also impact 
on the results. Another difference between my data and the data I used for 
comparisons was the endometrial dating. In Talbi et al. (2006) and Burney et al. 
(2007) studies, the endometrium was histologically assessed for defining the phases. 
Díaz-Gimeno et al. (2005) also used the LH surge as a reference, but they chose 
LH+2 and LH+7, labelled as early and mid-secretory endometrium, respectively. This 
may explain the less pronounced changes observed from mid- to late secretory phase 
in my data. Some authors include LH+11 day in the window of implantation (Achache 
and Revel, 2006, Fatemi and Popovic-Todorovic, 2013, Zhang et al., 2013).  
The GO terms that emerged in the mid-secretory phase are consistent with the events 
taking place during embryo implantation. The main changes observed in the plasma 
membrane of endometrial epithelial cells, during the window of implantation, are the 
expression of adhesion molecules (Singh and Aplin, 2009). A remodelling of the 
extracellular space and ECM occurs in order to accommodate the implanting 
blastocyst (Salamonsen and Nie, 2002). Recruitment of dendritic cells and 
macrophages are a common feature of response to wounding and uterine receptivity 
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(Lee et al., 2011). An acute inflammatory response takes place in the initial phase of 
implantation, involving intense cytokine signalling (Dekel et al., 2014). An increase in 
cytoplasmic vesicles in endometrial gland cells can be detected during the active 
period of gland secretion (Hempstock et al., 2004). The GO terms yielded from 
temporal cluster C match all these phenomena. DEGs in this cluster displayed a peak 
in the mid-secretory phase. By contrast, DEGs in the cluster E are down-regulated 
after the early secretory phase. The GO terms produced from this cluster are all 
related to cell division. P4 levels increase along the first half of luteal phase. 
Endometrial epithelial proliferation is inhibited by P4 (Kurita et al., 1998).  
The endometrial gland transcriptome of patients who suffered from RMM suggested 
possible affected cell functions in this condition. Out of 60 GO terms generated, 25 
were somehow involved in mitochondrial activity. All the genes in these categories 
were up-regulated in the recurrent miscarriage group. ATP synthases (ATP5I, 
ATP5G3, ATP5L, APT5E, ATP5J2, MT-ATP6) produce ATP from ADP and inorganic 
phosphate (Wittig et al., 2009, Pagadala et al., 2011). Cytochrome c oxidases (MT-
CO3, MT-CO2, COX5A, COX5B, COX6A1, COX7A2, COX7B, COX8A) and 
mitochondria encoded-NADH dehydrogenase (MT-ND2, MT-ND3, MT-ND4) are 
directly involved in oxidative phosphorylation and respiratory electron transport chain 
(Weiss et al., 1991, Abril et al., 2008, Wikström, 2010). COA3 regulates the assembly 
of cytochrome C (Ostergaard et al., 2015). Solute carriers family 25 A (SLC25A1, 
SLC25A14, SLC25A11, SLC25A22) and mitochondria outer and inner translocase 
complexes control the transport of small metabolites and proteins through the 
mitochondria membranes (Hönlinger et al., 1996, Rehling et al., 2004, Gutiérrez-
Aguilar et al., 2013, Palmieri, 2013). TXN2, PRDX5 and OSER1 have antioxidant 
roles (Nguyên-nhu and Knoops, 2003, Yuan et al. 2004, Pérez et al., 2007, Zhang et 
al., 2007, Barl et al., 2016). ALKBH7, MTCH1 and APOPT1 regulate mitochondria-
mediated apoptosis (Lamarca et al., 2007, Fu et al., 2013, Melchionda et al., 2014, 
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Wang et al., 2014). I postulated that an imbalance in gland-cells energy spending 
would lead to premature exhaustion of the endometrial glands, deficient histiotrophic 
support and, as a consequence, to foetal underdevelopment and demise. I have 
demonstrated reduced clonogenicity of endometrial gland cells in patients with 
recurrent missed miscarriage (Chapter 2). Mitochondria density and activity are low 
in stem-cells and increase upon differentiation (Mandal et al., 2010, Prigione et al., 
2010). Therefore higher expression of mitochondria related genes in recurrent missed 
miscarriage samples could simply reflect the lower amount of clonogenic cells in the 
glands of these patients. These possibilities need to be further explored.  
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Chapter 6 
 
Final Discussion 
____________________________________ 
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6.1 Isolation, Culture and Reprogramming of HEEC 
The problem of cell cycle arrest, disturbing proliferation of HEECs in vitro was 
corroborated by my research. Once cells were isolated from the tissue, plated as 
monolayers, and cultured in non-specific medium, they exhibited protracted growth 
and developed acute senescence compared to HESCs. Furthermore, stimulation with 
ovarian steroids and embryonic cues (trypsin and hCG) did not evoke differentiation 
responses. Conditional reprogramming, targeting cytoskeleton remodelling (ROCK 
inhibitor) and increase of TERT activity (conditioned medium from irradiated 
fibroblasts) improved HEEC proliferation and partially rescued them from acute 
senescence. This approach enabled expansion and freezing, allowing the 
establishment of stocks of cells from patients with specific clinical characteristics or 
conditions.  
Reprogrammed HEECs remained unresponsive to sex steroids and embryo-derived 
signals, however, decidualized stromal secreted factors elicited differentiation, 
enhanced proliferation, and reduced senescence. Which soluble factors from 
differentiated stroma induced the responses in the HEECs is still a matter of 
speculation, and future investigation could unravel another crucial aspect of the 
epithelial-stromal cross-talk.  An obvious candidate would be PRL, since it is a major 
protein secreted by the decidualized endometrial fibroblasts. However, no response 
was observed when HEECs were exposed to this hormone. Transcriptome, proteome 
and secretome analysis could provide a list of decidua-secreted proteins to be further 
investigated. Some of these studies detected noteworthy functional annotations such 
as cell cycle regulation, cytoskeleton remodelling, and growth factor and cytokine 
signalling (Takano et al., 2007, Garrido-Gomez et al., 2010, Paule et al., 2010). An 
interesting observation was that conditioned medium from HESCs decidualized for 4 
and 10 days trigger a similar response. Gene expression during decidualization is 
dynamic, with pronounced time-dependant changes. Salker et al. (2012) identified a 
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dramatic shift in the expression of several inflammatory mediators between HESCs 
decidualized for 2 or 8 days. Lucas et al. (2015) also observed great variability within 
18 secreted proteins (cytokines, chemokines and growth factors) from HESCs 
decidualized for 2, 4 or 8 days. These changes could help selecting the most likely 
HEEC differentiation factors, through elimination of those that show marked variation 
between early and late decidualization period. Some factors expressed by the stroma, 
such as HGF, FGF7, FGF10, WNT4, WNT5A, are involved in endometrial 
adenogenesis and development, and may be implicated in the gland differentiation 
observed with decidualized HESC conditioned medium (Taylor et al., 2001, Cooke et 
al., 2013).  
Basal adenylyl cyclase activity in the endometrium is increased during the secretory 
phase, and this activity is more highly induced upon PGE2 treatment in the same 
phase compared to proliferative phase (Tanaka et al., 1993). P4 enhances PGE2-
promoted cAMP production in HESCs (Houserman et al., 1989). This accounts for the 
extremely high tissular content of cAMP in the luteal-phase endometrium (Bergamini 
et al., 1985). Considering these observations, it is reasonable to cogitate that stroma-
derived cAMP could be a possible factor driving epithelial differentiation, during 
decidualization. Indeed, when later, I treated endometrial gland organoids with this 
second messenger an up-regulation of glycodelin gene was observed.  
The data corroborate the importance of the epithelial-stromal cross-talk in the 
endometrial function, and indicated a novel role for the decidual cells in the regulation 
of epithelial proliferation, differentiation and senescence.  
6.2 Three Dimensional Culture of HEECs 
Cells in monolayer culture do not polarize properly, having a limited space to interact 
with neighbouring counterparts (Baker and Chen, 2012). This problem is even more 
pronounced when using epithelial glandular cells (Rodriguez-Boulan and Macara, 
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2014). Trafficking of molecules must be organized to allow secretion through the 
lumen and cross-talk with the underlying compartment, and polarity is essential for 
this coordination. Furthermore, receptors and ion channels are usually located in the 
apical domain, which is also crucial for signal transduction (Kaplan et al., 2009). 
Based on these facts I conjectured that HEEC monolayers did not respond to 
differentiation stimuli due to deficient polarization, which prompted me to develop a 
method for 3D culture.  
HEEC spheroids were relatively easy to produce, however it is not so simple to handle 
them. Due to the limited volume of media in the hanging drops, the structures must 
be soon transferred to a plates or dishes that holds larger liquid volume. Rupture of 
the structures during the transfer were frequent, and a large number of spheroids 
were required to extract a reasonable mRNA amount. Another risk was the possibility 
of deficient perfusion of cells in the core of spheroids (Edmondson et al., 2014). Two 
approaches could be used to circumvent this problem. First, there are viability assays 
for spheroids described in the literature (Bell et al., 2016, McMillan et al., 2016). 
Assessing the viability, it would be possible to optimize the number of cells used to 
produce the spheroids, although risking to further reduce the quantity of retrieved 
mRNA. Second alternative is the use of microcarrier cultures, which are based on the 
use of microbeads for the cells to attach. The core is occupied by the beads and the 
cells are spread onto the surface. Many beads can be added in the dish at the same 
time, enabling work with larger number of cells (Goh et al., 2013).  
Another modality of 3D culture attempted was the polymer scaffolds. This work is still 
in progress, in order to optimize the material, the pore size and the chemoattractant 
used for coating the scaffold. I have demonstrated that the cells grow in a 3D 
disposition, however polarity is still to be tested with the staining of some subcellular 
structures, such as microvilli and adhesion molecules from the lateral and basal 
domains (Eritja et al., 2010). There is a strong possibility that the cells are laying in a 
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configuration more akin to LE than GE, based on the staining performed so far. 
Expansion medium could be tested to induce a glandular arrangement in the scaffold. 
An interesting alternative to the synthetic scaffolds has just been explored by our 
group: the use of decellularized scaffolds. Fragments of tissue are submitted to 
physical (agitation, thermal shock, ultrasound and hydrostatic pressure), chemical 
(detergents, solvents, ionic solutions) or enzymatic process to remove the cells and 
preserve the ECM (Tapias and Ott, 2014). The ECM scaffold can be then used to 
harbour new cells. Evidence has also indicated the advantage of the utilization of 
scaffolds coupled with microfluidic devices (Tehranirokh et al., 2013). Employing a 
system of channels and chambers, it is possible to delivery substrates, nutrients and 
reagents in a controlled way, improving the cell / tissue microenvironment. 
Using a modified adult stem-cell medium it was possible to establish endometrial 
gland organoids with high efficiency. These organoids could be derived from 
individual patients, expanded and be used for functional studies, enabling 
personalized study of uterine glands in vitro. Some improvements still must be done 
to further purify and characterize these structures. For example, the presence of a 
HEEC monolayer, underlying the Matrigel drop, possibly masks organoid responses 
to the differentiation cues applied. The clear more pronounced induction of PAEP in 
the organoids in OFE assays strongly suggests that. In this assay, a lower number of 
cells is seeded in a small volume of Matrigel, and the presence of HEECs attached 
to the well bottom is scarce or inexistent. Optimization of the seeding cell number, the 
volume of basement membrane matrix, and the harvesting of cells may solve this 
problem.  
Glycogen production did not differ between control and differentiated organoids. Once 
more, the presence of the underlying HEEC monolayer may be accounted for hiding 
the differences between the two groups. Another possibility is a technical problem 
with the employed assay. It ultimately measures glucose content in the lysate, after 
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digestion of glycogen. Reducing substances and high protein content in the samples 
may interfere with the observed results. The organoids are retrieved from Matrigel 
using Cell Recovery Solution and several washes, however it is impossible to totally 
remove the matrix. The composition of this product is variable, but a high amount of 
protein is always present (Kleinman et al., 1986, Vukicevic et al., 1992). Therefore it 
is not possible to rule out the chance of the Matrigel or even the medium components 
influencing the results of the assay. An interesting alternative is the periodic-acid 
Schiff staining. This method is used for detecting glycogen in tissue and could be 
used with the organoids, provided that sections of intact organoids are obtained.  
The possibility of studying endometrial glands in vivo creates opportunities to further 
investigate their role in stromal decidualization, endometrial receptivity and immune 
regulation of maternal tolerance to the foetus, or even to unravel new functions for 
these glands. Co-culture with stromal cells or blastocysts allows exploration of the 
exchange of signals between these endometrial compartments, and between the 
implanting embryo and the endometrium. Research on several clinical conditions, 
such as endometriosis, RPL, endometrial hyperplasia and endometrial cancer, can 
also profit with the establishment of patient-specific gland organoids. The discovery 
of specific gland defects in RPL and endometriosis can aid in the development of a 
treatment. Identified prognostic factors for hyperplasia clinical evolution, i.e. the 
chance of developing an invasive cancer, and for endometrial adenocarcinoma 
progression may guide therapeutic choices and even preventive measures. 
The use of 3D culture methods for investigation of endometrium is a promising tool in 
the advance of our knowledge on this intriguing and complex tissue. Furthermore, the 
study of uterine glands in vitro enables a deeper understanding of the role of these 
structures in reproduction and in pathological conditions.   
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6.3 Transcriptome of Endometrial Glands in the Mid-Secretory 
Phase 
The endometrial gland transcriptomic signature during the WOI was markedly 
concordant with previous whole endometrial tissue studies. This similarity suggests 
that the transformations taking place during the receptive phase are mainly due to 
changes in the GE. Actually, it is not possible at the moment to affirm that the same 
behaviour is not present in the LE. Remarkable differences have been demonstrated 
between these two portions of the endometrial compartment (Demir et al., 2002, 
Niklaus and Pollard, 2006), besides, several of the top most up-regulated genes in 
mid-secretory phase, such as PAEP, DPP4, CXCL14, DEFB1, SLP1 are chiefly 
expressed by GE (Sepällä et al., 2002, Imai et al., 1992, Mokhtar et al., 2010, Das et 
al., 2007, King et al., 2000). The significant GO terms that emerged from two clusters 
of my data are consistent with phenomena observed during the acquisition of 
endometrial receptivity and blastocyst implantation, corroborating the role of 
endometrial glands in the preparing the endometrium to accommodate the embryo.  
6.4 Endometrial Glands in RMM 
Due to the essential role of uterine glands to provide histiotrophic support to the foetus 
during early pregnancy I postulated that defects in these epithelial compartment 
would be implicated in cases or RMM. In such cases, the underdeveloped embryo 
cannot be identified or a protracted foetal development is followed by demise (Sur 
and Raine-Fenning 2009).  
Clonogenicity of endometrial gland cells from RMM cases was significantly decreased 
compared to that of control subjects, as demonstrated by the OFE assay. The number 
of organoids formed after seeding at clonal density was lower and the diameter was 
usually smaller in the RMM group. I postulate that these progenitor cells would fail to 
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expand when demanded, reducing the decidual gland density at the maternal-foetal 
interface, leading to deficient histiotrophic support and eventually foetal death.  
When analysing the RNA sequencing data from control subjects and RMM cases, 
principal components did not split the two groups, nevertheless a high number of 
DEGs were detected by DeSeq2 analysis. GO analysis produced several categories 
involved in mitochondrial functions, such as ATP synthesis, free-radical scavenging 
and apoptosis. All the DEGs were up-regulated in the RMM group. Gland secretion 
is a bioenergetically demanding activity, involving protein translation, assembly, 
folding, packaging, trafficking and exocytosis, requiring high efficiency from the 
mitochondrial machinery. I postulate that in RMM cases, the uterine glands develop 
premature exhaustion, before the establishment of the haemochorial support by 
placenta, due to mitochondrial defect. Since these organelles are also involved in 
regulation of apoptosis and prevention of excessive oxidative stress, it might be that 
impairment in these functions could lead to uncontrolled DNA damage and cell death 
in the placenta. The finding of higher expression of mitochondria-associated genes in 
the RMM cases may be related to my previous observation of decreased gland 
clonogenicity in such condition. Stem cells exhibit lower mitochondrial density and 
activity (Mandal et al., 2010, Prigione et al., 2010). RMM samples would harbour less 
stem-like cells, thereby presenting higher mitochondrial contents. Analysis of 
mitochondrial activity in endometrial gland organoids could further explore the role of 
the organelle in RMM. The Seahorse XF Cell Mito Stress Test (Seahorse Bioscience) 
measures direct cell oxygen consumption, estimating parameters of mitochondria 
function, such as basal respiration, ATP-linked respiration, H+ (proton) leak, maximal 
respiration, spare respiration and non-mitochondrial respiration (Isono et al., 2016). 
Ultrastructural analysis of the cells in the organoids could allow direct visualization of 
mitochondria, thereby enabling to analyse mitochondria density, shape and size. 
Curiously, Armstrong et al. (1973) described a giant mitochondria found exclusively 
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in endometrial gland cells, from day 13 to day 22 of the menstrual cycle. These 
organelles were frequently connected to the endoplasmic reticulum. Dockery et al. 
(1993) observed lower density and smaller size of mitochondria in infertile patients in 
the early secretory phase (LH +4). The same group detected a decrease in 
mitochondrial size at LH+5 in patients receiving the anti-progesterone drug, 
mifepristone (Dockery et al., 2007). 
Glandular defects are most likely associated with recurrent empty sacs or malformed 
foetus with normal karyotypes. In these cases, the deficient supply of nutrients 
(amongst them retinoic acid) and growth factors, by impaired endometrial glands, 
would lead to defective organogenesis, even though no chromosomal abnormality is 
present. Despite the reasonable number of samples, my results emerge only as a 
starting point for future investigation. It also pioneers the approach of the patient 
outside the pregnancy, being possible to establish a causal association. Larger 
sample sizes and stringent selection of cases and controls will help to validate or 
reject the observations.      
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Supplementary table 5.1: RNA integrity number (RIN) and 28s/18s rRNA ratio of 
the samples used in LH-timed endometrial gland assay 
Sample ID RIN 28s/18s rRNA ratio 
ES1 6.2 1.2 
ES2 6.8 1.2 
ES3 7.2 1.3 
MS1 6.9 1.2 
MS2 7.0 1.3 
MS3 7.0 1.2 
LS1 6.8 1.3 
LS2 6.8 1.2 
LS3 6.7 1.0 
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Supplementary table 5.2: GO terms and categories for temporal cluster C. 
Categories and terms were only included if P < 0.05.  
Category Term Adjusted  
P 
GO:0044421 extracellular region part 9.72E-07 
 GO:0005576 extracellular region 3.44E-06 
 GO:0009611 response to wounding 0.001993 
 GO:0005615 extracellular space 0.001696 
 GO:0002526 acute inflammatory response 0.020448 
 GO:0007155 cell adhesion 0.028643 
 GO:0022610 biological adhesion 0.021954 
 GO:0004896 cytokine receptor activity 0.04803 
 GO:0050729 positive regulation of inflammatory response 0.039032 
 GO:0031093 platelet alpha granule lumen 0.028022 
 GO:0060205 cytoplasmic membrane-bounded vesicle lumen 0.029373 
 GO:0005604 basement membrane 0.027283 
 GO:0044420 extracellular matrix part 0.023538 
 GO:0031983 vesicle lumen 0.02183 
 GO:0005578 proteinaceous extracellular matrix 0.020632 
 GO:0031410 cytoplasmic vesicle 0.02256 
 GO:0031012 extracellular matrix 0.02948 
 GO:0005577 fibrinogen complex 0.027822 
 GO:0031982 vesicle 0.026376 
 GO:0031091 platelet alpha granule 0.026035 
 GO:0032103 positive regulation of response to external stimulus 0.031942 
 GO:0042060 wound healing 0.036671 
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Supplementary table 5.3: Some of GO categories and terms for temporal cluster 
E. Categories and terms were only included if adjusted P < 0.05.  
Category Term   Adjusted  P 
GO:0000279 M phase 1.1E-10 
 GO:0000280 nuclear division 1.28E-10 
 GO:0007067 mitosis 1.28E-10 
 GO:0000087 M phase of mitotic cell cycle 1.2E-10 
 GO:0048285 organelle fission 1.36E-10 
 GO:0007049 cell cycle 1.39E-09 
 GO:0022402 cell cycle process 1.75E-09 
 GO:0022403 cell cycle phase 2.21E-09 
 GO:0000278 mitotic cell cycle 9.3E-09 
 GO:0051301 cell division 4.91E-08 
 GO:0007059 chromosome segregation 1.15E-07 
 GO:0015630 microtubule cytoskeleton 4.81E-07 
 GO:0005819 spindle 4.88E-06 
 GO:0007346 regulation of mitotic cell cycle 9.2E-06 
 GO:0000793 condensed chromosome 7.85E-06 
 GO:0044430 cytoskeletal part 2.5E-05 
 GO:0005694 chromosome 6.29E-05 
 GO:0000777 condensed chromosome kinetochore 8.93E-05 
 GO:0044427 chromosomal part 8.78E-05 
 GO:0043228 non-membrane-bounded organelle 8.99E-05 
 GO:0043232 intracellular non-membrane-bounded organelle 8.99E-05 
 GO:0000779 condensed chromosome, centromeric region 0.000144 
 GO:0000775 chromosome, centromeric region 0.000139 
 GO:0005856 cytoskeleton 0.000213 
 GO:0051726 regulation of cell cycle 0.001306 
 GO:0000776 kinetochore 0.000303 
 GO:0010564 regulation of cell cycle process 0.002878 
 GO:0000070 mitotic sister chromatid segregation 0.003354 
 GO:0000819 sister chromatid segregation 0.003588 
 GO:0000075 cell cycle checkpoint 0.004135 
 GO:0005815 microtubule organizing center 0.001249 
 GO:0005813 centrosome 0.002022 
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Supplementary table 5.4: Up-regulated genes from early to mid-secretory phase 
in natural menstrual cycle. Comparison of the present study with two similar 
studies. 
Gene name Present study    
(Fold change) 
Talbi et al., 2006          
(Fold change) 
Díaz-Gimeno et al., 2005  
(Fold change) 
DPP4 263.47 12.34 7.72 
GPX3 217.90 32.52 35.49 
COMP 203.97 14.22 30.95 
GAST 167.2541 6.44 5.00 
AOX1 152.87 5.26 4.82 
C4BPA 151.39 6.67 13.14 
CXCL14 132.06 39.13 14.02 
PAEP 119.93 23.55 31.43 
LAMB3 96.32 6.07 11.32 
CP 77.86 4.93 6.34 
LIF 77.30 4.11 15.03 
TSPAN8 73.06 11.57 12.90 
CD55 57.23 8.62 22.47 
SLC15A1 50.61 13.29 5.59 
ABCC3 46.54 2.35 5.98 
APOD 37.75 3.55 4.32 
TCN1 31.20 9.58 14.76 
NNMT 29.74 1.49 7.74 
SERPING1 22.91 4.82 5.16 
MAOA 21.9 3.99 9.39 
DEFB1 19.9 8.62 4.17 
MT1H 17.83 1.70 3.12 
SLC1A1 17.57 21.66 17.57 
GBP2 17.46 2.94 3.14 
MUC16 15.24 7.61 8.01 
CRISP3 13.32 3.90 5.09 
C3 12.10 4.35 4.67 
VCAN 11.40 4.37 3.24 
ANXA4 10.25 4.09 4.27 
SLPI 9.90 4.01 4.39 
SYNE2 9.30 4.22 3.52 
ARID5B 8.36 4.17 4.19 
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Supplementary table 5.5: Down-regulated genes from early to mid-secretory 
phase in natural menstrual cycle. Comparison of the present study with two other 
similar studies.  
Gene name Present study   
(Fold change) 
Talbi et al., 2006 
(Fold change) 
Díaz-Gimeno et al., 2005 
(Fold change) 
ALPL -60.48 -5.75 -4.44 
PLA1A -46.93 0.98 -3.42 
LRP4 -45.92 -9.64 -5.87 
CTNNA2 -32.78 -13.35 -8.02 
OPRK1 -24.41 -19.40 -3.17 
CSRP2 -21.69 -10.65 -9.62 
HLA-DOB -21.05 -13.27 -11.06 
SLC15A2 -19.55 -8.31 -8.44 
LRRC17 -19.30 -6.39 -4.64 
ATP6V0E2 -19.30 -5.33 -9.82 
EDN3 -16.51 -4.09 -5.30 
NR4A2 -15.15 -4.53 -7.05 
SORD -14.32 -4.38 -3.21 
BUB1B -13.40 -1.52 -3.05 
CCNB2 -11.61 -1.29 -3.23 
GALNT12 -11.00 -4.33 -4.85 
PRKCQ -9.50 -2.84 -3.08 
IDH1 -9.46 -5.31 -3.68 
NDRG2 -8.92 -3.29 -3.40 
KHDRBS3 -8.46 -3.61 -3.51 
SOX17 -7.90 -4.76 -4.24 
CKB -7.79 -2.51 -3.61 
CREB3L1 -7.56 -4.29 -3.77 
BARD1 -7.55 -3.53 -3.47 
ANK3 -7.06 -5.31 -4.79 
STEAP4 -6.86 -5.47 -3.04 
DFNB31 -6.56 -4.94 -3.54 
HSD11B2 -5.63 -3.01 -4.03 
MSX1 -5.10 -3.49 -3.26 
MMP26 -4.74 -3.45 -4.66 
OFD1 -3.41 -3.92 -3.44 
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Supplementary table 5.6: RNA integrity number (RIN) and 28s/18s rRNA ratio of 
the samples used in missed miscarriage assay. 
Sample ID RIN 28s/18s rRNA ratio 
C1 6.9 1.0 
C2 6.6 1.2 
C3 6.4 1.0 
C4 7.8 1.1 
C5 6.0 1.0 
C6 6.3 1.0 
C7 6.4 1.0 
C8 7.2 1.1 
C9 6.9 1.1 
RMM1 6.4 1.1 
RMM2 6.8 1.3 
RMM3 6.6 1.0 
RMM4 6.1 1.1 
RMM5 7 1.4 
RMM6 7.3 1.3 
RMM7 7.2 1.1 
RMM8 5.7 1.1 
RMM9 7.1 1.2 
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Supplementary table 5.7: GO categories and terms of recurrent missed 
miscarriage versus control subjects RNA sequencing data. Categories and terms 
were only included if adjusted P < 0.05.   
Category Term Adjusted 
P 
  
GO:0005743 mitochondrial inner membrane 1.00882E-25 
 
GO:0006120 mitochondrial electron transport, NADH to ubiquinone 1.47052E-21 
 
GO:0005747 mitochondrial respiratory chain complex I 4.74348E-20 
 
GO:0008137 NADH dehydrogenase (ubiquinone) activity 9.02256E-18 
 
GO:0032981 mitochondrial respiratory chain complex I assembly 6.10612E-16 
 
GO:0003735 structural constituent of ribosome 1.12726E-09 
 
GO:0006123 mitochondrial electron transport, cytochrome c to 
oxygen 
1.5118E-09 
 
GO:0004129 cytochrome-c oxidase activity 1.97895E-09 
 
GO:0006412 translation 3.28961E-06 
 
GO:0070125 mitochondrial translational elongation 6.84563E-07 
 
GO:0005762 mitochondrial large ribosomal subunit 7.19562E-07 
 
GO:0070126 mitochondrial translational termination 8.07507E-07 
 
GO:1902600 hydrogen ion transmembrane transport 2.12992E-06 
 
GO:0006754 ATP biosynthetic process 2.47538E-06 
 
GO:0005753 mitochondrial proton-transporting ATP synthase 
complex 
2.17475E-05 
 
GO:0005840 ribosome 0.003633511 
 
GO:0005751 mitochondrial respiratory chain complex IV 0.000102057 
 
GO:0042776 mitochondrial ATP synthesis coupled proton transport 0.000154348 
 
GO:0019058 viral life cycle 0.000306093 
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GO:0006094 gluconeogenesis 0.000553001 
 
GO:0006614 SRP-dependent cotranslational protein targeting to 
membrane 
0.000937854 
 
GO:0000184 nuclear-transcribed mRNA catabolic process, 
nonsense-mediated decay 
0.002383755 
 
GO:0015078 hydrogen ion transmembrane transporter activity 0.000154348 
 
GO:0022625 cytosolic large ribosomal subunit 0.003589483 
 
GO:0048029 monosaccharide binding 0.005821039 
 
GO:0003899 DNA-directed RNA polymerase activity 0.005857744 
 
GO:0006364 rRNA processing 0.006877368 
 
GO:0005665 DNA-directed RNA polymerase II, core complex 0.00707246 
 
GO:0050434 positive regulation of viral transcription 0.007731698 
 
GO:0042744 hydrogen peroxide catabolic process 0.009941164 
 
GO:0036258 multivesicular body assembly 0.010299137 
 
GO:0006098 pentose-phosphate shunt 0.010477153 
 
GO:0039536 negative regulation of RIG-I signaling pathway 0.010743627 
 
GO:0019083 viral transcription 0.011011321 
 
GO:0031902 late endosome membrane 0.011362093 
 
GO:0006368 transcription elongation from RNA polymerase II 
promoter 
0.011630563 
 
GO:0006370 7-methylguanosine mRNA capping 0.013396146 
 
GO:0001054 RNA polymerase I activity 0.013814991 
 
GO:0039702 viral budding via host ESCRT complex 0.014011183 
 
GO:0000276 mitochondrial proton-transporting ATP synthase 
complex, coupling factor F(o) 
0.014052432 
 
GO:0098641 cadherin binding involved in cell-cell adhesion 0.017618238 
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GO:0005736 DNA-directed RNA polymerase I complex 0.017676902 
 
GO:0006413 translational initiation 0.018523761 
 
GO:0051537 2 iron, 2 sulfur cluster binding 0.019506866 
 
GO:0031145 anaphase-promoting complex-dependent catabolic 
process 
0.021562589 
 
GO:0016197 endosomal transport 0.02443826 
 
GO:0061621 canonical glycolysis 0.024971643 
 
GO:0000302 response to reactive oxygen species 0.026270112 
 
GO:0005868 cytoplasmic dynein complex 0.026337883 
 
GO:0098609 cell-cell adhesion 0.029300056 
 
GO:0005913 cell-cell adherens junction 0.030422093 
 
GO:0051287 NAD binding 0.032811347 
 
GO:0000398 mRNA splicing, via spliceosome 0.034105971 
 
GO:0042542 response to hydrogen peroxide 0.034439994 
 
GO:0051436 negative regulation of ubiquitin-protein ligase activity 
involved in mitotic cell cycle 
0.034715987 
 
GO:1902041 regulation of extrinsic apoptotic signaling pathway via 
death domain receptors 
0.035568928 
 
GO:0000920 cell separation after cytokinesis 0.041337226 
 
GO:0006283 transcription-coupled nucleotide-excision repair 0.042083084 
 
GO:0045454 cell redox homeostasis 0.047517331 
 
GO:0051437 
  
positive regulation of ubiquitin-protein ligase activity 
involved in regulation of mitotic cell cycle transition 
0.047517331 
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[Abstract] The isolation and primary culture of cells from human endometrial biopsies provides valuable 
experimental material for reproductive and gynaecological research. Whole endometrial biopsies are 
collected from consenting women and digested with collagenase and DNase I to dissociate cells from 
the extracellular matrix. Cell populations are then isolated through culturing, filtering and magnetic 
separation using cell-surface antigen markers. Here we provide a comprehensive protocol on how to 
isolate and culture individual cell types from whole endometrial tissues for use in in vitro experiments. 
 
[Background] The human endometrium is the inner most mucosal layer of the uterus. It consists of a 
columnar epithelium and basal stromal layer that undergoes cyclical regeneration, growth and 
transformation in response to circulating hormones. The differentiation of the endometrial lining into a 
glandular secretory phenotype provides a hospitable environment for blastocyst implantation and 
successful pregnancy. In the absence of pregnancy this layer is shed, leading to menstruation. The 
isolation and culture of cells from human endometrial biopsies allows for in vitro functional assessment 
and the study of cell characteristics in relation to patient outcomes. The isolation and culture of 
endometrial cells is an invaluable research model to investigate many aspects of gynaecological and 
obstetrical medicine including infertility, implantation failure, recurrent miscarriage and menstrual 
disorders. Whole human endometrial biopsies contain human endometrial stromal cells (HESCs), 
luminal and glandular endometrial epithelial cells (HEECs), red blood cells and a mixed population of 
immune cells. HESCs can be easily and inexpensively isolated from whole biopsies and actively 
proliferate in culture for up to 5 passages without significant change in their growth dynamics. This 
provides a large window of opportunity for experimental analysis. Furthermore, within dissociated 
HESCs there is a sub-population of perivascular progenitor mesenchymal stem-like cells that can be 
isolated using the perivascular-specific antigen SUSD2 and its cognate antibody W5C5. Here we 
provide in detail an updated and expanded protocol from those published previously (Masuda et al., 
2012; Chen and Roan, 2015) to describe steps in isolating and culturing different cell types from whole 
human endometrium. We provide further information on biopsy collection, detailed protocols for isolation 
of progenitor cells and additional procedures to increase epithelial cell yield and culturing efficiency. 
 
Materials and Reagents 
 
1. Petri-dish 92 x 16 mm (SARSTEDT, catalog number: 82.1473) 
2. Disposable scalpels (Swann Morton, catalog number: 0501) 
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3. 15 ml CELLSTAR® tubes (Greiner Bio One, catalog number: 188261) 
4. 50 ml CELLSTAR® tubes (Greiner Bio One, catalog number: 227270) 
5. 7 ml Bijoux tubes (Greiner Bio One, catalog number: 189176) 
6. FisherBrandTM Nylon mesh cell strainer, 40 µm (Thermo Fisher Scientific, Fisher Scientific, 
catalog number: 11587522) 
7. 0.2 µm Minisart® NML syringe filter (Sartorius Stedim Biotech, catalog number: 16534-K) 
8. 20 ml syringes (BD, catalog number: 300613) 
9. 60 ml syringes (BD, catalog number: 309653) 
10. Sterile pipette filter-tips 1,000 µl (Alpha Laboratories, catalog number: ZP1250S) 
11. Sterile pipette filter-tips 100 µl (Alpha Laboratories, catalog number: ZP1200S) 
12. FisherbrandTM glass Pasteur pipettes (Thermo Fisher Scientific, Fisher Scientific, catalog 
number: 1156-6963) 
13. MS columns (Miltenyi Biotec, catalog number: 130-042-201) 
14. Wallach Endocell® disposable endometrial cell sampler (Wallach Surgical Decices, catalog 
number: 908014A) 
15. Human endometrial biopsies (see step A) 
16. Cell culture media 
a. DMEM/F12 (1:1) with phenol red (Thermo Fisher Scientific, GibcoTM, catalog number: 
31330-038) 
b. L-glutamine (Thermo Fisher Scientific, GibcoTM, catalog number: 25030-081) 
c. Antibiotic/antimycotic (Thermo Fisher Scientific, GibcoTM, catalog number: 15240-062) 
d. β-estradiol (Sigma-Aldrich, catalog number: E2758) 
e. Recombinant human insulin (Sigma-Aldrich, catalog number: 91077C) 
f. Acetic acid, glacial ≥ 99.7% (Sigma-Aldrich, catalog number: 695092) 
17. Tissue digestion media  
a. DMEM/F12, phenol-free media (Thermo Fisher Scientific, GibcoTM, catalog number: 11039-
021) 
b. Collagenase from Clostridium histolyticum (Sigma-Aldrich, catalog number: C9891-500MG) 
c. DNase I from bovine pancreas (Roche Diagnostics, catalog number: 11284932001) 
18. Trypsin-EDTA, 0.25% (Thermo Fisher Scientific, GibcoTM, catalog number: 25200-056) 
19. Ficoll-paque plus medium (GE Healthcare, catalog number: 17-1440-02) 
20. Separation buffer (see Recipes) 
a. Bovine serum albumin (BSA) (Sigma-Aldrich, catalog number: A2153) 
b. Phosphate-buffered saline (PBS) (Dulbecco A) OxoidTM (Thermo Fisher Scientific, Thermo 
ScientificTM, catalog number: BR0014G) 
21. PE anti-human SUSD2, clone: W5C5 antibody (Biolegend, catalog number: 327406) 
22. Anti-PE microbeads (Miltenyi Biotec, catalog number: 130-048-801) 
23. Ethanol, absolute (Thermo Fisher Scientific, Fisher Scientific, catalog number: 10437341) 
24. Sterile distilled water 
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25. Dextran-coated charcoal (DCC)-treated FBS (see Recipes)  
a. Charcoal (Sigma-Aldrich, catalog number: C9157) 
b. Dextran 70 (Sigma-Aldrich, catalog number: 1179741) 
c. Fetal bovine serum (FBS) (Thermo Fisher Scientific, GibcoTM, catalog number: 10500-064) 
26. Digestion media (see Recipes) 
27. Culture media (see Recipes) 
 
Equipment 
 
1. 25 cm2 CELLSTAR® culture flasks (Greiner Bio One, catalog number: 690175) 
2. 75 cm2 CELLSTAR® culture flasks (Greiner Bio One, catalog number: 658175) 
3. 5 ml serological pipettes (Greiner Bio One, catalog number: 606180) 
4. 10 ml serological pipettes (Greiner Bio One, catalog number: 607180) 
5. Pipette controller/pipette aid (e.g., STARLABS, catalog number: S7166-0010) 
6. Vacuum-driven 0.22 μm filtration system (EMD Millipore, catalog number: SCGPT05RE)  
7. LUNATM BF automated cell counter (Logos Biosystems, catalog number: L10001) 
8. LUNATM cell counting slides (Logos Biosystems, catalog number: L12001) 
9. miniMACS separator (Miltenyi Biotec, catalog number: 130-042-102) 
10. MACS multistand (Miltenyi Biotec, catalog number: 130-042-303) 
11. Walker Class II cell culture microbiological safety cabinet (Walkers Safety Cabinets, model: 
Class II MSC) 
12. FisherbrandTM FB 70155 aspirator (Thermo Fisher Scientific, Fisher Scientific, catalog number: 
11533485) 
13. Grant Instruments water bath (Grant Instruments, model: OLS200) 
14. Thermo Scientific HeracellTM 150i humidified tissue culture incubator (set at 37 °C and 5% CO2) 
(Thermo Fisher Scientific, catalog number: 51026280) 
15. Sigma 3-16KL bench-top centrifuge (Sigma Laborzentrifugen, model: 3-16KL) 
16. Bright-field Leica DMIL microscope (Leica Microsystems, model: Leica DMIL) 
 
Procedure 
 
A. Collection of human endometrial biopsies 
Endometrial biopsies are obtained from women attending the Implantation Clinic, a dedicated 
research clinic at University Hospitals Coventry and Warwickshire National Health Service Trust. All 
research was undertaken with full ethical approval and with written informed consent obtained from 
all participants in accordance with the guidelines in The Declaration of Helsinki 2000. Biopsies are 
taken during the secretory phase of the menstrual cycle using an Endocell cannula, starting from 
the uterine fundus and moving downward to the internal cervical ostium. The endometrial biopsy is 
placed in a labelled Bijoux tube containing 5 ml cell culture media, and processed immediately. 
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Notes:  
a. Biopsy sizes vary considerably depending on the patient and clinical professional performing 
the procedure. The hormonal status of the patient and the stage of menstrual cycle in which 
biopsies are obtained will effect yielding and cell composition due to the transient phasic 
dynamics of the endometrium. Our biopsies are timed to the secretory phase of the menstrual 
cycle, but readers are encouraged to time collections around their own experimental hypothesis. 
b. Typically, biopsies have a uniform thickness (see Figure 1B) but can vary in length from < 1-6 
cm. Tissue is also fragile and may fragment on collection or in transit, or be contaminated with 
blood or mucus. Readers should follow the protocol exactly in all situations. The only exception 
is when mucus content exceeds that of endometrial tissue. In this case the biopsy is discarded.  
 
B. Tissue digestion, isolation and culture of Human Endometrial Stromal Cells (HESCs) 
Note: Ensure sterility. Work in a Class II microbiological safety cabinet and ensure full aseptic 
technique. 
1. Pre-prepare digestion media and pre-warm to 37 °C in a water bath. 
2. Decant as much media as possible from the Bijoux vial into the lid of the Petri-dish without 
discarding tissue. Transfer biopsy and any remaining media into the Petri-dish (Figure 1A). 
 
 
Figure 1. Preparation of endometrial biopsies for digestion. Collect whole biopsies in 
culture media and process immediately (A). Remove all media using a manual pipette (B) before 
dicing using a down-ward tapping motion with a sterile scalpel (C) for 5 min or until pulp-like (D). 
Tissue pieces are then digested for 1 h at 37 °C with collagenase and DNase I. 
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3. Manually aspirate the excess media from around the tissue using a P1000 filter tip (Figure 1B). 
Note: Do not use an aspirator or risk losing tissue. 
4. Dice the tissue with the scalpel using a downward tapping motion for at least 5 min (Figure 1C) 
or until large pieces have disappeared and the tissue appears pulp-like (Figure 1D). 
5. Add 10 ml of digestion media to the Petri-dish through a 20 ml syringe and 0.2 µm syringe filter. 
6. Transfer the media with the tissue fragments to a 50 ml conical tube using a 10 ml serological 
pipette. 
7. Shake the tube for 15 sec and incubate at 37 °C for 1 h. Shake for 15 sec at 20 min intervals to 
aid digestion.  
8. After 1 h add 10 ml of culture media to neutralize enzymatic activity and centrifuge the tube at 
280 x g for 5 min at room temperature.  
Note: It is at this stage that epithelial cells (HEECs) (see step C) or perivascular stem-cells (see 
step D) can be isolated for separate cultures. 
9. After centrifugation, aspirate the supernatant, re-suspend the cell pellet in 15 ml of culture media 
and transfer to a 75 cm2 culture flask.  
Note: Tilt the flask gently to distribute the cell suspension evenly across the culture surface. 
Avoid rotational mixing to risk concentrating cells in the center. 
10. Incubate at 37 °C in a humidified 5% CO2 environment. 
11. Change the culture media after 6-18 h to remove blood cells, tissue debris and any unattached 
human endometrial epithelial cells (HEECs). Examination under the microscope should reveal 
sub-confluent stromal cells (Figure 2A).  
Note: Confluency will vary depending on size and quality of biopsy. At this stage (see also Figure 
6), immune cells can be collected from the supernatant and separated by antigen-specific 
magnetic separation or FACS, the details of which go beyond the remit of this protocol but 
readers are directed elsewhere (e.g., Manaster et al., 2008; Basu et al., 2009). 
12. Cells will continue to proliferate (Figure 2B) until confluent (Figure 2C). Change the culture 
media every other day until passage (see step E) or assay.  
Notes:  
a. HEEC contamination (Figure 2D) should be minimal, please refer to ‘Notes’ section. 
b. Typical HESC yields vary considerably depending on digestion efficiency, mucus and blood 
content and varying cell attachment rates, but they will correlate with the size and quality of 
the tissue. As a guide we would expect to obtain 1-5 x 105 cells from a small biopsy (< 1 
cm), 0.5-1 x 106 for an average biopsy (2-3 cm) and 1-2 x 106 for larger biopsies (> 4 cm) 
(counted 24 h after seeding). Readers are encouraged to allow cells to proliferate in culture 
until desired cell numbers are obtained. 
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Figure 2. Cultured HESCs (bright-field microscope). A. HESC culture day one post-seeding. 
B. HESC culture day 3 post-seeding. C. Confluent culture of HESCs ready for passage or 
seeding. D. Culture of HESCs contaminated by HEECs, present as a whorl-like group of cells 
in the center. 
 
C. Separation of HEECs 
1. After digestion (step B8, refer also to Figure 6), filter the cell solution through a 40 µm nylon 
mesh cell-strainer. Flow-through will contain stromal, red blood and immune cells, but 
endometrial gland clumps are retained in the strainer (Figure 3A). 
2. Back-wash the filter using 20 ml of additive-free DMEM/F12 media and collect the glandular 
clumps in a 50 ml tube (Figure 3B). 
3. Centrifuge at 280 x g for 5 min, room temperature. 
4. Aspirate the supernatant and re-suspend the pellet in 1 ml 0.25% trypsin-EDTA to dissociate 
any clumps. Glandular clumps do not attach well to substrate and can be lost during media 
changes. This additional trypsin-dissociation step differs from previous protocols (Chen and 
Roan, 2015), and increases HEEC yield by dispersing clustered cells. 
5. Incubate the tube at 37 °C for 10 min. 
6. Add 9 ml of culture media and dissociate glandular clumps by vigorous pipetting up and down. 
A single cell solution of HEECs should result. 
7. Centrifuge at 280 x g for 5 min, room temperature. 
8. Aspirate the supernatant and re-suspend and seed the HEEC as required.  
Notes:  
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a. HEEC yielding will depend on biopsy size and quality. Freshly isolated HEECs counted after 
step C8 typically yield 1-3 x 105 from small biopsies (< 1 cm), 3-9 x 105 for medium (2-3 cm) 
and 1 x 106 for large biopsies (> 4 cm). However, readers are encouraged to allow 
proliferation in culture to obtain desired numbers. 
b. The culture of HEECs requires non-standard culture techniques that go beyond the remit of 
this protocol. Readers are therefore directed elsewhere (e.g., Chan et al., 2004; Defrere et 
al., 2005; MacDonald et al., 2007). 
 
 
Figure 3. Separation and isolation of HESCs and HEECs. A. Following tissue digestion, 
collect HESCs as flow-through through a 40 μm cell strainer. B. Collect glandular epithelial 
clumps by back-washing (note inverted cell strainer) and disperse into single cell HEECs 
suspensions via trypsin incubation. 
 
D. Isolation of endometrial perivascular progenitor mesenchymal stem-like cells 
1. Following step B8 (refer also to Figure 6), aspirate the supernatant and re-suspend the pellet in 
8 ml culture media. 
2. Underlay 4 ml of Ficoll-paque to the bottom of the tube (Figure 4A). Ficoll-paque is a density 
gradient media used to separate out red blood cells.  
Note: It is important to have two distinct layers before centrifugation (Figure 4B). To underlay 
Ficoll-paque, fill a 5 ml serological pipette, but dispense only 4 ml to the bottom of the tube, thus 
avoiding expulsion of bubbles and air mixing. Discard the remaining 1 ml. Dispense the 4 ml 
slowly and turn down the speed on the pipette-aid to its slowest setting. Avoid mixing at all times 
by handling carefully. Do not mix, knock or invert.  
3. Centrifuge at 770 x g for 10 min, room temperature. Red blood cells will pellet and HESCs will 
reside within the interphase between the 2 layers (Figures 4C and 4D). 
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Figure 4. Separation of red blood cells using Ficoll-paque. A. Slowly underlay 4 ml Ficoll-
paque beneath the digested tissue. B. 2 distinct layers should be visible. C-D. After 
centrifugation, red blood cells are pelleted and HESCs and HEECs as well as immune cells 
remain in the interphase from where they can be collected. 
 
4. Carefully aspirate the majority of supernatant and collect the interphase containing the stromal 
cells and transfer to a 15 ml tube.  
5. Add 8 ml of culture media and mix well with a pipette.  
6. Wash cells free of Ficoll-paque by centrifugation (280 x g for 5 min, room temperature), 
aspiration of supernatant and resuspension in 10 ml culture media. 
7. Repeat step D6 twice more. 
8. Aspirate the supernatant and re-suspend the cell pellet in 5 ml of culture media and count the 
cells using an automated cell counter or haemocytometer. 
9. Centrifuge at 280 x g for 5 min, room temperature. 
10. Aspirate the supernatant and re-suspend the cell pellet in separation buffer (see Recipes) 
containing PE-conjugated W5C5 antibody. Use 100 µl of separation buffer and 5 µl of antibody 
per 106 cells. 
11. Mix well and incubate for 20 min in the dark at 4 °C. 
12. Wash the cells to remove unbound antibodies by adding 1 ml of separation buffer per 106 cells 
and centrifuge at 280 x g for 5 min at room temperature.  
13. Aspirate the supernatant completely and re-suspend the cell pellet in separation buffer 
containing anti-PE microbeads. Use 80 µl of buffer and 20 µl of anti-PE microbeads per 107 
cells. 
14. Mix well and incubate for 20 min in the dark at 4 °C. 
15. Wash the cells by adding 1 ml of separation buffer per 106 cells and centrifuge at 280 x g for 5 
min at room temperature. 
16. Aspirate the supernatant completely and re-suspend up to 107 cells in 500 µl of separation buffer. 
17. Place the MACS separator on the multi-stand and place the MS column in the MACS separator 
(Figure 5A). 
18. Mix the cell suspension by pipette, and apply to the column. Avoid adding air bubbles to the 
column. 
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19. Collect unlabelled cells that pass through and wash MS column by addition of 500 µl separation 
buffer three times. Only add fresh 500 µl of buffer when the column reservoir is empty. Collect 
total effluent. This is the W5C5 negative fraction.  
20. Remove the MS column from the separator and place it in a sterile 15 ml tube. 
21. Immediately add 1 ml separation buffer into the column and flush out the magnetically labelled 
cells by firmly pushing the plunger into the column (Figure 5B). Flow-through will now contain 
the W5C5 positive fraction. 
22. To increase purity of the magnetically labelled cells, repeat magnetic separation on positive 
fraction (steps D18 to D21) using a new MS column. 
23. Centrifuge at 280 x g for 5 min at room temperature. 
24. Aspirate the supernatant, re-suspend the cell pellet and seed as required. 
Although a high level of patient-to-patient variability is observed, isolated W5C5+ cells typically 
constitute between 4-8% of stromal cell populations (Murakami et al., 2013). They maintain 
many mesenchymal stem cell characteristics (Masuda et al., 2012), and can be cultured and 
differentiated (Ulrich et al., 2014) and assessed for clonogenicity using CFU (Colony Forming 
Units) assay (Masuda et al., 2012; Murakami et al., 2013; 2014) as required. 
 
 
Figure 5. Magnetic separation of endometrial perivascular progenitor mesenchymal 
stem-like cells. Following antibody-labelling of W5C5+ cells (steps D9-D15), gravity-feed cell 
suspensions through columns in the magnetic stand. The flow-through will be the negatively 
labelled fraction (A). Remove the column from the magnetic stand and flush-through W5C5 
positively labelled cells by immediate addition of 1 ml separation buffer and expulsion via the 
plunger (B). These steps can be repeated with the positive fraction using a fresh MS column to 
increase purity. 
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Figure 6. Work flow to separate different cell types within human endometrial biopsies 
 
E. Passage of HESCs 
1. Passage cells at 80-90% confluency (see Figure 2C). 
2. Pre-warm culture media, sterile PBS and 0.25% trypsin-EDTA to 37 °C in the water bath. 
3. Aspirate the culture media from the flask. 
4. Add 10 ml of PBS, rinse the cell monolayer and aspirate. 
5. Add 2 ml of 0.25% trypsin-EDTA solution, tilting the flask to ensure the solution covers the entire 
surface and return to incubator for 2-3 min or until cells have dislodged.  
Note: Cells can be loosened by gentle agitation of the flask and checked under the light 
microscope. 
6. Add 8 ml of culture medium into the flask to neutralize the trypsin and pipette the media 
repeatedly over the bottom of flask to wash any remaining cells. 
7. Transfer the cell suspension to a 15 ml tube and centrifuge for 5 min at 280 x g, room 
temperature. 
8. Re-suspend pellet in 9 ml culture media and seed 3 ml into a new 75 cm2 culture flask containing 
12 ml culture media. For maintenance of culture, cells are usually split at a ratio of 1:3, but can 
at this stage be seeded into plasticware suitable for desired experiments. 
 
Notes 
 
1. When preparing DCC-FBS the vacuum filtration stops  
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a. Filtration units are easily clogged. Avoid aspirating the charcoal from the bottom of the tube. 
b. Change the filtration system. Sometimes it takes two filter changes to accomplish total 
filtration.  
2. Culture is contaminated with epithelial cells (see Figure 2D) 
a. After biopsy digestion, (step B8) filter the solution using a 40 µm cell strainer. The stromal 
cells pass through the filter and the majority of glandular clumps are retained. 
b. Perform the first media change earlier (3 to 6 h). Most stromal cells, but few epithelial cells, 
will be attached at this time. 
c. During the passage of the contaminated flask reduce the trypsin time to 2 min. Epithelial 
cells take longer to detach. 
3. Few HESCs have attached and they are slow growing 
a. If the biopsy is too small seed the cells in a 25 cm2 culture flask instead of 75 cm2. 
b. Check for infection. The presence of a bacterial or fungal infection would restrict cell growth 
by starving cells of nutrients. Infections manifest in different forms but readers should be 
concerned by cloudy media, fungal colonies, or bacterial or fungal spores viewed under a 
light microscope. If infection is suspected, discard culture and bleach cells and media to 
avoid repeat infections. 
4. The number of cells is too low even when the biopsy was large 
a. This may be due to inadequate digestion. Ensure tissue slicing/chopping removes all large 
pieces to aid digestion.  
b. Cell loss is possible during the Ficoll-paque separation. After the centrifugation with Ficoll-
paque do not aspirate the top media phase. Transfer all media along with the interphase. 
Be sure to transfer the whole interphase even if you transfer a certain amount of Ficoll-
paque along with it. The transferred Ficoll-paque will be cleared through washing. 
 
Recipes 
 
Note: Ensure sterility. Work in a Class II microbiological safety cabinet and ensure full aseptic 
technique. 
1. Digestion media 
10 ml phenol and additive-free DMEM/F12 culture media 
0.5 mg/ml collagenase (prepare 50 mg/ml 100 µl stock aliquots) 
0.1 mg/ml DNase I (prepare 10 mg/ml 100 µl stock aliquots) 
2. Dextran-coated charcoal (DCC)-treated FBS 
a. Add 1.25 g of charcoal and 125 mg of dextran 70 to 500 ml of FBS, mix thoroughly and 
incubate at 56 °C in the water bath for 2 h, shaking every 30 min 
b. Transfer the FBS to 50 ml tubes and centrifuge at 1,800 x g, for 30 min 
c. Sterile-filter the supernatant using the vacuum-driven filtration system 
d. Aliquot to 50 ml volumes, label and store at -20 °C 
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3. Culture medium 
500 ml DMEM/F-12 with phenol red 
50 ml (10% [v/v]) DCC-FBS 
5 ml (1% [v/v]) antibiotics/antimycotics 
5 ml (1% [v/v]) L-glutamine 
1 nM β-estradiol (prepare 100 µM stock in ethanol, store at -20 °C, add 5 µl) 
2 μg/ml recombinant human insulin (prepare 10 mg/ml stock solution in acidified water [1.5%, 
v/v, acetic acid in sterile water, add 100 µl]) 
4. Separation buffer (for magnetic separation of perivascular endometrial mesenchymal stem-like 
cells [0.5% BSA in PBS]) 
Dissolve 500 mg of BSA in 100 ml of sterile 1x PBS 
Sterile-filter through 0.2 µm filter 
Store for up to a month at 4 °C before use 
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